<SEC-DOCUMENT>0001753926-25-000783.txt : 20250513
<SEC-HEADER>0001753926-25-000783.hdr.sgml : 20250513
<ACCEPTANCE-DATETIME>20250513124542
ACCESSION NUMBER:		0001753926-25-000783
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20250530
FILED AS OF DATE:		20250513
DATE AS OF CHANGE:		20250513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLEARONE INC
		CENTRAL INDEX KEY:			0000840715
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE & TELEGRAPH APPARATUS [3661]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				870398877
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33660
		FILM NUMBER:		25938667

	BUSINESS ADDRESS:	
		STREET 1:		5225 WILEY POST WAY
		STREET 2:		SUITE 500
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84116
		BUSINESS PHONE:		8019757200

	MAIL ADDRESS:	
		STREET 1:		5225 WILEY POST WAY
		STREET 2:		SUITE 500
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLEARONE COMMUNICATIONS INC
		DATE OF NAME CHANGE:	20020204

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENTNER COMMUNICATIONS CORP
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENTNER ELECTRONICS CORP
		DATE OF NAME CHANGE:	19910808
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>g084805_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:clro="http://clearoneinc.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_clro_clearoneinc.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000840715 -->
<!-- Field: Set; Name: xdx; ID: xdx_075_XDX_Z%2D%2D\XBRL JOB\2025\Q2\05 MAY\Genesis\iXBRL__ClearOne Inc. __ g084805__ DEF 14A\Out Bound\V3\Dispatch\GFHg084805__ClearOne DEF14A__V3\Ixbrl\g084805__def14a.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0000840715</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011" name="dei:EntityRegistrantName">CLEARONE INC</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0028" decimals="0" sign="-" unitRef="USD">8983000</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0034" decimals="0" sign="-" unitRef="USD">560000</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0040" decimals="0" sign="-" unitRef="USD">20556000</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0046" decimals="0" sign="-" unitRef="USD">7694000</ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="xdx2ixbrl0078" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="xdx2ixbrl0079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="xdx2ixbrl0080" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="xdx2ixbrl0086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="xdx2ixbrl0087" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="xdx2ixbrl0088" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="xdx2ixbrl0089" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="xdx2ixbrl0090" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0101" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0102" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0103" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" id="xdx2ixbrl0104" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="xdx2ixbrl0106" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="xdx2ixbrl0107" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0113" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0119" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" id="xdx2ixbrl0120" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0122" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0123" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0124" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0125" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0126" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0127" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" id="xdx2ixbrl0128" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="clro-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-05-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-05-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-252022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-25</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000840715</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000047 Footnote000050"/>
  <ix:relationship fromRefs="xdx2ixbrl0028" toRefs="Footnote000047 Footnote000051"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000047 Footnote000050"/>
  <ix:relationship fromRefs="xdx2ixbrl0034" toRefs="Footnote000047 Footnote000051"/>
  <ix:relationship fromRefs="Fact000035" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000036" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000037" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000038" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000039" toRefs="Footnote000047 Footnote000050"/>
  <ix:relationship fromRefs="xdx2ixbrl0040" toRefs="Footnote000047 Footnote000051"/>
  <ix:relationship fromRefs="Fact000041" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000042" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000043" toRefs="Footnote000047 Footnote000048"/>
  <ix:relationship fromRefs="Fact000044" toRefs="Footnote000047 Footnote000049"/>
  <ix:relationship fromRefs="Fact000045" toRefs="Footnote000047 Footnote000050"/>
  <ix:relationship fromRefs="xdx2ixbrl0046" toRefs="Footnote000047 Footnote000051"/>
  <ix:relationship fromRefs="Fact000065" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000066" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000067" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000068" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000069" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000070" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000071" toRefs="Footnote000137"/>
  <ix:relationship fromRefs="Fact000072" toRefs="Footnote000137"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b><br/>
<b>SECURITIES AND EXCHANGE COMMISSION</b><br/>
<b>WASHINGTON, DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--DocumentType_dxL_c20240101__20241231_zVYlfebwgBF1" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE
14A</span></span></b><br/>
<b>(Rule 14a-101)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE
14A INFORMATION</b><br/>
Proxy Statement Pursuant to Section 14(a) of<br/>
the Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant [X]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant [    &#160;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)).</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to &#167;240.14a-12.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center">&#160;</p>

<p id="xdx_98A_edei--EntityRegistrantName_dxL_c20240101__20241231_zEj8rXDB0T5d" title="::XDX::CLEARONE%20INC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span style="-sec-ix-hidden: xdx2ixbrl0011">ClearOne,
Inc.</span></span></b><br/>
(Name of Registrant as Specified in its Charter)<br/>
(Name of Person(s) Filing Proxy Statement, if other than Registrant)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class of securities to which transaction applies:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
    the filing fee is calculated and state how it was determined):</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    maximum aggregate value of transaction:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    fee paid:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
    fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date
    of its filing.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    Previously Paid:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form,
    Schedule or Registration Statement No.:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
    Party:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Filed: </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; color: #FF4338">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CLEARONE,
INC.</b><br/>
<b>Notice of Special Meeting in Lieu of Annual Meeting of Shareholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 83%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    30, 2025</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9:30
    a.m. Mountain time</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5225
    Wiley Post Way, Suite 500, Salt Lake City, UT 84116</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record
    date</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    9, 2025. Only shareholders of record at the close of business on the record date are entitled to receive notice of, and to
    vote at, the Special Meeting.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
    voting</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         proxy statement (&#8220;Proxy Statement&#8221;) is being furnished to the shareholders
                                         (the &#8220;Shareholders&#8221;) of ClearOne, Inc., a Delaware corporation (the &#8220;Company&#8221;
                                         or &#8220;ClearOne&#8221;), in connection with the solicitation of proxies by the Board
                                         of Directors of the Company (the &#8220;Board&#8221;) from the Shareholders for use at
                                         the Special Meeting in Lieu of Annual Meeting of Shareholders to be held at 9:30 a.m.,
                                         Mountain Time, on Friday, May 30, 2025, and any continuations, postponements or adjournments
                                         thereof (the &#8220;Special Meeting&#8221;).</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
        you plan to attend the Special Meeting, please note that for security reasons, before being admitted you must present
        your proof of stock ownership (or if you hold your shares in street name, a signed legal proxy from your bank, broker
        or other nominee giving you the right to vote your shares) and valid photo identification at the door. All hand-carried
        items will be subject to inspection, and any bags, briefcases, or packages must be checked at the registration desk prior
        to entering the meeting room. If you do not have proof of ownership and valid photo identification, you will not be admitted
        to the Special Meeting. Please also note that the use of cell phones, smartphones, pagers, recording and photographic
        equipment and/or computers is strictly prohibited at the Annual Meeting. No recording of the Special Meeting is permitted,
        including audio and video recording. If you need to obtain directions on how to attend the Special Meeting and vote in
        person, please contact our corporate offices at +1 (801) 975-7200.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMPORTANT
        NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR OUR SPECIAL MEETING IN LIEU OF ANNUAL MEETING TO BE HELD ON MAY
        30, 2025.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
        we have elected to utilize the &#8220;full set delivery&#8221; option, we are delivering to all Shareholders paper copies
        of all of our proxy materials, including a proxy card, as well as providing access to our proxy materials on a publicly
        accessible website. Our proxy statement, form of proxy card, and Annual Report on Form 10-K for the year ended December
        31, 2024 (the &#8220;2024 Annual Report&#8221;) are available online at <span style="text-decoration: underline">www.colonialstock.com/clro2024</span>.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
        or about May 13, 2025, we will have sent to our Shareholders a proxy statement, a form of proxy card, and the 2024 Annual
        Report. Whether or not you plan to attend the Special Meeting, the Company urges you to read this material carefully and
        vote your shares. Shareholders will have the opportunity to present questions, including regarding the 2024 Annual Report,
        to management at the Special Meeting, which is being held, in part, to satisfy the 2024 annual meeting requirement under
        Delaware law and our bylaws and the requirement of the Nasdaq Stock Market LLC to have held an annual meeting within twelve
        months of our fiscal year ended December 31, 2023. Accordingly, the Special Meeting is being held in lieu of and shall
        constitute the Company&#8217;s 2024 annual meeting of shareholders.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
</table>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Items
    of business</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 83%"><div style="font: 10pt Times New Roman, Times, Serif; padding: 0in 0in 0in 5pt; margin-right: 0in; margin-left: 0.25in; border-left-width: 0in; border-left-color: Black"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&#160;&#160;&#160;&#160;&#160;To
                                         elect three members of our Board of Directors;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#160;&#160;&#160;&#160;&#160;To
        approve an amendment to the Company&#8217;s Certificate of Incorporation to increase our authorized shares of Common Stock
        from 50,000,000 to 150,000,000 shares;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#160;&#160;&#160;&#160;&#160;To
        approve an amendment to approve an amendment to the Company&#8217;s Certificate of Incorporation to authorize 50,000,000
        shares of &#8220;blank check&#8221; Preferred Stock;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#160;&#160;&#160;&#160;&#160;To
        approve an amendment to the Company&#8217;s Certificate of Incorporation on or before June 2, 2025, at the discretion
        of the Board of Directors, to effect a reverse stock split of the Company&#8217;s outstanding shares of common stock by
        a ratio of between 1-for-10 to 1-for-15, with such ratio to be determined at the discretion of the Board of Directors;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#160;&#160;&#160;&#160;&#160;To
        approve an amendment to the Company&#8217;s Certificate of Incorporation to eliminate the prohibition against shareholders
        acting by written consent and expressly authorize shareholders to act by written consent;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&#160;&#160;&#160;&#160;&#160;To
        recommend, by non-binding vote, the frequency of the advisory vote on compensation of named executive officers;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&#160;&#160;&#160;&#160;&#160;To
        transact such other business as may properly come before the meeting or any adjournment thereof.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</div>

        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
        items of business are more fully described in the proxy statement accompanying this notice.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
Brewer<br/>
Chief Financial Officer and Corporate Secretary</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salt
Lake City, Utah<br/>
May 13, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="img001.jpg" alt="" style="height: 44px; width: 229px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notice
of Special Meeting in Lieu of Annual Meeting of Shareholders</b><br/>
<b>Proxy Statement </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement is solicited by and on behalf of the Board of Directors of ClearOne, Inc., a Delaware corporation (hereinafter
referred to as the &#8220;Company,&#8221; &#8220;ClearOne,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;), for
use at the Special Meeting in Lieu of Annual Meeting of Shareholders (the &#8220;Special Meeting&#8221;), to be held on May 30,
2025 at 5225 Wiley Post Way, Suite 500, Salt Lake City, UT 84116, at 9:30 A.M. local time, or at any continuations thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
proxy solicitation materials will be distributed on or about May 13, 2025 to all shareholders entitled to vote at the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUESTIONS
AND ANSWERS REGARDING THE ANNUAL MEETING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
is ClearOne distributing the proxy materials? </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearOne
has elected to utilize the &#8220;full set delivery&#8221; option. We are delivering to all shareholders paper copies of all of
our proxy materials, including a proxy card, as well as providing access to our proxy materials on a publicly accessible website.
Our proxy statement, form of proxy card, and Annual Report on Form 10-K for the year ended December 31, 2024 are available online
at <span style="text-decoration: underline">www.colonialstock.com/clro2024</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
or about May 13, 2025, we will have sent to our stockholders a proxy statement, a form of proxy card, and the Annual Report on
Form 10-K for the year ended December 31, 2024 (the &#8220;2024 Annual Report&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is the purpose of this Proxy Statement and accompanying Proxy?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Proxy Statement is a document that the regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) require us to
give you when we ask you to sign a proxy designating individuals to vote on your behalf. A proxy is your legal designation of
another person to vote the stock you own and are entitled to vote. That other person is called a proxy. If you designate someone
as your proxy in a written document, that document is also called a proxy or a proxy card. We have designated two of our officers
with full power of substitution as proxies for the Special Meeting. These officers are Derek L. Graham and Simon Brewer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors is soliciting your proxy to give all shareholders of record the opportunity to vote on matters that will be
presented at the Special Meeting. This Proxy Statement provides you with information on these matters to assist you in voting
your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is the purpose of the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Special Meeting is being held, in part, to satisfy the 2024 annual meeting requirement under Delaware law and our bylaws and the
requirement of the Nasdaq Stock Market LLC to have held an annual meeting within twelve months of our fiscal year ended December
31, 2023. Delaware law requires that we hold an annual meeting within 13 months of the end of our fiscal year, and our bylaws
require our annual meeting to be held within 13 months of the preceding year&#8217;s annual meeting. In addition, Nasdaq Listing
Rule 5620(a) requires that we hold an annual meeting of stockholders within 12 months after the end of each fiscal year. Our last
annual meeting of stockholders was held on December 28, 2023. As previously disclosed in the Company&#8217;s Form 8-K filed with
the SEC on November 25, 2024, a Special Transaction Committee (the &#8220;Special Transaction Committee&#8221;) of the Board of
Directors has been conducting a comprehensive review of strategic alternatives focused on maximizing shareholder value, including
but not limited to, equity or debt financing alternatives, merger and acquisition transactions, divestiture of assets, licensing
opportunities, joint ventures, collaborations or other partnerships with other companies, or a spin-off of the Company&#8217;s
current business and operations to its current stockholders (each, a &#8220;Strategic Transaction&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
the Special Transaction Committee and management team focused on the ongoing review of potential Strategic Transactions, the Company
determined to delay its 2024 annual meeting of stockholders (the &#8220;2024 Annual Meeting&#8221;). As a result of the delayed
2024 Annual Meeting, on January 10, 2025, the Company received a letter (the &#8220;Notice&#8221;) from the Listing Qualifications
Department (the &#8220;Staff&#8221;) of the Nasdaq Stock Market (&#8220;Nasdaq&#8221;) informing</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">the Company that because the
Company did not hold an annual meeting of stockholders in 2024, the Company is not in compliance with the requirement to conduct
an annual meeting of stockholders no later than one year after the end of its fiscal year, as set forth in Nasdaq Marketplace
Rule 5620(a) (the &#8220;Annual Meeting Requirement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to regain compliance with the Annual Meeting Requirement, the Special Meeting shall constitute the 2024 Annual Meeting.
In addition to sending our stockholders this Proxy Statement, we are also sending the 2024 Annual Report, so that at the Special
Meeting, shareholders may discuss and ask questions of Management with respect to the 2024 Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Special Meeting is to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&#160;&#160;&#160;&#160;
To elect three members of our Board of Directors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#160;&#160;&#160;&#160;
To approve an amendment to the Company&#8217;s Certificate of Incorporation to increase our authorized shares of Common Stock
from 50,000,000 to 150,000,000 shares;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#160;&#160;&#160;&#160;
To approve an amendment to approve an amendment to the Company&#8217;s Certificate of Incorporation to authorize 50,000,000 shares
of &#8220;blank check&#8221; Preferred Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#160;&#160;&#160;&#160;
To approve an amendment to the Company&#8217;s Certificate of Incorporation on or before June 2, 2025, at the discretion of the
Board of Directors, to effect a reverse stock split of the Company&#8217;s outstanding shares of common stock by a ratio of between
1-for-10 to 1-for-15, with such ratio to be determined at the discretion of the Board of Directors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#160;&#160;&#160;&#160;
To approve an amendment to the Company&#8217;s Certificate of Incorporation to eliminate the prohibition against shareholders
acting by written consent and expressly authorize shareholders to act by written consent;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&#160;&#160;&#160;&#160;
To recommend, by non-binding vote, the frequency of the advisory vote on compensation of named executive officers;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&#160;&#160;&#160;&#160;
To transact such other business as may properly come before the meeting or any adjournment thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Board of Directors does not anticipate that any other issues will come before the Special Meeting, your completed and executed
proxy gives the official proxies the right to vote your shares that you are entitled to vote in accordance with your instructions
at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is the record date for voting at the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
record date for purposes of determining the number of outstanding shares of our common stock eligible to vote at the Special Meeting,
and for determining the shareholders entitled to vote at the Special Meeting, is the close of business on May 9, 2025 (the &#8220;Record
Date&#8221;). As of the Record Date, 25,992,995 shares of common stock were issued and outstanding. No other series of stock is
outstanding. Holders of the shares of common stock have no preemptive rights. The transfer agent for the common stock is:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colonial
Stock Transfer Company, Inc.<br/>
7840 S. 700 E.<br/>
Sandy, UT 84070<br/>
Phone: 801-355-5740<br/>
Fax: 801-355-6505</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is the quorum requirement for the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum must be present at the meeting in order for the shareholders to take official action. Under Delaware law and our Certificate
of Incorporation and Bylaws, a quorum will exist if a majority of the total number of shares entitled to vote are present, in
person or by proxy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>What
is a broker non-vote and how is it counted?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
applicable rules, brokers are permitted to vote their customers&#8217; stock held in street name on routine matters when the brokers
have not received voting instructions from their customers. However, brokers are not allowed</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">to vote their customers&#8217; stock
held in street name on non-routine matters unless they have received voting instructions from their customers. In such cases,
the uninstructed shares for which the broker is unable to vote are called broker non-votes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
routine matters will be voted on at the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no routine matters on which brokers may vote in their discretion on behalf of customers who have not provided voting instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
non-routine matters will be voted on at the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the matters to be voted upon at the Special Meeting are non-routine matters on which brokers are not allowed to vote unless
they have received voting instructions from their customers. Your broker will not be allowed to vote your shares on any non-routine
matters without your specific instructions. Accordingly, it is particularly important that beneficial owners instruct their brokers
how they wish to vote their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
many votes are needed to approve each Proposal?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
all matters, except as otherwise provided by Delaware law, each holder of common stock will be entitled to one vote for each share
of common stock held on the Record Date. Assuming that a quorum is present, the votes needed to approve each Proposal are set
forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
1 &#8211; The Election of Directors: </i></b>In the election of directors, shareholders will not be allowed to cumulate their
votes. The election of directors will be determined by plurality vote. Abstentions and broker non-votes will not affect the outcome
of the election of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
2 &#8211; Amendment to Certificate of Incorporation to Increase Authorized Shares of Common Stock From 50,000,000 to 150,000,000
shares:</i></b> The approval of an amendment to our certificate of incorporation must receive &#8220;For&#8221; votes from the
holders of a majority of shares of voting capital stock issued and outstanding. Broker non-votes and abstentions will have the
same effect as an &#8220;Against&#8221; vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
3 &#8211; Amendment to Certificate of Incorporation to Authorize 50,000,0000 shares of &#8220;Blank Check&#8221; Preferred Stock:
</i></b>The approval of an amendment to our certificate of incorporation must receive &#8220;For&#8221; votes from the holders
of a majority of shares of voting capital stock issued and outstanding. Broker non-votes and abstentions will have the same effect
as an &#8220;Against&#8221; vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
4 &#8211; Amendment to Certificate of Incorporation to Authorized A Reverse Stock Split </i>by a Ratio of Between 1-for-10 to
1-for-15<i>: </i></b>The approval of an amendment to our certificate of incorporation must receive &#8220;For&#8221; votes from
the holders of a majority of shares of voting capital stock issued and outstanding. Broker non-votes and abstentions will have
the same effect as an &#8220;Against&#8221; vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
5 &#8211; Amendment to Certificate of Incorporation to Allow Shareholders to Eliminate the Prohibition Against Stockholders Acting
by Written Consent and Expressly Authorize Shareholders to Act by Written Consent: </i></b>The approval of an amendment to our
certificate of incorporation must receive &#8220;For&#8221; votes from the holders of a sixty-six and two-thirds percent (66.66%)
majority of shares of voting capital stock issued and outstanding. Broker non-votes and abstentions will have the same effect
as an &#8220;Against&#8221; vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proposal
6 &#8211; Non-Binding Advisory Vote of the Frequency of the Advisory Vote on Compensation of Named Executive Officers: </i></b>In
the non-binding advisory vote on the frequency of the advisory votes on executive compensation, the approval will be determined
by a majority of votes cast. Abstentions and broker non-votes will not affect the outcome of the non-binding advisory vote on
the frequency of the advisory votes on executive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
7 &#8211; Other Matters</b><i>: </i>Any other matter properly presented for approval by the shareholders at the Special Meeting
will generally be approved if the number of votes cast in favor of such matter exceeds the number of votes cast in opposition.
With respect to any such matter, abstentions and broker non-votes are not likely to affect the outcome of a vote on such matter.
We are not currently aware of any other matters to be presented at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
are the Board of Director&#8217;s recommendations on the Proposals?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors recommends that shareholders cast their votes on the Proposals as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         1 &#8211; &#8221;FOR&#8221; </b>the election of all three director nominees;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         2 &#8211; &#8221;FOR&#8221; </b>the approval of the amendment to our certificate of incorporation
                                         to increase the authorized shares of Common Stock from 50,000,000 to 150,000,000 shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         3 &#8211; &#8221;FOR&#8221; </b>the approval of the amendment to our certificate of incorporation
                                         to authorize 50,000,000 shares of &#8220;Blank Check&#8221; Preferred Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         4 &#8211; &#8221;FOR&#8221; </b>the approval of the amendment to our certificate of incorporation
                                         to authorize a reverse stock split by a ratio of between 1-for-10 to 1-for-15;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         5 &#8211; &#8221;FOR&#8221; </b>the approval of the amendment to our certificate of incorporation
                                         to eliminate the prohibition against shareholders acting by written consent and expressly
                                         authorize shareholders to act by written consent;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         6 &#8211; &#8221;EVERY THREE YEARS&#8221;</b> for the non-binding advisory vote of the
                                         frequency of the advisory vote on compensation of named executive officers; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                         7 &#8211; &#8220;FOR&#8221;</b> such other matters properly presented by the Board of
                                         Directors for approval by the Shareholders at the Special Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is the difference between a &#8220;shareholder of record&#8221; and a &#8220;street name&#8221; holder?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
terms describe how your shares are held. If your shares are registered directly in your name with Colonial, our transfer agent,
you are a &#8220;shareholder of record.&#8221; If your shares are held in the name of a brokerage, bank, trust or other nominee
as a custodian, you are a &#8220;street name&#8221; holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Will
I get more than one copy of the proxy statement or annual report if there are multiple shareholders at my address?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, only one copy of this proxy statement or 2024 Annual Report is being delivered to multiple shareholders sharing an
address unless we have received contrary instructions from one or more of the shareholders. We will deliver promptly, upon a written
or oral request, a separate copy of this proxy statement or the 2024 Annual Report to a shareholder at a shared address to which
a single copy of the document was delivered. Shareholders sharing an address may also submit requests for delivery of a single
copy of the proxy statement or 2024 Annual Report, but in such event will still receive separate proxies for each account. To
request separate or single delivery of these materials now or in the future, a shareholder may submit a written request to the
Corporate Secretary, ClearOne, Inc., 5225 Wiley Post Way, Suite 500, Salt Lake City, Utah 84116 or a shareholder may make a request
by calling the Corporate Secretary at (801) 975-7200, or by contacting our transfer agent, Colonial Stock Transfer Company, Inc,
7840 S. 700 E., Sandy, UT 84070 or calling (801) 355-5740.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
do I vote?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares of common stock are held in street name by a broker, bank or other nominee, you will receive information from your
nominee as to how to instruct them to vote your shares of common stock for each of the Proposals discussed in this proxy statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a shareholder of record and hold common stock in your own name, you may give instructions on how to vote your shares of
common stock by following the instructions on the proxy card on how to vote over the Internet, by phone, or by mail by completing,
signing, dating and returning the proxy card.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
completing and submitting the proxy (whether over the internet, by telephone, or by signing, dating and mailing the accompanying
proxy card), the shareholder authorizes Derek L. Graham, Chief Executive Officer, and Simon Brewer, Corporate Secretary and Chief
Financial Officer, as designated on the face of the proxy, to vote all shares for the shareholder. All proxies that are properly
completed and submitted will be voted as the shareholder directs. If no direction is given, executed proxies will be voted FOR
the election of all three director nominees, FOR</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Proposals 2, 3, 4, 5 and 7, and &#8220;EVERY THREE YEARS&#8221; for the non-binding
advisory vote on the frequency of the advisory votes on compensation of our names executive officers. Votes will be tabulated
by Colonial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
do I revoke my proxy?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may revoke your proxy before the vote is taken at the Special Meeting by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">completing,
    signing and submitting a new proxy with a later date;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attending
    the Special Meeting and voting in person; or</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">filing
    a signed, written notice of revocation with the Corporate Secretary of the Company.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
attendance at the Special Meeting will not automatically revoke your proxy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the common stock you own is held on your behalf by a broker, bank or other nominee, you must contact the nominee to receive instructions
as to how you can revoke your proxy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may obtain an additional proxy card by writing to Corporate Secretary, ClearOne, Inc., 5225 Wiley Post Way, Suite 500, Salt Lake
City, Utah 84116.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Where
can I find the voting results of the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will announce the preliminary voting results at the Special Meeting and disclose the final voting results in a current report
on Form 8-K filed with the SEC within four (4) business days of the date of the Special Meeting, unless only preliminary voting
results are available at that time. To the extent necessary, we will file an amended report on Form 8-K to disclose the final
voting results within four business days after the final voting results are known. You may access or obtain a copy of these and
our other reports filed with the SEC free of charge on our web site at <i>http://www.clearone.com</i>. Also, such Form 8-K, any
amendments thereto and other reports we file with the SEC are available to you over the Internet at the SEC&#8217;s web site at
<i>http://www.sec.gov</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
can I view the shareholder list?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
complete list of shareholders of record entitled to vote at the Special Meeting will be available for viewing during ordinary
business hours for a period of ten (10) days before the Special Meeting at our offices located at 5225 Wiley Post Way, Suite 500,
Salt Lake City, Utah 84116.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
pays for the proxy solicitation related to the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will bear the costs of the solicitation. The solicitation of proxies by the Board of Directors will be conducted primarily by
mail and through the Internet. Additionally, our officers, directors and employees may solicit proxies personally or by telephone,
email or other forms of wire or facsimile communication. These officers, directors and employees will not receive any extra compensation
for these services. We may reimburse brokers, custodians, nominees and fiduciaries for reasonable expenses incurred by them in
forwarding proxy material to beneficial owners of our common stock as of the record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
can I obtain a copy of the 2024 Annual Report?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will be mailing the 2024 Annual Report along with a proxy statement and a proxy card. We will also provide, without charge, a
printed copy of our 2024 Annual Report, to each shareholder of record as of the record date that requests a copy in writing. Any
such requests should be directed to our Corporate Secretary at our corporate offices set forth in this proxy statement.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may also access or obtain a copy of our 2024 Annual Report and other reports filed with the SEC free of charge on our web site
at http://www.clearone.com, or at the SEC&#8217;s web site at http://www.sec.gov. The 2024 Annual Report contains financial and
other information about our company but is not incorporated into this proxy statement and is not to be considered a part of these
proxy soliciting materials or subject to Regulations 14A or 14C or to the liabilities of Section 18 of the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The information contained in the &#8220;Audit and Compliance Committee
Report&#8221; shall not be deemed &#8220;filed&#8221; with the Securities and Exchange Commission or subject to Regulations 14A
or 14C or to the liabilities of Section 18 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. </b>1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ELECTION
OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and bylaws provide that our Board of Directors shall consist of not less than three or more than
nine members as determined by the Board of Directors or our shareholders from time to time. The Board of Directors has currently
fixed the number of directors at four. The term of each of our directors expires at the Special Meeting. As previously disclosed
in the Company&#8217;s Current Report on Form 8-K as filed with the SEC on November 25, 2024, Larry Hendricks advised the Board
of Directors that he would not stand for re-election to the Board at the next annual or special meeting of stockholders at which
directors are elected. Mr. Hendricks&#8217; decision to not stand for re-election was not the result of any disagreement with
the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have nominated current directors Ms. Higley, Mr. Robinson and Mr. Whaley for election at the meeting to serve until the next annual
meeting of shareholders or until their respective successors are duly elected and qualified. In the event any nominee is unable
to serve, the proxies will be voted for a substitute nominee, if any, to be designated by our Board of Directors. The Board of
Directors has no reason to believe any nominee will be unable or will decline to serve as a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; ELECTION OF THE DIRECTOR NOMINEES NAMED HEREIN.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
and Nominees for Director</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding our three nominees for election as directors at the Special Meeting,
including our three current directors continuing in office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
    <br/>
Since </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 39%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric.
    L Robinson </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 10%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Director <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 10%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
    B. Higley </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce
    Whaley </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019
    </span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the Audit and Compliance Committee, Compensation Committee and Nominating Committee. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eric.
L Robinson</b> has served as a director of our company since July 2015 and was named Chairman of the Board in February 2022. Mr.
Robinson spent fourteen years in private practice as a corporate attorney, including eleven years as a partner in the Salt Lake
City, Utah law firm of Blackburn &amp; Stoll, LC. Mr. Robinson&#8217;s law practice focused on securities, corporate and other
business transactions. For the past five years, Mr. Robinson has been principally employed by MicroPower Global Limited, a company
in the semiconductor business, OUR Rescue, Inc. and as a private attorney. At MicroPower, Mr. Robinson acted as General Counsel,
Chief Financial Officer and a director. At OUR Rescue, Inc. he acts as VP of Legal Affairs. Mr. Robinson also maintains a law
practice and serves as counsel to a number of companies in the fields of regenerative medicine and commercial construction. Mr.
Robinson previously served as chief financial officer, in-house counsel, secretary and treasurer of ActiveCare, Inc. from July
2016 until his voluntary resignation in June 2017, and subsequent to Mr. Robinson&#8217;s departure, ActiveCare filed a voluntary
bankruptcy petition under Chapter 11 of the U.S. Bankruptcy Code on July 15, 2018. His legal practice included working with companies
in connection with public and private offerings of securities, corporate partnering, mergers and acquisitions, licensing technology
transfer, contracts and construction. He graduated from the University of Utah with honors with a B.S. degree in accounting and
he subsequently passed the CPA exam (unlicensed). He graduated from Vanderbilt University with a J.D. where he graduated Order
of the Coif and acted as a Managing Editor of the Law Review. Mr. Robinson has previously served as corporate and securities legal
counsel to the Company and the Company&#8217;s largest shareholder, E. Dallin Bagley.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lisa
B. Higley </b>was appointed a director of our Company effective July 20, 2020. Ms. Higley has been self-employed as a CPA since
June 2009. Previously, she was the CFO for Daisy D&#8217;s Paper Company from March 2007 until January 2009, where she managed
all aspects of the company&#8217;s financial and accounting responsibilities. Additionally, Ms. Higley was the CFO for Tunex International
from April 2006 to March 2007 where she was accountable for all financial aspects of the corporation. Prior to that, Ms. Higley
was a staff tax accountant at Wisen, Smith, Racker &amp; Prescott LLP from February 2004 to April 2006. Ms. Higley earned her
Bachelor of Science in</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Accounting from the University of Oregon and her MBA from Utah State University, and has been a Utah CPA
since 2004. Ms. Higley is the daughter of Edward D. Bagley, our former Chairman of the Board. Mr. Edward D. Bagley beneficially
owns 49.60% of our issued and outstanding common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Bruce
Whaley</b> was appointed a director of our Company effective April 16, 2019. Mr. Whaley has extensive experience as a stockbroker
for nearly five decades. Mr. Whaley is currently a broker trading at Wilson &amp; Davis, a regional brokerage firm based in Salt
Lake City, Utah. He has been with Wilson &amp; Davis since 1988. Until March 2023, Mr. Whaley also held a real estate license
and worked as a real estate agent for Coldwell Banker. Mr. Whaley attended the University of Utah between 1968 and 1971 and studied
many subjects including business administration, accounting and finance. He did not graduate with a degree.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CORPORATE
GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
Relating to Corporate Governance and the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has determined, after considering all the relevant facts and circumstances, that Messrs. Hendricks, Robinson
and Whaley are independent directors, as &#8220;independence&#8221; is defined by the listing standards of NASDAQ. This determination
was made because Messrs. Hendricks, Robinson and Whaley have no relationship with us that would interfere with their exercise
of independent judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has an Audit and Compliance Committee, a Compensation Committee, and a Nominating Committee, each consisting
entirely of independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has adopted charters for the Audit and Compliance, Compensation and Nominating Committees describing the authority
and responsibilities delegated to each committee by the Board. We post on our website at <i>www.clearone.com</i> the charters
of our Audit and Compliance, Compensation and Nominating Committees, our Code of Ethics, and any amendments or waivers thereto
and any other corporate governance materials contemplated by SEC or NASDAQ regulations. These documents are also available in
print to any shareholder requesting a copy in writing from our Corporate Secretary at our corporate offices located at the address
set forth in this proxy statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Leadership Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that there is no one best leadership structure model that is most effective in all circumstances. The Board adheres
to a flexible approach to the question of whether to separate the positions of Chairman and Chief Executive Officer (&#8220;CEO&#8221;)
and the necessity of a lead independent director, and will consider a variety of factors in making a decision, including, but
not limited to, the current performance of the Company and the experience, knowledge and temperament of the Chief Executive Officer.
The Board remains flexible and committed to a strong corporate governance structure and board independence. The Board is committed
to adopting corporate management and governance policies and strategies that promote our effective and ethical management. In
this regard, the Board strongly believes that it should have maximum flexibility in deciding whether the offices of Chairman and
Chief Executive Officer are combined or separate and, if separate, whether the Chairman should be an independent director or an
employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
roles of Chairman and Chief Executive Officer were separated in February 2022 when Mr. Robinson was named Chairman of the Board
in light of Mr. Robinson&#8217;s leadership, experience, and knowledge of the Company and its shareholders. The Board determined
and continues to believe that it was in our best interests and our stockholders&#8217; best interests to separate the roles of
Chairman and Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chief Executive Officer and the independent directors have different perspectives and roles in strategy development. The Chief
Executive Officer brings Company-specific experience and expertise, while the Company&#8217;s independent directors bring experience,
oversight, and expertise from outside the Company and its industry. The Board believes its independent directors provide effective
oversight of management, and that the separation of Chief Executive Officer and Chairman together with a Board whose majority
of directors are independent, provides the appropriate balance between independent oversight of management and the development
of strategy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Board
Role in Risk Oversight</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board of Directors is responsible for overseeing the management of the business and affairs of the Company, but delegates day-to-day
management of the Company to the Chief Executive Officer and our executive management team. The Board of Directors is generally
responsible for risk oversight, and the Audit and Compliance Committee assists the Board in fulfilling its responsibilities for
general oversight of risk assessment and risk management. In addition, the other Board committees are also tasked with specific
risk oversight functions pursuant to the terms of the committee charters or applicable NASDAQ rules. The Board as a whole and
the various standing committees, in performing their respective risk oversight functions, have access to our company&#8217;s management
team and external advisors, as necessary, and receive periodic presentations and reports from management, and incidental reports
as matters arise with respect to strategic, operational, financial, legal or other risks and the plans management has to control
such risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
and Compliance Committee.</b> The Audit and Compliance Committee meets to review and discuss our accounting practices and procedures
with management and independent public accountants and to review our quarterly and annual financial statements. The Audit and
Compliance Committee assists the Board of Directors in fulfilling its responsibility for oversight of the quality and integrity
of our accounting, auditing, and reporting practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit and Compliance Committee&#8217;s primary duties include reviewing the scope and adequacy of our internal accounting and
financial controls; reviewing the independence of our independent registered public accounting firm; approving the scope of our
independent registered public accounting firm&#8217;s audit activities; approving the fees of our independent registered public
accounting firm; approving any non-audit related services; reviewing the audit results; reviewing the objectivity and effectiveness
of our internal audit function; and reviewing our financial reporting activities and the application of accounting standards and
principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Audit and Compliance Committee are Eric L. Robinson (Chairman), Larry R. Hendricks and Bruce Whaley. Each member
of the audit committee, in addition to being independent under the standards of NASDAQ, is independent under the standards of
the Securities and Exchange Commission&#8217;s rules and regulations pertaining to listed company audit committees. The Board
of Directors has determined that Eric L. Robinson is an &#8220;audit committee financial expert&#8221; in accordance with applicable
rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee.</b> The Compensation Committee is responsible for overseeing, reviewing, and approving our executive compensation and
benefit programs and administers the Company&#8217;s equity incentive plans for employees. Under its charter, the Compensation
Committee may delegate authority to subcommittees of the Compensation Committee or to executive officers of the Company, particularly
the President and CEO with respect to compensation determinations for persons who are not executive officers of the Company. The
members of the Compensation Committee are Bruce Whaley (Chairman), Larry R. Hendricks and Eric L. Robinson.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation objectives for executive officers are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    attract and retain highly qualified individuals capable of making significant contributions to the long-term success of our
    company; </span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    use incentive compensation to reinforce strategic performance objectives; </span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    align the interest of our executives with the interests of our shareholders such that the risks and rewards of strategic decisions
    are shared; and </span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    reflect the value of each officer&#8217;s position in the marketplace and within our company. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Policies
and Practices Related to ClearOne&#8217;s Compensation Program</i>. We strive to create an overall compensation package for each
executive officer that satisfies the aforementioned objectives, recognizing that certain elements of compensation are better suited
to reflect different compensation objectives. For example, as base salaries are the only element of compensation that are fixed
in amount in advance of the year in which the compensation will be earned, the Compensation Committee believes that it is most
appropriate to determine base salaries with a focus on the market practices for similarly situated officers at comparable companies
as adjusted to reflect the individual officer&#8217;s performance during the preceding year. In contrast, cash bonuses and long-term
incentives are better able</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">to reflect our company&#8217;s performance as measured by financial metrics and are well-suited to
motivate officers to achieve specific performance goals that the Compensation Committee has determined are in the best interests
of our company. Equity grants are also well-suited to drive long-term performance and align management&#8217;s interests with
those of shareholders. The Compensation Committee believes that as an officer&#8217;s responsibility increases, so does his or
her ability to influence the performance of our company and accordingly, the proportion of his or her compensation that consists
of his or her salary and cash bonus should decrease while the proportion of equity incentives to total compensation should increase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Comparable
Companies</i>. In making compensation decisions, including assessing the competitiveness of the total compensation structure for
each named executive officer, the Compensation Committee considers compensation survey data from companies that the Compensation
Committee has selected as comparable in terms of industry, size and location. The Compensation Committee periodically reviews
the companies that are included as comparable companies and makes revisions to the group as appropriate. The Compensation Committee
also reviews executive compensation information for several Utah based publicly-traded companies having revenues similar to those
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000013" name="ecd:AwardTmgMnpiDiscTextBlock"><p id="xdx_841_eecd--AwardTmgMnpiDiscTextBlock_zHfIXq293Jp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Equity
Grant Practices</i>. The Compensation Committee recognizes the importance of equity ownership in the alignment of shareholder
and management interests. The exercise price of each stock option awarded to our executive officers under our incentive compensation
programs is equal to the closing price of our common stock on the date of grant, which is the date when the Compensation Committee
acts to approve equity awards for senior executives. Performance-based equity awards are also granted to our named executive officers
at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Compensation Committee establishes the criteria, and directs the implementation, of all compensation program elements for the
executive officers. The Compensation Committee considers the Chief Executive Officer&#8217;s appraisal of other executive officers&#8217;
general performance and looks especially to performance against predetermined goals before making its recommendation to the Board
of Directors. <span id="xdx_909_eecd--AwardTmgMethodTextBlock_c20240101__20241231_zJtJubIV0rEh" title="Award Timing Method" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000015" name="ecd:AwardTmgMethodTextBlock">The Chief Executive Officer recommends for the Compensation Committee&#8217;s approval the stock option <span id="xdx_90A_eecd--AwardTmgPredtrmndFlag_dbT_c20240101__20241231_zFbkr6XPFoPa" title="Award Timing Predetermined" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000017" name="ecd:AwardTmgPredtrmndFlag">grants</ix:nonNumeric></span> and
compensation related to achievement of non-quantitative goals under non-equity-based incentive plans for other executive officers</ix:nonNumeric></span>.
The Compensation Committee did not employ any compensation consultants during the year ended December 31, 2024.</span></p>

</ix:nonNumeric><p id="xdx_851_z8pHSCVR7c95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
Committee.</b> The Nominating Committee is responsible for overseeing the nomination of our directors. The Nominating Committee
selects, evaluates, and recommends to the full Board of Directors qualified candidates for election to the Board of Directors.
The members of the Nominating Committee are Larry R. Hendricks (Chairman), Eric L. Robinson, and Bruce Whaley.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors will consider recommendations by shareholders for director nominees if the names of those nominees and relevant
biographical information are submitted in writing to our company&#8217;s Secretary in the manner described for shareholder nominations
below under the heading &#8220;Shareholder Proposals.&#8221; The Nominating Committee identifies and evaluates nominees for our
Board of Directors, including nominees recommended by shareholders, based on numerous factors it considers appropriate, some of
which may include strength of character, mature judgment, career specialization, relevant technical skills, diversity, and the
extent to which the nominee would fill a present need on our Board of Directors. Although the Nominating Committee does not have
a formal policy with regard to the consideration of diversity in identifying director nominees, the Nominating Committee strives
to nominate directors with a variety of complementary skills so that, as a group, the Board will possess the appropriate talent,
skills and expertise to oversee the Company&#8217;s business. All director nominations, whether submitted by a shareholder, the
Nominating Committee, or the Board of Directors, will be evaluated in the same manner. All of the current nominees for director
were recommended by the Nominating Committee and nominated by the Board of Directors. All director nominees have consented to
serve as directors, if elected, until the next annual meeting of shareholders or until their successors are elected and qualified
and have consented to be named as nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Special
Transaction Committee.</b> In November 2024, the Board of Directors formed a Special Transaction Committee, consisting of Larry
R. Hendricks, Eric L. Robinson and Bruce Whaley as its members. to oversee the Board&#8217;s comprehensive review of strategic
alternatives focused on maximizing shareholder value, including but not limited to, equity or debt financing alternatives, merger
and acquisition transactions, divestiture of assets, licensing opportunities, joint ventures, collaborations or other partnerships
with other companies, or a spin-off of the Company&#8217;s current business and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Board
and Committee Meetings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
Board of Directors held a total of 9 meetings in 2024. No director attended fewer than 75% of the aggregate of (i) the total number
of meetings of the Board of Directors; and (ii) the total number of meetings held by all committees of the Board of Directors
on which such director was a member. Although we currently have no formal policy with respect to the attendance of members of
the Board of Directors at the Annual Meetings of Shareholders, we encourage each of our directors to attend each annual meeting
of shareholders. To that end, and to the extent reasonably practicable, we regularly schedule a meeting of the Board of Directors
on the same day as our annual meeting of shareholders. All members of our current Board of Directors attended the 2023 Annual
Meeting of Shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
2024, the Audit and Compliance Committee held 4 meetings, the Compensation Committee held 3 meetings, the Nominating Committee
held no meetings and the Special Transaction Committee held no meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Diversity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify; text-indent: 35.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we and our Board benefit from diversity with respect to professional background, education, race, ethnicity, gender,
age and geography, as well as other individual qualities and attributes that contribute to the total mix of viewpoints and experience
represented on our Board. Although our Board of Directors does not maintain a specific policy with respect to Board diversity,
our Board of Directors believes that the Board should be a diverse body, and the Nominating and Corporate Governance Committee
considers a broad range of perspectives, backgrounds and experiences when considering whether to recommend the nomination of any
particular director candidate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify; text-indent: 35.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
    Diversity Matrix (as of April 25, 2025) </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Number of Directors: </b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4
    </b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Female
    </b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Male
    </b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Binary
    </b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Did
    Not Disclose Gender </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gender:
    </b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Demographic
    Background: </b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">African
    American or Black </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alaskan
    Native or Native American </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asian
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hispanic
    or Latinx </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Native
    Hawaiian or Pacific Islander </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
    or More Races or Ethnicities </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Did
    Not Disclose Demographic Background </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0
    </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.7pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.7pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
16(a) Beneficial Ownership Reporting Compliance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.7pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Securities Exchange Act, of 1934 as amended, requires our directors, executive officers and persons who own more
than 10% of a registered class of our equity securities to file with the SEC initial reports of ownership on Form 3 and reports
of changes of ownership of our equity securities on Forms 4 and 5. Officers, directors, and greater than 10% shareholders are
required to furnish us with copies of all Section 16(a) reports they file. Based solely on a review of the reports furnished to
us for the year ended December 31, 2024, we believe that each person who, at any time during such fiscal year was a director,
officer, or beneficial owner of more than 10% of our common stock complied with all Section 16(a) filing requirements during such
period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors adopted a code of ethics that applies to our Board of Directors, executive officers, and employees. The Company&#8217;s
Code of Ethics is posted on our website at www.clearone.com.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider
Trading Policies and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_908_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240101__20241231_zbRjRTxbn2k2" title="Insider Trading Policies and Procedures Adopted" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000019" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">adopted</ix:nonNumeric></span> a Statement of Policy Regarding Compliance with Insider Trading Laws (the &#8220;Insider Trading Policy) that
establishes policies and procedures governing the purchase, sale, and/or other dispositions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s securities
by directors, officers and employees. The Insider Trading Policy requires compliance with all applicable laws, rules and regulations
governing the offer and sale of securities and prohibits directors, officers and employees from engaging in transactions in the
Company&#8217;s securities while in possession of material nonpublic information. The Insider Trading Policy establishes quarterly
blackout periods during which trading in the Company&#8217;s securities is prohibited. These blackout periods begin 15 days prior
to the end of each fiscal quarter and ends at the opening of trading on the first business day after the public dissemination
of Company&#8217;s financial results for that quarter for a full trading day. In addition, the Insider Trading Policy requires
senior officers and key employees to obtain pre-approval of any transactions in Company securities from the Company&#8217;s Compliance
Officer under the Insider Trading Policy, which currently is the Interim Chief Financial Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nomination
Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">No
changes have been made to the procedures by which our shareholders may recommend nominees to our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
and Compliance Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a separate Audit and Compliance Committee and its members are Eric L. Robinson (Chairman), Larry R. Hendricks and
Bruce Whaley. The Board of Directors has determined that Eric L. Robinson is an &#8220;audit committee financial expert&#8221;
and each member is independent in accordance with applicable rules and regulations of NASDAQ and the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officer
    <br/>
Since </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 39%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derek
    L. Graham </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
    Brewer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Corporate Secretary </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derek
L. Graham </b>is our Chief Executive Officer. He was appointed as Interim CEO in May 2022 and was confirmed as the permanent CEO
in January 2023. He joined our company in July 2003 as Lead Engineer for Conferencing Cameras. In 2004, he was promoted to Engineering
Operations Manager. In 2006, he was promoted to Director of Research and Development. In 2007, he was promoted to Sr. Director
of Research and Development. In 2009, he was promoted to Vice President of Research and Development. In 2011, he was promoted
to Sr. Vice President of Research and Development. In those prior roles, Derek was responsible for funding, staffing, and execution
of parallel engineering programs that resulted in successful development of professionally installed audio and video conferencing,
video streaming, wireless microphone, digital signage, and camera products. Derek is a named inventor on 13 patents. Prior to
joining ClearOne, Derek held engineering and management positions at Intel Corporation in the areas of audio conferencing and
telephony technologies. Mr. Graham earned a Bachelor of Science in Electrical Engineering, with highest honors, and a Master&#8217;s
Degree in Electrical Engineering from the Georgia Institute of Technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Simon
Brewer</b> was appointed as Chief Financial Officer of ClearOne Inc. in April 2024, bringing over 25 years of experience in finance,
operations, and leadership across technology, manufacturing, e-commerce, biotech, and non-profit sectors. He oversees the company&#8217;s
finance and accounting functions, helping drive strategic initiatives to position ClearOne for scalable growth. Prior to ClearOne,
Mr. Brewer was CFO and COO at an international non-profit dedicated to eradicating human trafficking (2021&#8211;2024), and CFO
at Predictive Technology Group Inc. (2018&#8211;2021), leading its transition to a public company. He also held CFO roles at Norbest
LLC (2016&#8211;2018) and senior finance and IT positions at Wilson Electronics (2013&#8211;2016) and Backcountry.com (2009&#8211;2013),
consistently achieving revenue growth and operational efficiencies. Mr. Brewer transitioned to a dedicated accounting career at
KPMG LLP (2005&#8211;2009), managing audits and advisory for high-profile clients, after beginning his career in 1999 as a programmer
and accountant at Prospect Planet Dotcom. He holds a Master of Accounting and a Bachelor of Arts in Accounting (Cum Laude) with
a Minor in Russian from the University of Utah and is a Certified Public Accountant (CPA) in Utah and Nevada and a Chartered Global
Management Accountant (CGMA).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the compensation paid or earned by each named executive officer for the years ended December 31, 2024
and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY
COMPENSATION TABLE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Principal Position </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity
    Incentive Plan Compensation </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Other Compensation </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derek
    Graham, Chief Executive Officer <sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended December 31, 2024 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238,621
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,336
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,096<sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,053
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended December 31, 2023 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,147
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,900
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000<sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,047
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Simon
    Brewer - Chief Financial Officer <sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended December 31, 2024 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193,846
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,560
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,406
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended December 31, 2023 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derek
    L. Graham was appointed as Interim CEO on May 24, 2022 and became permanent CEO on Jan 26, 2023. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
    Brewer was appointed Chief Financial Officer on April 15, 2024. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonuses
    reflect achievement of specific performance metrics approved by the Compensation Committee. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information on the holdings of stock options by the named executive officers as of December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    </b></span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Securities <br/>
Underlying <br/>
Unexercised Options </b></span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td colspan="2" rowspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    <br/>
Exercise Price ($) </b></span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" rowspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Grant <br/>
Date </b></span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td colspan="2" rowspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    <br/>
Expiration <br/>
Date </b></span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable
    </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derek
    Graham </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.500
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12-14-2020
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12-14-2026
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000<sup></sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><sup>(1)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.010
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06-15-2023
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">06-15-2029
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000<sup></sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><sup>(2)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.490
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-27-2024
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-26-2030
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
    Brewer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000<sup></sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><sup>(2)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.490
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-27-2024
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-26-2030
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One-third
    of the shares underlying each stock option vest on the first anniversary of the grant date and the remaining shares vest equally
    over a period of 24 months following the first anniversary of the grant date. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of the shares underlying each stock option vest on the first anniversary of the grant date or upon a change of control; whichever
    occurs first. </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>OPTION
EXERCISES AND STOCK VESTED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no exercises of stock options by named executive officers during 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Payments Upon Termination or Change in Control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Agreements. </i>As of the year ended December 31, 2024, none of our named executive officers was party to an employment or severance
agreement with us, and each named executive officer&#8217;s employment was on an &#8220;at-will&#8221; basis, permitting either
us or the executive to terminate his or her employment for any reason or for no reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accelerated
Stock Option Vesting Upon a Change in Control</i>. For certain option grants to executive officers and directors, in the event
of a change in control, all of such optionee&#8217;s unvested stock options will vest and become exercisable immediately prior
to the event or the closing of the transaction causing the change in control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the option grants, a &#8220;<i>Change in Control&#8221;</i> means a change in ownership or control of the Company effected through
either of the following transactions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the acquisition, directly or indirectly, by any person or related group of persons (other than the Company or a person that directly
or indirectly controls, is controlled by, or is under common control with, the Company), of beneficial ownership (within the meaning
of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of
the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s shareholders,
or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a change in the composition of the Board over a period of thirty-six (36) consecutive months or less, such that a majority of
the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who
either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office
at the time the Board approved such election or nomination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise set forth in an option grant, in the event of a change in control of our company, the Board of Directors has the
sole authority to elect that the vesting of each outstanding option automatically accelerate so that each such option shall, immediately
prior to the effective date of the corporate transaction, become fully exercisable for all of the shares of common stock at the
time subject to such option and may be exercised for any or all of those shares as fully vested shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
our stock price of about $[0.5325] per share on April 25, 2025, none of our named executive officers would benefit from any potential
accelerated vesting of unvested stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the compensation paid to non-employee directors for the year ended December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
    Earned or <br/>
Paid in Cash </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
    <br/>
Compensation </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Larry
    R. Hendricks </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,400
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,400
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
    B. Higley </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,500
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,500
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    L. Robinson </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,200
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,200
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce
    Whaley </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,400
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,400
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
directors are reimbursed by the Company for their out-of-pocket travel and related expenses, if any, incurred in attending all
Board of Directors and committee meetings. However, during 2024 no expenses were reimbursed to any director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize that transactions between us and any of our directors, executives or other related persons can present potential or
actual conflicts of interest and create the appearance that our decisions are based on considerations other than the best interests
of our Company and shareholders. Therefore, as a general matter and in accordance with our Code of Ethics, it is our preference
to avoid such transactions. Nevertheless, we recognize that there are situations where such transactions may be in, or may not
be inconsistent with, the best interests of our Company. Under the terms of its charter, our Audit and Compliance Committee reviews
and, if appropriate, approves or ratifies any such transactions. Pursuant to the charter, the Committee will review any transaction
in which we are or will be a participant and the amount involved exceeds $120,000, and in which any of our directors or executives
had, has or will have a direct or indirect material interest. After its review, the Committee will only approve or ratify those
transactions that are in, or are not inconsistent with, the best interests of our Company and our shareholders, as the Committee
determines in good faith. The Company&#8217;s Board of Directors adopted the Company&#8217;s Related Party Transactions Policy
on January 18, 2017. This policy is available on our website at http://investors.clearone.com/corporate-governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions: Consulting Agreement with Edward D. Bagley</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2015, the Company entered into a Consulting Agreement with Edward D. Bagley, former Chairman of the Board and greater
than 10% shareholder (&#8220;Consulting Agreement&#8221;) which became effective on July 29, 2015 for an initial term of three
years which was renewed in 2018 for an additional term of three years and renewed again in 2021 for an additional term of 3 years
through 2024. Pursuant to the terms of the Consulting Agreement Mr. Bagley is paid a fee of $5,000 per month and is eligible to
participate in our equity incentive programs and will be granted stock options commensurate with grants of stock options made
to our directors. During 2024, he was paid $65,000 as consulting fees. During 2024, he did not receive any grant of stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has determined, after considering all the relevant facts and circumstances, that Larry Hendricks, Eric Robinson
and Bruce Whaley are independent directors, in accordance with the definition of &#8220;independence&#8221; under the listing
standards of NASDAQ, because they have no relationship with us that would interfere with their exercise of independent judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has an Audit and Compliance Committee, a Compensation Committee, a Nominating Committee, and a Special Transaction
Committee, each consisting entirely of independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>AUDIT
AND COMPLIANCE COMMITTEE REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Audit and Compliance Committee of the Board of Directors is comprised of three directors, all of whom are independent as defined
in NASDAQ and SEC rules and regulations. The members of the Audit and Compliance Committee are Eric L. Robinson (Chair), Larry
R. Hendricks, and Bruce Whaley. Eric L. Robinson is the Board of Directors&#8217; designated &#8220;audit committee financial
expert&#8221; as that term is defined in the securities laws. The Audit and Compliance Committee serves as an independent and
objective party to monitor and provide general oversight of the Company&#8217;s financial accounting and reporting process, selection
of critical accounting policies, system of internal control, internal audit function, audit process for monitoring compliance
with laws and regulations and the Company&#8217;s standards of business conduct. The Audit and Compliance Committee performs these
oversight responsibilities in accordance with its charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s management has primary responsibility for preparing the Company&#8217;s financial statements and the Company&#8217;s
financial reporting process, including its system of internal control over financial reporting. The Company&#8217;s independent
registered public accountants, Tanner LLC, are responsible for expressing an opinion on the conformity of the Company&#8217;s
2024 audited financial statements to accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Audit and Compliance Committee discussed with the Company&#8217;s independent registered public accountants the overall scope
and plans for its audits. The Audit and Compliance Committee met with the Company&#8217;s independent registered public accountants,
with and without management present, to discuss the results of their examinations, their evaluations of the Company&#8217;s internal
control over financial reporting, and the overall quality of the Company&#8217;s financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this context, the Audit and Compliance Committee hereby reports as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&#160;&#160;&#160;&#160;
The Audit and Compliance Committee has reviewed and discussed the 2024 audited financial statements with the Company&#8217;s management,
including the quality, not just the acceptability, of the Company&#8217;s accounting principles, the reasonableness of significant
judgments, and the clarity of disclosures in the financial statements;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#160;&#160;&#160;&#160;
The Audit Committee has discussed with the Company&#8217;s independent registered public accountants the matters required to be
discussed by the applicable requirements of the Public Company Accounting Oversight Board and the Securities and Exchange Commission;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#160;&#160;&#160;&#160;
The Audit and Compliance Committee has received the written disclosures and the letter from the Company&#8217;s independent registered
public accountants required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent
registered public accountant&#8217;s communications with the Audit and Compliance Committee concerning independence, and has discussed
with the Company&#8217;s independent registered public accountants the independent registered public accountants&#8217; independence
from management and the Company; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#160;&#160;&#160;&#160;
Based on the review and discussions referred to in paragraphs (1) through (3) above, the Audit and Compliance Committee recommended
to the Board of Directors (and the Board of Directors has approved) that the audited financial statements be included in the Company&#8217;s
Annual Report on Form 10-K for the year ended December 31, 2024, which were filed with the Securities and Exchange Commission
on March 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Audit and Compliance Committee Report does not constitute soliciting material and shall not be deemed filed or incorporated
by reference into any other Company filing under the Securities Act of 1933, as amended, or Exchange Act, except to the extent
the Company specifically incorporates this Audit and Compliance Committee Report by reference therein. Each of the members of
the Audit and Compliance Committee is independent as defined under the standards of the NASDAQ Capital Market and the Securities
and Exchange Commission, and meets all other requirements of such exchange and of such rules of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Respectfully
submitted by the members of the Audit and Compliance Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
L. Robinson (Chair), Larry R. Hendricks and Bruce Whaley</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000021" name="ecd:PvpTableTextBlock"><p id="xdx_80D_eecd--PvpTableTextBlock_dU_zCdGZOumUPA8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAY
VERSUS PERFORMANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_988_eecd--Additional402vDisclosureTextBlock_c20240101__20241231_z5vbjxqxEUcg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000022" name="ecd:Additional402vDisclosureTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 953(a) of the Dodd-Frank Act and Item 402(v) of SEC Regulation S-K, we are providing the following information about
the relationship between executive &#8220;compensation actually paid&#8221; (or &#8220;CAP&#8221;), as defined by SEC rules, to
the Company&#8217;s principal executive officer (&#8220;PEO&#8221;) and non-PEO named executive officer (the &#8220;Non-PEO NEOs&#8221;)
and certain aspects of the financial performance of the Company. The Compensation Committee does not utilize CAP as the basis
for making compensation decisions.</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding <b>pay <span style="color: #252525">versus performance</span></b> as
of December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_307_zKvkjphnUBCe" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
    <sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
    </b><br/>
    <b>Compensation </b><br/>
    <b>Table Total </b><br/>
    <b>for PEO ($) <sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    </b><br/>
    <b>Actually Paid </b><br/>
    <b>to PEO ($) <sup>(3)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
    Compensation <br/>
Table Total <br/>
for Non-PEO NEO <br/>
($) <sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    <br/>
Actually Paid <br/>
to Non-PEO <br/>
NEO ($) <sup>(3)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ClearOne</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder</b><br/>
        <b>Return ($) <sup>(4)</sup></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income (Loss) </b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000) <sup>(5)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td id="xdx_987_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEpKDIp_zKZkMbQt60Vf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,053</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_fKDEpKDMp_zrAJkg0U8RCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="0" unitRef="USD">301,654</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEpKDIp_zaUFirdKEGL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">313,016</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDEpKDMp_zRToSV5od2zd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">346,567</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--TotalShareholderRtnAmt_c20240101__20241231_fKDEpKDQp_zC0vievn2Urc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_dxL_c20240101__20241231_fKDEpKDUp_zk0Umzwpha67" title="::XDX::-8983000" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0028">(8,983</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEpKDIp_z7dZGVZfxyX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">366,047</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDEpKDMp_zefMaHFoZlWj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">366,476</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEpKDIp_zS0qesyw9Wh6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,940</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDEpKDMp_zH6KK4rf15p3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">324,129</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--TotalShareholderRtnAmt_c20230101__20231231_fKDEpKDQp_zCdLGP4yhkok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-31" id="Fact000033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_dxL_c20230101__20231231_fKDEpKDUp_ztJ0gyOHgeQ5" title="::XDX::-560000" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0034">(560</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEpKDIp_z5chmf2WeW47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">557,277</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDEpKDMp_zk9KQNqddKW5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">532,457</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEpKDIp_zGUJQibgNuSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDEpKDMp_zoJpt6h6OjSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">222,409</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--TotalShareholderRtnAmt_c20220101__20221231_fKDEpKDQp_zRpuB6tx2Kg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--NetIncomeLoss_dxL_c20220101__20221231_fKDEpKDUp_zYtnSTDvfPCa" title="::XDX::-20556000" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0040">20,556</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEpKDIp_zJrYtK1zF6ge" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,750</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKDEpKDMp_zOnO9sOKd7ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">378,848</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEpKDIp_zdGI7hg4Rjsk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">251,625</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKDEpKDMp_zfELDaCihS59" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-01-012021-12-31" id="Fact000044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,684</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--TotalShareholderRtnAmt_c20210101__20211231_fKDEpKDQp_zBIxb2JNU3Rb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2021-01-012021-12-31" id="Fact000045" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57</ix:nonFraction>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLoss_dxL_c20210101__20211231_fKDEpKDUp_zGTbYnMA4MBe" title="::XDX::-7694000" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0046">(7,694</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; width: 0.3in; visibility: hidden"><span id="xdx_F06_zz3oS2A8Jhpg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F1B_zejlcHmtQpPg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><ix:footnote id="Footnote000047" xml:lang="en-US">Zeynep
    Hakimoglu served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. Derek L. Graham
    served as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO
    NEO for 2021, 2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting
    April 17, 2024. &#160;</ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F07_zaAaXyETk6Bc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F15_zNjgxfPMlYag" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><ix:footnote id="Footnote000048" xml:lang="en-US">Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#8220;SCT&#8221;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. </ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F04_zoHHm6RBVyW6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(3)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F11_zfUjOVmZwz4h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><ix:footnote id="Footnote000049" xml:lang="en-US">Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. </ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F06_zEsHeG9JWfxa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(4)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F11_zu3zMLy0CcNi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><ix:footnote id="Footnote000050" xml:lang="en-US">Total
    Shareholder Return (&#8220;TSR&#8221;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. </ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F0D_zN7vWGotiKVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(5)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F1E_zYSQZBxFL9D4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><ix:footnote id="Footnote000051" xml:lang="en-US">The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. </ix:footnote></span></td></tr>
</table>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000053" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_846_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIHNkDeAmKH6" style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in">(1)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90B_eecd--PeoName_c20210101__20211231_zc8nXPLn9QD1"><span id="xdx_90B_eecd--PeoName_c20220101__20220524_zW16YPtlQJk8"><ix:nonNumeric contextRef="From2021-01-012021-12-31" id="Fact000054" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-05-24" id="Fact000055" name="ecd:PeoName">Zeynep Hakimoglu</ix:nonNumeric></ix:nonNumeric></span></span> served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. <span id="xdx_900_eecd--PeoName_c20240101__20241231_zDhwQLISGaU5"><span id="xdx_90D_eecd--PeoName_c20230101__20231231_ztC3eFAM8tTh"><span id="xdx_90E_eecd--PeoName_c20220525__20221231_zX92O3nknRK6"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000056" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-31" id="Fact000057" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-05-252022-12-31" id="Fact000058" name="ecd:PeoName">Derek L. Graham</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span> served
as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO NEO for 2021,
2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting April 17, 2024.</td></tr>
</table>

</ix:nonNumeric><p id="xdx_856_z3BMs82CEOYd" style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#8220;SCT&#8221;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. </span></td></tr>
</table>

<ix:exclude><p id="xdx_239_zubPPgBPV1C8" style="margin: 0">&#160;</p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>











































<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>




<ix:exclude><p id="xdx_23C_zDfNAld5uhx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Shareholder Return (&#8220;TSR&#8221;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. </span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_818_z2NnvNKSqtNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
reconciliation of the adjustments for PEOs (Zeynep Hakimoglu and Derek L. Graham) and for Non-PEO NEOs (Narsi Narayanan and Simon
Brewer) is set forth in the following table, which describes the adjustments, each of which is prescribed by the SEC rules, to
calculate the CAP from SCT amounts. Equity values are calculated in accordance with FASB ASC 718.</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000062" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_840_eecd--AdjToPeoCompFnTextBlock_dU_zktbON4pGhN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000064" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_895_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zw5UFPqMe3Dg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_303_zjvMQTE3PX8c" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b>&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Compensation Table
    Total<sup>(1)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEp_ztIEVFc6FXAg" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,053</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEp_zFPmHf2vIwqj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">313,016</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zs2jyxiUvAid" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">366,047</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEp_znd71MrwH95c" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,940</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zCqWFJsTt7R9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">557,277</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEp_zkQD2Vnx0Co9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zVTwDOePmla1" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,750</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEp_zhYv502HjhBj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">251,625</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(-) Grant Date Fair Value of Option Awards Granted
    in Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_znKNoIZXEsub" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,336</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zVc01fFMYQPc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">40,560</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zq34aOVQdG94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="Fact000075" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,900</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zGd3guyWU8Gl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" id="Fact000076" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,600</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zIANvmwVty55" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0077">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zAIi2qc9MMa1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0078">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_ztwx085tLj71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0079">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zvvIvGUGwn7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0080">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Fair Value at Fiscal Year End of Outstanding
    and Unvested Option Awards Granted in Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zZxr8Fsx34qd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,466</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znqZFeJo54Ih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,111</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHmKunO23AH5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,637</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znuQY7veDSDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" id="Fact000084" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,697</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zy7s2t0gBNna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0085">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zBKbaang0jij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0086">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zqrafkcuAcH3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0087">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zIDYUORb0Pjg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0088">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Change in Fair Value of Outstanding and
    Unvested Option Awards Granted in Prior Fiscal Years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zwoVAV218org" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0089">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z2EIQc5WZRug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0090">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zIgiQtYUlTme" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="Fact000091" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,309</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zqfSUrmqcYpj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="Fact000092" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,926</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zvdjqdD8nBZk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">22,059</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zkX0zoAL3LNf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="Fact000094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,600</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z4V364rvF1ye" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="Fact000095" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">43,666</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zNnR0wAjszf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" id="Fact000096" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,200</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Fair Value at Vesting of Option Awards Granted
    in Fiscal Year that Vested During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_znrA0X8DAk48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0097">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zlx3MMLgiKu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0098">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zdrOO2zhcnU8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0099">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zV6tkOMW46Of" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0100">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zDI6thyn3B15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0101">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zgcSl3baLeD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0102">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zYcJbkfnMQih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0103">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_z2QDDjF2SUPh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0104">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Change in Fair Value as of Vesting Date
    of Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zysPhLGdjCRf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="Fact000105" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,529</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zrcLuTUJm3a8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0106">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zm6kMphRlx5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0107">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zFzkm9XlUjjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,588</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zAcF1aiDI3O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="Fact000109" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,761</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_z0GLaxEzulb5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="Fact000110" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,991</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zDu1oRGQ3MLc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="Fact000111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,764</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zGohn6Bl0isf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,259</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(-) Fair Value as of Prior Fiscal Year End of
    Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zotxkpBz5QL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0113">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zleyzy3NohWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zj6ZlravDgui" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0115">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zLfrp7KWOThk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0116">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zeUVwtb205Rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ztozsQZraVr1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zJOtatw5hSt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ziwbjX4D5jX5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0120">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Value of Dividends or other Earnings Paid
    on Stock or Option Awards Not Otherwise Reflected in Fair Value or Total Compensation for the Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zJi6E5UgPrMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMNENFfHkyia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0122">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zOT8D8xZCAG" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0123">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zc00AY3wS4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0124">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zwY27UfvKNL6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0125">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zbL6TbuFEaa4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0126">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zvLNBkFrSD77" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0127">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zP7UBF0gL6X3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0128">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Actually Paid</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zhs5glIOxzo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">301,654</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_ztgmL40trfU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">346,567</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zBOPWg0YxqNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">366,476</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zVKATGF2znuh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">324,129</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_zgGURNbWeN4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">532,457</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zA1NR0PhJkL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">222,409</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_z4I0ZThw5uDi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-01-012021-12-31" id="Fact000135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">378,848</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_zZRQn6mBJ7b3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-01-012021-12-31" id="Fact000136" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,684</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.35in; text-align: left"><span id="xdx_F0F_zO3McgkuRBwj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1C_zk49F7torW5c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000137" xml:lang="en-US">Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A0_zHdolzGOK756" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_859_zHCl4jVfRKE7" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Item 402(v) of SEC Regulation S-K, we are providing the following graphic descriptions of the relationships between information
presented in the pay versus performance table provided above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000139" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_84C_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKG2IF5OZYmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between CAP and Total Shareholder Return (&#8220;TSR&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Non-PEO NEO CAP and our TSR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><img src="img002.jpg" alt=""/></span></p>

</ix:nonNumeric><p id="xdx_85B_zepD84DGYJag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000141" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_84E_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zDtRPUQV0v12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between CAP and Net Income (Loss)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Non-PEO NEO CAP and Net Income (Loss) <b><sup>1</sup></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><img src="img003.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
the amount of net income (loss) reported in the Company&#8217;s audited financial statements for the applicable year.</span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_852_zXvR4IoqRFB" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 2</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMENDMENT
TO CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES <br/>
OF COMMON STOCK FROM 50,000,000 TO 150,000,000 SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has unanimously adopted a resolution (i) approving an amendment to our Certificate of Incorporation to increase
the authorized number of shares of Common Stock from 50,000,000 shares to 150,000,000 shares, par value of $0.001 per share (the
&#8220;Increase in Authorized Shares&#8221;) and (ii) directing that the Increase in Authorized Shares be submitted to the shareholders
for approval at the Special Meeting. Approval of the Increase in Authorized Shares will grant the Board of Directors the authority,
without further action by the shareholders, to carry out the amendment to the Certificate of Incorporation after the date shareholder
approval for the amendment is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the Record Date, 25,992,995 shares of our Common Stock were issued and outstanding, 569,016 unissued shares of Common Stock
are reserved for issuance in connection with outstanding options to purchase Common Stock, and 5,022,123 unissued shares of Common
Stock are reserved for issuance in connection with outstanding warrants to purchase Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights
of Additional Authorized Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional shares of Common Stock resulting from the Increase in Authorized Shares, if and when issued, would be part of the existing
class of Common Stock and would have rights and privileges identical to our Common Stock currently outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Advantages of the Increase in Authorized Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that the authorized number of shares of Common Stock should be increased to provide sufficient shares
of Common Stock for such corporate purposes as may be determined by our Board of Directors to be necessary or desirable. Although
the Company has not entered into any definitive plans, arrangements, or understandings for the remaining portion of the authorized
but unissued shares of Common Stock that will be available following the Increase in Authorized Shares, the Company expects to
do so in the near future to obtain external financing to provide additional working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
authorized, the additional shares of Common Stock may be issued with approval of our Board of Directors but without further approval
of our shareholders, unless applicable law, rule or regulation requires shareholder approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Disadvantages of the Increase in Authorized Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
issuances of Common Stock or securities convertible into Common Stock could have a dilutive effect on the earnings per share,
book value per share, voting power and percentage interest of holdings of current shareholders. In addition, the availability
of additional shares of Common Stock for issuance could, under certain circumstances, discourage or make more difficult efforts
to obtain control of the Company. The Board of Directors is not aware of any attempt, or contemplated attempt, to acquire control
of the Company. This proposal is not being presented with the intent that it be used to prevent or discourage any acquisition
attempt, but nothing would prevent the Board of Directors from taking any appropriate actions not inconsistent with its fiduciary
duties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Procedure
for Effecting the Increase in Authorized Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this proposal is approved by our shareholders, our Board of Directors will cause the Increase in Authorized Shares to be implemented
by filing an amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware. The Increase
in Authorized Shares will become effective on the date that it is filed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Discretionary
Authority of the Board of Directors to Abandon the Increase in Authorized Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board of Directors reserves the right to abandon the Increase in Authorized Shares without further action by our shareholders
at any time before the effectiveness of the amendment to the Certificate of Incorporation, even if the Increase in Authorized
Shares has been authorized by our shareholders at the Special Meeting. By voting in favor</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">of the Increase in Authorized Shares,
you are expressly also authorizing our Board of Directors to determine not to proceed with, and abandon, the Increase in Authorized
Shares if it should so decide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
Relating to the Increase in Authorized Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
form of the amendment to our Certificate of Incorporation relating to this Proposal No. 2 and Proposal No. 3, which we would file
with the Secretary of State of the State of Delaware to effect the Increase in Authorized Shares and the Preferred Stock Authorization
described herein below under Proposal No. 3, is attached to this proxy statement as <span style="text-decoration: underline">Appendix A</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Effects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Increase in Authorized Shares is not motivated by anti-takeover concerns and is not considered by our Board of Directors to
be an anti-takeover measure, the availability of additional authorized shares of Common Stock could enable the Board of Directors
to issue shares defensively in response to a takeover attempt or to make an attempt to gain control of our company more difficult
or time-consuming. For example, shares of Common Stock could be issued to purchasers who might side with management in opposing
a takeover bid that the Board of Directors determines is not in the best interests of our shareholders, thus diluting the ownership
and voting rights of the person seeking to obtain control of our company. In certain circumstances, the issuance of Common Stock
without further action by the shareholders may have the effect of delaying or preventing a change in control of the company, may
discourage bids for our Common Stock at a premium over the prevailing market price and may adversely affect the market price of
our Common Stock. As a result, increasing the authorized number of shares of our Common Stock could render more difficult and
less likely a hostile takeover of our company by a third-party, or a tender offer or proxy contest, assumption of control by a
holder of a large block of our stock, and the possible removal of our incumbent management. We are not aware of any proposed attempt
to take over the company or of any present attempt to acquire a large block of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of shareholders that represent a majority of the shares of voting capital stock issued and outstanding is required
to approve the Increase in Authorized Shares. Abstentions and broker non-votes will be treated as votes against the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE APPROVAL OF THE INCREASE IN AUTHORIZED SHARES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 3</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF AMENDMENT TO CERTIFICATE OF INCORPORATION TO AUTHORIZE 50,000,000 <br/>
SHARES OF &#8220;BLANK CHECK&#8221; PREFERRED STOCK.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has unanimously adopted (i) a resolution approving an amendment to our Certificate of Incorporation to authorize
50,000,000 shares of &#8220;blank check&#8221; Preferred Stock, par value $0.001 per share (the &#8220;Preferred Stock Authorization&#8221;)
and (ii) directing that the Preferred Stock Authorization be submitted to the shareholders for approval at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this proposal is approved, and the Preferred Stock is authorized, it may be issued, from time to time, as authorized by the Board
of Directors in one or more series, in such numbers of shares, with such designations, powers, including voting powers, full or
limited, or no voting powers, preferences, and relative, participating, optional, or other special rights, qualifications, limitations,
and restrictions as the Board of Directors determines. The powers, preferences, and relative, participating, optional, or other
special rights of each series of Preferred Stock, and any qualifications, limitations, or restrictions of a series may differ
from those of any other series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has determined that the Preferred Stock Authorization proposal is in the best interests of the Company and
recommends approval by shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Advantages of the Preferred Stock Authorization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has adopted the proposed amendment to provide maximum financial and strategic flexibility with respect to future
financing transactions as well as providing liquidation preferences for all existing holders of Common Stock in connection with
any potential strategic transactions. Preferred Stock is commonly authorized by publicly traded companies and can be used as a
preferred means of raising capital or ensure liquidation preferences to one or more classes of shareholders. In some circumstances,
companies, including ours, have been required to issue senior classes of securities to raise capital, with the terms of those
securities being negotiated and tailored to meet the needs of both investors and issuing companies. Such senior securities often
include liquidation preferences and dividend rights, conversion privileges and other rights not found in Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the proposal is approved, and our Certificate of Incorporation is amended, our Board of Directors would be able to issue the additional
shares of authorized Preferred Stock with such designations, preferences and relative, participating, optional, conversion or
other special rights (if any) of such series and the qualifications, limitations or restrictions (if any) thereof, as the Board
of Directors may in the future establish by resolution or resolutions and by filing a certificate pursuant to the Delaware General
Corporation Law (a &#8220;Preferred Stock Designation&#8221;), from time to time, providing for the issuance of such Preferred
Stock. No vote of the holders of our Common Stock or Preferred Stock, unless otherwise expressly provided in the Certificate of
Incorporation or in a Preferred Stock Designation creating any series of Preferred Stock or, to the extent the Company chooses
to comply with any limiting rules of any securities exchange or quotation system on which shares of our common or Preferred Stock
are then listed or traded, will be a prerequisite to the issuance of any series of Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the proposed amendment will not alter or modify the rights, preferences, privileges or restrictions of outstanding shares of
our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Disadvantages of the Preferred Stock Authorization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authorized but unissued shares of Preferred Stock may generally be issued from time to time for such proper corporate purposes
as may be determined by our Board or, as required by law or the rules of the Nasdaq Stock Market, with the approval and authorization
of our shareholders. Our Board does not intend to solicit further shareholder approval prior to the issuance of shares of Preferred
Stock, except as may be required by applicable law or by the rules of the Nasdaq Stock Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
possible future issuance of shares of our Preferred Stock or securities convertible or exercisable into our Preferred Stock could
affect our current shareholders in a number of ways. The issuance of new shares of Preferred Stock could cause immediate dilution
of the ownership interests and the voting power of our existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">New issuances of Preferred Stock may also affect
the number of dividends, if any, paid to such shareholders and may reduce the share of the proceeds that they would receive upon
the future liquidation, if any, of the company.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the future issuance of shares of our Preferred Stock or securities convertible or exercisable into shares of our Preferred
Stock could:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dilute
the market price of our Common Stock, to the extent that the shares of Common Stock are issued and sold at prices below current
trading prices, or, if the issuance consists of securities convertible or exercisable into Common Stock, to the extent that the
securities provide for the conversion or exercise into Common Stock at prices that could be below current trading prices of the
Common Stock, which dilution, in each case, may increase the volatility and affect the market value of our trading securities&#894;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dilute
the earnings per share, if any, and book value per share of the outstanding shares of our Common Stock&#894; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
the payment of dividends on Common Stock, if any, potentially more expensive.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">No
specific shares of Preferred Stock are being designated at this time, and we do not currently have any plans to issue shares of
Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Effects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the proposed amendment is not motivated by anti-takeover concerns and is not considered by the Board to be an anti-takeover measure,
the availability of authorized shares of Preferred Stock could enable the Board to issue shares defensively in response to a takeover
attempt or to make an attempt to gain control of the Company more difficult or time-consuming. For example, Preferred Stock could
be issued to purchasers who might side with management in opposing a takeover bid which the Board determines is not in the best
interests of the Company and its shareholders, thus diluting the ownership and voting rights of the person seeking to obtain control
of the Company. In certain circumstances, issuing Preferred Stock without further action by the shareholders may delay or prevent
a change of control of the Company, may discourage bids for the Company&#8217;s Common Stock or Preferred Stock at a premium over
the market price of the Common Stock or Preferred Stock, and may adversely affect the market price of the Common Stock or Preferred
Stock. Thus, increasing the authorized Preferred Stock could render more difficult and less likely a hostile merger, tender offer,
or proxy contest, assumption of control by a holder of a large block of the Company&#8217;s stock, and the possible removal of
the Company&#8217;s incumbent management. We are not aware of any proposed attempt to take over the Company or of any attempt
to acquire a large block of our stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Appraisal Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware General Corporation Law, the Company&#8217;s shareholders are not entitled to appraisal rights with respect to the proposed
amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Procedure
for Implementing the New Class of Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this proposal is approved by our shareholders, our Board of Directors will cause the &#8220;Blank Check&#8221; Stock Authorization
to be implemented by filing an amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware.
The Preferred Stock Authorization will become effective on the date that it is filed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discretionary
Authority of the Board to Abandon Preferred Stock Authorization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors reserves the right to abandon the Preferred Stock Authorization without further action by our shareholders
at any time before the effectiveness of the amendment to the Certificate of Incorporation, even if the Authorization has been
authorized by our shareholders at the Special Meeting. By voting in favor of the Authorization, you are expressly also authorizing
our Board to determine not to proceed with, and abandon, the Preferred Stock Authorization if it should so decide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
Relating to the Preferred Stock Authorization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
form of the amendment to our Certificate of Incorporation relating to this Proposal No. 3 and Proposal No. 2, which we would file
with the Secretary of State of the State of Delaware to effect the Preferred Stock Authorization</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">and the Increase in Authorized
Shares described herein above under Proposal No. 2, is attached to this proxy statement as <span style="text-decoration: underline">Appendix A</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of shareholders that represent a majority of the shares of voting capital stock issued and outstanding is required
to approve the Preferred Stock Authorization. Abstentions and broker non-votes will be treated as votes against the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221; THE PROPOSAL TO AUTHORIZE A NEW CLASS OF &#8220;BLANK CHECK&#8221;
PREFERRED STOCK</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 4</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Approval
of an Amendment to the CERTIFICATE OF INCORPORATION to effect A <br/>
reverse stock split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors is requesting shareholder approval of an amendment to our Certificate of Incorporation to effect a reverse
stock split of our outstanding Common Stock at a reverse stock split ratio ranging from any whole number between 1-for-10 and
1-for-15 (the &#8220;Reverse Stock Split&#8221;), subject to and as determined by the Board of Directors, by June 2, 2025. Our
Board of Directors has unanimously approved and declared advisable the amendment relating to the Reverse Stock Split and recommends
that our shareholders approve the amendment. The new language shall be added to Section (b) of Article III of our Certificate
of Incorporation and contained in an amendment to effect the Reverse Stock Split attached to this proxy statement as <span style="text-decoration: underline">Appendix
B</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary reason we are seeking shareholder approval of the Reverse Stock Split is to attempt to increase the per share market price
of our Common Stock to meet the minimum per share bid price requirements for continued listing on The Nasdaq Capital Market. We
believe that if the Reverse Stock Split proposal is not approved by our shareholders, it is possible that our Common Stock will
be delisted from The Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our shareholders approve this proposal, then we will cause an amendment to our Certificate of Incorporation to be filed with the
Delaware Secretary of State and effect the Reverse Stock Split if and only if our Board of Directors subsequently determines that
the Reverse Stock Split would be in the best interests of the Company and its shareholders. As filed, the amendment would state
the number of outstanding shares to be combined into one share of our Common Stock, at the ratio approved by our Board of Directors
within the range approved by our shareholders. Following the shareholders&#8217; approval of this Proposal No. 4, no further action
on the part of the shareholders will be required to either implement or abandon the Reverse Stock Split and the Board of Directors
may effect and implement the Reverse Stock Split at any time prior to June 2, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors also may determine, in its sole discretion, not to effect the Reverse Stock Split and not to file the related
amendment. Although we presently intend to effect the Reverse Stock Split to regain compliance with The Nasdaq Capital Market&#8217;s
minimum bid price requirement, our Board of Directors has reserved the right, notwithstanding our shareholders&#8217; approval
of the proposed amendment of the Certificate of Incorporation, to abandon the proposed amendment at any time (without further
action by our shareholders) before the amendment of the Certificate of Incorporation is filed with the Secretary of State of the
State of Delaware. Our Board of Directors may consider a variety of factors in determining whether or not to proceed with the
proposed amendment of the Certificate of Incorporation, including overall trends in the stock market, recent changes and anticipated
trends in the per-share market price of our Common Stock, rule changes and/or guidance from Nasdaq, business developments, and
our actual and projected stock price performance. If the closing bid price of our Common Stock on The Nasdaq Capital Market reaches
a minimum of $1.00 per share and remains at or above that level for a minimum of ten consecutive trading days (or longer, if required
by the Nasdaq Listing Qualifications Panel), as discussed more fully below, our Board of Directors may decide to abandon the filing
of the proposed amendment of the Certificate of Incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the Record Date, there were 25,992,995 shares of our Common Stock issued and outstanding, 569,016 unissued shares of Common
Stock are reserved for issuance in connection with outstanding options to purchase Common Stock, and 5,022,123 unissued shares
of Common Stock are reserved for issuance in connection with outstanding warrants to purchase Common Stock. Based on such number
of shares of our Common Stock issued and outstanding, immediately following the effectiveness of the Reverse Stock Split, we will
have, depending on the Reverse Stock Split ratio selected by our Board, issued and outstanding shares of stock as illustrated
by the table under the caption &#8220;Effects of the Reverse Stock Split &#8211; Effect on Shares of Common Stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split will not change the number of authorized shares of our Common Stock or the relative voting power of such holders
of our outstanding Common Stock. The relative number of authorized but unissued shares of our Common Stock will materially increase
and will be available for issuance by the Company. The Reverse Stock Split, if effected, would affect all holders of our Common
Stock uniformly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of our Common Stock would be issued as a result of the Reverse Stock Split. Instead, any shareholders who would
have been entitled to receive fractional shares as a result of the Reverse Stock Split would</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">receive one whole share of Common
Stock in lieu of such fractional shares. Each holder of our Common Stock would hold the same percentage of the outstanding Common
Stock immediately following the Reverse Stock Split as that shareholder did immediately prior to the Reverse Stock Split. The
par value of our Common Stock would continue to be $0.001 per share (see &#8220;Effects of the Reverse Stock Split &#8211; Reduction
in Stated Capital&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is publicly traded and listed on The Nasdaq Capital Market under the symbol &#8220;<b>CLRO</b>&#8221;. Our primary
objective in effectuating the Reverse Stock Split would be to attempt to raise the per-share trading price of our Common Stock
to continue our listing on The Nasdaq Capital Market. To maintain listing, The Nasdaq Capital Market requires, among other things,
that our Common Stock maintain a minimum closing bid price of $1.00 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2024, we received a written notice (&#8220;Notice&#8221;) from Nasdaq stating that we are not currently in compliance
with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing
Rule 5550(a)(2) because our Common Stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive
business days (&#8220;Minimum Bid Price Requirement&#8221;). The Notice indicated that, consistent with Nasdaq Listing Rule 5810(c)(3)(A),
we had 180 days, or until December 17, 2024, to regain compliance with the Minimum Bid Price Requirement by having the minimum
bid price of our Common Stock meet or exceed $1.00 per share for at least ten consecutive business days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 18, 2024, the Company received a letter from Nasdaq advising that the Company has been granted a 180-day extension to
June 16, 2025 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing bid price for our Common Stock on The Nasdaq Capital Market since June 20, 2024 has continued to be below $1.00 per share.
We strongly encourage you to vote in favor of this Proposal No. 4 to increase the likelihood that compliance may be achieved prior
to action being taken to delist us from The Nasdaq Capital Market in the event that the closing bid price for our Common Stock
does not become compliant with the Minimum Bid Price Requirement prior to June 16, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are seeking shareholder approval for the authority to effectuate the Reverse Stock Split as a means of increasing the share price
of our Common Stock at or above $1.00 per share in order to attempt to avoid delisting by Nasdaq, in the event we are not able
to satisfy the minimum bid price requirement in adequate time before the deadline. We expect that the Reverse Stock Split would
increase the bid price per share of our Common Stock above the $1.00 per share minimum price for the required number of days,
thereby satisfying this listing requirement. However, there can be no assurance that the Reverse Stock Split would have that effect,
initially or in the future, or that it would enable us to maintain the listing of our Common Stock on The Nasdaq Capital Market.
We are not aware of any present efforts by anyone to accumulate our Common Stock, and the proposed Reverse Stock Split is not
intended to be an anti-takeover device.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we believe that the low per-share market price of our Common Stock impairs its marketability to, and acceptance by,
institutional investors and other members of the investing public and creates a negative impression of the Company. Theoretically,
decreasing the number of shares of our Common Stock outstanding should not, by itself, affect the marketability of the shares,
the type of investor who would be interested in acquiring them or our reputation in the financial community. In practice, however,
many investors, brokerage firms and market makers consider low-priced stocks as unduly speculative in nature and, as a matter
of policy, avoid investment and trading in such stocks. Moreover, the analysts at many brokerage firms do not monitor the trading
activity or otherwise provide coverage of lower-priced stocks. The presence of these factors may be adversely affecting, and may
continue to adversely affect, not only the price of our Common Stock but also its trading liquidity. In addition, these factors
may affect our ability to raise additional capital through the sale of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the decrease in the number of shares of our outstanding Common Stock because of the Reverse Stock Split, and the
anticipated increase in the price per share, would possibly promote greater liquidity for our shareholders with respect to their
shares. However, liquidity may be adversely affected by the reduced number of shares that would be outstanding if the Reverse
Stock Split is effected, particularly if the price per share of our Common Stock begins a declining trend after the Reverse Stock
Split is effectuated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
can be no assurance that the Reverse Stock Split would achieve any of the desired results. There also can be no assurance that
the price per share of our Common Stock immediately after the Reverse Stock Split would increase proportionately with the Reverse
Stock Split, or that any increase would be sustained for any period of time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
believe the Reverse Stock Split is the most likely way to support the price of our Common Stock in reaching the minimum bid level
required by The Nasdaq Capital Market, although effecting the Reverse Stock Split cannot guarantee that we would be in compliance
with the minimum bid price requirement for even the minimum ten-day trading period. In addition, the Reverse Stock Split cannot
guarantee we would be in compliance with the other criteria required to maintain our listing on the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
evaluating whether to seek shareholder approval for the Reverse Stock Split, our Board of Directors took into consideration negative
factors associated with reverse stock splits. These factors include: the negative perception of reverse stock splits that investors,
analysts and other stock market participants may hold; the fact that the stock prices of some companies that have effected reverse
stock splits have subsequently declined, sometimes significantly, following their reverse stock splits; the possible adverse effect
on liquidity that a reduced number of outstanding shares could cause; and the costs associated with implementing a reverse stock
split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Even
if our shareholders approve the Reverse Stock Split, our Board of Directors reserves the right not to effect the Reverse Stock
Split if in our Board&#8217;s opinion it would not be in the best interests of the Company or our shareholders to effect such
Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Criteria
the Board May Use to Determine Whether to Implement the Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
determining whether to implement the Reverse Stock Split, and which Reverse Stock Split ratio to implement, if any, following
the receipt of shareholder approval, the Board of Directors may consider various factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         historical trading price and trading volume of our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         then-prevailing trading price and trading volume of our Common Stock and the expected
                                         impact of the Reverse Stock Split on the trading market for our Common Stock in the short-
                                         and long-term;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         listing requirements, other rules and guidance from The Nasdaq Capital Market;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         number of shares of our Common Stock outstanding;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         anticipated impact of a particular ratio on our ability to reduce administrative and
                                         transactional costs; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevailing
                                         general market, legal and economic conditions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Risks and Potential Disadvantages Associated with a Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
cannot assure that an implemented Reverse Stock Split will increase our stock price and for the required time period.</i></b>
We expect that, if implemented, the Reverse Stock Split will increase the market price of our Common Stock; however, the effect
of the Reverse Stock Split on the market price of our Common Stock cannot be predicted with any certainty, and the history of
reverse stock splits for other companies in our industry is varied. Some investors may view a reverse stock split negatively.
It is possible that the per share price of our Common Stock after the Reverse Stock Split will not increase in the same proportion
as the reduction in the number of our outstanding shares of Common Stock following the Reverse Stock Split. Furthermore, the Reverse
Stock Split may not result in a per share price that would attract investors who do not trade in lower priced stocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
addition, although we believe the Reverse Stock Split may enhance the marketability of our Common Stock to certain potential investors,
we cannot assure you that, if implemented, our Common Stock will be more attractive to investors. </i></b>Even if we implement
the Reverse Stock Split, the market price of our Common Stock may decrease due to factors unrelated to the Reverse Stock Split,
including our future performance or general market trends. If the Reverse Stock Split is consummated and the trading price of
the Common Stock declines, the percentage declines as an absolute number and as a percentage of our overall market capitalization
may be greater than would occur in the absence of the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>If
implemented, the proposed Reverse Stock Split may decrease the liquidity of our Common Stock and result in higher transaction
costs. </i></b>The liquidity of our Common Stock may be negatively impacted by the Reverse Stock Split, given the reduced number
of shares that would be outstanding after the Reverse Stock Split, particularly if the stock price does not increase as a result
of the Reverse Stock Split. Additionally, if the Reverse Stock Split is implemented, it will increase the number of our shareholders
who own &#8220;odd lots&#8221; of fewer than 100 shares of Common Stock. Brokerage commissions and other costs of transactions
in odd lots are generally higher than the costs of transactions of more than 100 shares of Common Stock. Accordingly, the Reverse
Stock Split may not achieve the desired results of increasing marketability of our Common Stock as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
Reverse Stock Split will not result in a decrease in our authorized shares. </i></b>Although the Reverse Stock Split would not
have any dilutive effect on our shareholders, the Reverse Stock Split without a reduction in the number of shares authorized for
issuance would reduce the proportion of shares owned by our shareholders relative to the number of shares authorized for issuance,
resulting in an effective increase in the relative number of authorized shares available for issuance in the discretion of the
Board of Directors. The Board of Directors from time to time may deem it to be in the best interests of the Company and its shareholders
to enter into transactions and other ventures that may include the issuance of shares of our Common Stock. If the Board of Directors
authorizes the issuance of additional shares of Common Stock subsequent to the Reverse Stock Split, the dilution to the ownership
interest of our existing shareholders may be greater than would occur had the Reverse Stock Split not been effected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effective
Time</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effective time of the Reverse Stock Split (the &#8220;Effective Time&#8221;), if approved by shareholders and implemented by the
Board of Directors, will be the date and time set forth in the Certificate of Amendment to the Amended and Restated Certificate
of Incorporation that is filed with the Delaware Secretary of State, which will be no later than June 2, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at any time prior to the filing of such amendment with the Delaware Secretary of State, the Board of Directors, in its discretion,
determines that it is in our best interests and the best interests of our shareholders to delay the filing of such amendment or
abandon the Reverse Stock Split, the Reverse Stock Split may be delayed or abandoned, without any further action by our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fractional
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
would not receive fractional shares of Common Stock in connection with the Reverse Stock Split. Instead, any shareholder who would
otherwise be entitled to a fractional share of our Common Stock as a result of the Reverse Stock Split shall be entitled to receive
one whole share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effects
of the Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Effective Time of the Reverse Stock Split, should the Board of Directors elect to implement it, each shareholder will own
a reduced number of shares of Common Stock. The Reverse Stock Split would affect all of our shareholders uniformly, however, and
would not affect any shareholder&#8217;s percentage ownership interests in the Company, except to the extent that the Reverse
Stock Split results in any of our shareholders owning a fractional share as described above. Voting rights and other rights and
preferences of the holders of our Common Stock would not be affected by the Reverse Stock Split (other than as a result of the
issuance of one whole share of Common Stock in lieu of fractional shares). For example, a holder of 3% of the voting power of
the outstanding shares of our Common Stock immediately prior to the Reverse Stock Split would continue to hold 3% (assuming there
is no impact as a result of the issuance of one whole share of Common Stock in lieu of issuing fractional shares) of the voting
power of the outstanding shares of our Common Stock immediately after the Reverse Stock Split. The number of shareholders of record
would not be affected by the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal effects of the Reverse Stock Split would be that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                         10 to 15 shares of our Common Stock owned by a shareholder (depending on the Reverse
                                         Stock Split ratio selected by the Board of Directors), would be combined into one new
                                         share of our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">no
                                         fractional shares of Common Stock would be issued in connection with the Reverse Stock
                                         Split; instead, holders of Common Stock who would otherwise receive a fractional share
                                         of Common Stock pursuant to the Reverse Stock Split would receive one whole share of
                                         Common Stock as explained above;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">by
                                         reducing the number of shares of Common Stock outstanding without reducing the number
                                         of shares of available but unissued Common Stock, the Reverse Stock Split will effectively
                                         increase the relative number of authorized but unissued shares, which the Board of Directors
                                         may use in connection with future financings or other issuances;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">based
                                         upon the Reverse Stock Split ratio selected by the Board of Directors, proportionate
                                         adjustments would be made to the per share exercise price and the number of shares issuable
                                         upon the exercise or vesting of all then outstanding equity awards and Common Stock warrants
                                         with respect to the number of shares of Common Stock subject to such award or warrant
                                         and the exercise price thereof, in each case to the extent applicable, subject to the
                                         terms of such awards and warrants;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
                                         number of shares of Common Stock authorized under our equity compensation plans will
                                         be proportionately adjusted for the Reverse Stock Split ratio selected by the Board of
                                         Directors; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
                                         number of shareholders owning &#8220;odd lots&#8221; of less than 100 shares of our Common
                                         Stock may potentially increase; odd lot shares may be more difficult to sell and brokerage
                                         commissions and other costs of transactions in odd lots generally are proportionately
                                         higher than the costs of transactions in &#8220;round lots&#8221; of even multiples of
                                         100 shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
believe that any potential negative effects are outweighed by the benefits of the Reverse Stock Split.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
on Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of providing examples of the effect of the Reverse Stock Split on our Common Stock, the following table contains
approximate information, based on share information as of the Record Date, of the effect of a Reverse Stock Split at certain ratios
within the range of the proposed Reverse Stock Split ratios on the number of shares of our Common Stock authorized, outstanding
and authorized but not outstanding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Status</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares of <br/>
Common Stock <br/>
Authorized</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares of <br/>
Common Stock Issued<br/>
 and Outstanding<sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares of <br/>
Common Stock <br/>
Authorized but Not<br/>
 Outstanding<sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Pre-Reverse
    Stock Split</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,992,995</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,591,161</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Post-Reverse
    Stock Split 10:1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,599,800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">522,909</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Post-Reverse
    Stock Split 11:1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,363,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">475,380</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Post-Reverse
    Stock Split 12:1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,583</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,767</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Post-Reverse
    Stock Split 13:1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,999,962</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">403,249</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Post-Reverse
    Stock Split 14:1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,857,143</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">393,507</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Post-Reverse
    Stock Split 15:1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,733,367</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">348,819</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
issuance of 500 shares in respect of fractional shares for round lots.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes
issuance of options to purchase 22 shares in respect of fractional share interests in options held by persons other than directors
and officers.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">After
the Effective Time of the Reverse Stock Split that our Board of Directors elects to implement, our Common Stock would have a new
CUSIP number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Effect
on Outstanding Equity Awards and Equity Plans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Reverse Stock Split is approved by our shareholders and our Board of Directors decides to implement the Reverse Stock Split,
as of the Effective Time, based on the Reverse Stock Split ratio selected by the Board of Directors, proportionate adjustments
will be made to all then-outstanding equity awards with respect to the number of shares of Common Stock subject to such award
and the exercise price thereof, with any fractional share amounts being rounded up to the next whole share of Common Stock. In
addition, the number of shares of Common Stock available</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">for issuance under our equity compensation plans will be proportionately
adjusted for the Reverse Stock Split ratio selected by the Board of Directors, such that fewer shares will be subject to such
plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Effect
on Outstanding Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">If
the Reverse Stock Split is approved by our shareholders and our Board of Directors decides to implement the Reverse Stock Split,
as of the Effective Time, based on the Reverse Stock Split ratio selected by the Board of Directors, proportionate adjustments
will be made to all then-outstanding warrants to purchase Common Stock with respect to the number of shares of Common Stock subject
to such warrant and the exercise price thereof, with any fractional share amounts being rounded up to the next whole share of
Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Reduction
in Stated Capital</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the Reverse Stock Split, the par value of our Common Stock would remain $0.001 per share. As a result of the Reverse Stock
Split, at the Effective Time, the stated capital on our balance sheet attributable to our Common Stock would be reduced in proportion
to the size of the Reverse Stock Split, subject to a minor adjustment in respect of the treatment of fractional shares, and the
additional paid-in capital account would be credited with the amount by which the stated capital is reduced. Our shareholders&#8217;
equity, in the aggregate, would remain unchanged.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares
Held in Book-Entry and Through a Broker, Bank or Other Holder of Record</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combination of, and reduction in, the number of our outstanding shares of Common Stock as a result of the Reverse Stock Split
will occur automatically at the Effective Time without any additional action on the part of our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the Reverse Stock Split, we intend to treat shareholders holding shares of our Common Stock in &#8220;street name&#8221; (that
is, through a broker, bank or other holder of record) in the same manner as registered shareholders whose shares of our Common
Stock are registered in their names. Brokers, banks or other holders of record will be instructed to effect the Reverse Stock
Split for their beneficial holders holding shares of our Common Stock in &#8220;street name&#8221;; however, these brokers, banks
or other holders of record may apply their own specific procedures for processing the Reverse Stock Split. If you hold your shares
of our Common Stock with a broker, bank or other holder of record, and you have any questions in this regard, we encourage you
to contact your holder of record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold registered shares of our Common Stock in a book-entry form, you do not need to take any action to receive your post-Reverse
Stock Split shares of our Common Stock in registered book-entry form. A transaction statement will automatically be sent to your
address of record as soon as practicable after the Effective Time indicating the number of shares of our Common Stock you hold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold any of your shares of our Common Stock in certificate form, you will receive a transmittal letter from our transfer agent
as soon as practicable after the Effective Time. The transmittal letter will be accompanied by instructions specifying how you
can exchange your certificate representing the pre-Reverse Stock Split shares of our Common Stock for either: (1) a certificate
representing the post-Reverse Stock Split shares of our Common Stock or (2) post-Reverse Stock Split shares of our Common Stock
in a book-entry form, evidenced by a transaction statement that will be sent to your address of record indicating the number of
shares of our Common Stock you hold. Beginning at the Effective Time of the Reverse Stock Split, each certificate representing
pre-Reverse Stock Split shares of our Common Stock will be deemed for all corporate purposes to evidence ownership of post-Reverse
Stock Split shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholders
should not destroy any share certificate(s) and should not submit any share certificate(s) until requested to do so.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of Certain Persons in Matters to be Acted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
officer or director has any substantial interest, direct or indirect, by security holdings or otherwise, in the Reverse Stock
Split that is not shared by all of our other shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Reservation
of Right to Delay the Filing of the Amendment, or Abandon the Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board of Directors reserves the right, notwithstanding shareholder approval of this Proposal No. 4 and without further action
by the shareholders, to elect not to proceed with the Reverse Stock Split if the Board of Directors, in its sole discretion, determines
that it is no longer in our best interests and the best interests of our shareholders to proceed with the Reverse Stock Split.
Such determination will be based upon factors the Board of Directors deems appropriate, including our then current stock price,
the existing and expected marketability and liquidity of our Common Stock, prevailing market conditions, rule changes and/or guidance
by Nasdaq, and the likely effect on the market price of our Common Stock. If a certificate of amendment effecting the Reverse
Stock Split has not been filed with the Secretary of State of the State of Delaware on or before June 2, 2025, the Board of Directors
will be deemed to have abandoned the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>No
Dissenters&#8217; Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
Delaware law, shareholders have no rights to exercise dissenters&#8217; rights of appraisal with respect to the Reverse Stock
Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>No
Going Private Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Notwithstanding
the decrease in the number of outstanding shares following the proposed Reverse Stock Split, our Board of Directors does not intend
for this transaction to be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule 13e-3 of the
Exchange Act.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. Federal Tax Consequences of the Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of material U.S. federal income tax consequences of an implemented Reverse Stock Split to U.S.
Holders (as defined below). This summary is based upon the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
Treasury regulations promulgated thereunder, published rulings and administrative pronouncements of the Internal Revenue Service
(&#8220;IRS&#8221;), and judicial decisions in each case in existence on the date hereof, all of which are subject to change.
Any such change could apply retroactively and could adversely affect the tax consequences described below. No assurance can be
given that the IRS will agree with the consequences described in this summary, or that a court will not sustain any challenge
by the IRS in the event of litigation. No advance tax ruling has been or will be sought or obtained from the IRS regarding the
tax consequences of the transactions described herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &#8220;U.S. Holder&#8221; is a beneficial owner of shares of our Common Stock that is (a) an individual
who is a citizen of the United States or who is resident in the United States for U.S. federal income tax purposes, (b) an entity
that is classified for U.S. federal income tax purposes as a corporation and that is organized under the laws of the United States,
any state thereof, or the District of Columbia, or is otherwise treated for U.S. federal income tax purposes as a domestic corporation,
(c) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (d) a trust (i) whose
administration is subject to the primary supervision of a court within the United States and all substantial decisions of which
are subject to the control of one or more United States persons as described in Section 7701(a)(30) of the Code (&#8220;United
States persons&#8221;), or (ii) that has a valid election in effect under applicable Treasury regulations to be treated as a United
States person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary does not discuss all U.S. federal income tax considerations that may be relevant to U.S. Holders in light of their particular
circumstances or that may be relevant to certain beneficial owners that may be subject to special treatment under U.S. federal
income tax law (for example, tax-exempt organizations, S corporations, partnership and other pass through entities (and investors
therein), mutual funds, insurance companies, banks and other financial institutions, dealers in securities, brokers or traders
in securities, commodities or currencies, that elect to use a mark-to-market method of accounting, real estate investment trusts,
regulated investment companies, individual retirement accounts, qualified pension plans, persons who hold shares of our Common
Stock as part of a straddle, hedging, constructive sale, conversion, or other integrated transaction, U.S. Holders that have a
functional currency other than the U.S. dollar, and persons who acquired shares of our Common Stock as a result of the exercise
of employee stock options or otherwise as compensation or through a tax-qualified retirement plan). Furthermore, this summary
does not discuss any alternative minimum tax consequences or the Medicare contribution tax on net investment income and does not
address any aspects of U.S. state or local or non-U.S. taxation. This summary only</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">applies to those beneficial owners that hold
shares of our Common Stock as &#8220;capital assets&#8221; within the meaning of Section 1221 of the Code (generally, property
held for investment).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">If
an entity classified for U.S. federal income tax purposes as a partnership owns shares of our Common Stock, the tax treatment
of a member of the entity will depend on the status of the member and the activities of the entity and such member. The tax treatment
of such an entity, and the tax treatment of any member of such an entity, are not addressed in this summary. Any entity that is
classified for U.S. federal income tax purposes as a partnership and that owns shares of our Common Stock, and any members of
such an entity, are encouraged to consult their tax advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">BENEFICIAL
OWNERS OF SHARES OF OUR COMMON STOCK ARE ENCOURAGED TO SEEK ADVICE FROM THEIR OWN TAX ADVISORS REGARDING THE INCOME TAX CONSEQUENCES
OF THE REVERSE STOCK SPLIT TAKING INTO ACCOUNT THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK
SPLIT ARISING UNDER THE U.S. FEDERAL INCOME, ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING
JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
intend to take the position that the Reverse Stock Split constitutes a recapitalization for U.S. federal income tax purposes pursuant
to Section 368(a)(1)(E) of the Code. Assuming the Reverse Stock Split qualifies as a recapitalization:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a
                                         U.S. Holder will not recognize gain or loss on the Reverse Stock Split;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
                                         aggregate tax basis of the shares of our Common Stock received by a U.S. Holder in the
                                         Reverse Stock Split will be equal to the aggregate tax basis of the shares exchanged
                                         therefor; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
                                         holding period of the shares of our Common Stock received by a U.S. Holder in the Reverse
                                         Stock Split will include the holding period of the shares exchanged therefor.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">U.S.
Treasury regulations provide detailed rules for allocating the tax basis and holding period among shares of Common Stock which
were acquired by a shareholder on different dates and at different prices. U.S. Holders that acquired shares of our Common Stock
on different dates or at different prices should consult their tax advisors regarding the allocation of the tax basis and holding
period among such shares. The tax treatment of the receipt of a full share of Common Stock in lieu of a fractional share is unclear.
Shareholders should consult their own tax advisors to determine the consequences to them of receiving such a full share in lieu
of a fractional share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
Relating to the Reverse Stock Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
form of the amendment to our Certificate of Incorporation relating to this Proposal No. 4, which we would file with the Secretary
of State of the State of Delaware to effect the Reverse Stock Split, is attached to this proxy statement as <span style="text-decoration: underline">Appendix B</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of shareholders that represent a majority of the shares of voting capital stock issued and outstanding is required
to approve the Reverse Stock Split. Abstentions and broker non-votes will be treated as votes against the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221; THE REVERSE STOCK SPLIT</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
NO. 5</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Approval
of an Amendment to the CERTIFICATE OF INCORPORATION to eliminate <br/>
the prohibition against sHAREholders acting by written consent
AND EXPRESSLY <br/>
AUTHORIZE SHAREHOLDERS TO ACT BY WRITTEN CONSENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are submitting for shareholder approval an amendment to our Certificate of Incorporation to remove the prohibition against shareholders
taking action by written consent without holding a meeting. Our Board of Directors has unanimously approved, and recommends that
all shareholders approve, the proposed amendment to Section (a) of Article VI of the Certificate of Incorporation to remove this
prohibition by deleting Section (a) of Article VI in its entirety and expressly authorize shareholders to act by written consent.
The discussion regarding this proposal is qualified in its entirety by reference to the complete text of Section (a) of Article
VI of the Certificate of Incorporation, which is set forth below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
Action by Written Consent</i>. Any action required or permitted to be taken by the shareholders of the Corporation may be effected
only at a duly called annual or special meeting of shareholders of the Corporation and may not be effected by any consent in writing
by such shareholders.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you approve Proposal No. 5, the above section will be deleted from our Certificate of Incorporation and the following text will
be approved as new Section (a) of Article VI of the Certificate of Incorporation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<i>Action by Written Consent</i>. Any action required or permitted to be taken at any annual or special meeting of stockholders
of the Corporation may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing,
setting forth the action so taken, shall be signed by the holders of outstanding stock of the Corporation having not less than
the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled
to vote thereon were present and voted and shall be delivered to the Corporation by delivery to its registered office in Delaware,
its principal place of business, or to an officer or agent of the Corporation having custody of the book in which proceedings
of meetings of stockholders are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
urge you to carefully read the section in its entirety and consider the implications of amending the Certificate of Incorporation
to eliminate the prohibition against shareholders acting by written consent and expressly authorize shareholders to act by written
consent because this summary may not contain all the information about this amendment that is important to you.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Background
and Reason for the Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the Board of Directors&#8217; review of our corporate governance policies, the Board considered the advantages and disadvantages
of prohibiting shareholder action by written consent similar to that currently found in Section (a) of Article VI of our Certificate
of Incorporation. This type of prohibition generally is intended to facilitate corporate stability by requiring shareholder action
to occur at a duly called and convened shareholder meeting. These voting limitations prohibiting shareholder action by written
consent may also have the effect of providing anti-takeover protection to the Company. However, many investors and others view
prohibitions against shareholder action by written consent as conflicting with principles of good corporate governance by preventing
shareholders from fully exercising their voting rights as shareholders due to the need to convene at an annual or special meeting
to effect change. Section 228 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) allows shareholders to act by written
consent unless otherwise provided in the corporation&#8217;s certificate of incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
considering the advantages and disadvantages of the prohibition on shareholder action by written consent set forth in Section
(a) of Article VI of our Certificate of Incorporation, the Board of Directors has unanimously voted to propose to the shareholders
that Section (a) of Article VI be amended to remove the prohibition, and instead allow shareholders to take actions as provided
by Section 228 of the DGC. In reaching this determination to propose this amendment to our Certificate of Incorporation, the Board
of Directors concluded that the benefits of prohibiting shareholder action by written consent were outweighed by the Board of
Directors&#8217; belief that removing the prohibition is a meaningful step towards achieving our goal of ensuring that our corporate
governance policies conform to current best practices and maximizing the ability of our shareholders to appropriately participate
in the affairs of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">For
the reasons described above, our Board believes that this Proposal No. 5 to amend our Certificate of Incorporation by deleting
Section (a) of Article VI is advisable and in the best interests of the Company and its shareholders, and to amend and restate
Section (a), Article VI of the Certification of Incorporation as set forth above to expressly authorize shareholders to act by
written consent.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
Relating to the Elimination of the Prohibition on Against Shareholders Acting by Written Consent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
form of the amendment to our Certificate of Incorporation relating to this Proposal No. 5, which we would file with the Secretary
of State of the State of Delaware to eliminate the prohibition against shareholders acting by written consent and expressly authorize
shareholders to act by written consent, is attached to this proxy statement as <span style="text-decoration: underline">Appendix C</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Amendment to our Bylaws</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has conditionally approved an amendment to our bylaws, subject to shareholder approval of this Proposal No.
5, to eliminate related provisions set forth in Section 1.11 of Article I our Bylaws that prohibited shareholders from acting
by written consent and adopt provisions in Section 1.11 to expressly authorize shareholders to act by written consent in lieu
of a meeting. The form of this bylaw amendment is attached to this Proxy Statement as <span style="text-decoration: underline">Appendix D</span>, and will become effective
upon filing of the amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware relating
to.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required
Vote</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of shareholders that represent a sixty-six and two-thirds percent (66.66%) majority of the shares of voting capital
stock issued and outstanding is required to approve the elimination of the prohibition against shareholders acting by written
consent and to expressly authorize shareholders to act by written consent in lieu of a meeting. Abstentions and broker non-votes
will be treated as votes against the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE &#8220;FOR&#8221; THE ELIMINATION OF THE PROHIBITION AGAINST SHAREHOLDERS
ACTING BY WRITTEN CONSENT AND EXPRESS AUTHORIZATION OF SHAREHOLDERS TO ACT BY WRITTEN CONSENT</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding ownership of our Common Stock as of March 28, 2025, except as otherwise
stated, by (i) each director and nominee for director, (ii) the named executive officers, (iii) all of our named executive officers
and directors as a group, and (iv) each person known to us to be the beneficial owner of more than 5% of our outstanding Common
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    Beneficially Owned </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Currently
    <br/>
Owned </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Currently&#160;<br/>
Owned&#160;<br/>
Percent&#160;<sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    that <br/>
could be <br/>
acquired <br/>
within <br/>
60 days </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Beneficial Owner <sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(A)
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(B)
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(C)
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(D)
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(E)
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Directors and Executive
    Officers: </span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derek L. Graham </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,260</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.02</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,760</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Larry R. Hendricks </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,048</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,048</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa B. Higley<sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,051</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,051</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.09</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric L. Robinson </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,333</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,398</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Whaley </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon Brewer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total (Directors and Officers) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,424</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,833</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,257</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">5% Shareholders: </span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward D. Bagley <sup>(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,590,528</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">723,628</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,314,156</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
    as otherwise indicated, each person named in the table has sole voting and investment power, subject to applicable community
    property law. Except as otherwise indicated, each person may be reached at our corporate offices c/o ClearOne, Inc., 5225
    Wiley Post Way, Suite 500, Salt Lake City, Utah 84116. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The percentages
    shown in Column (B) are calculated based on shares of Common Stock outstanding on March 27, 2025. The numbers shown in Column
    (D) and percentages shown in Column (E) include the shares of Common Stock actually owned as of March 27, 2025 and the shares
    of Common Stock that the identified person or group had the right to acquire within 60 days of such date. In calculating the
    percentage of ownership, all shares of Common Stock that each identified person or group had the right to acquire within 60
    days of March 27, 2025 upon the exercise of the stock options and warrants shown in Column (C) are deemed to be outstanding
    for the purpose of computing the percentage of the shares of Common Stock owned by the persons or groups listed above. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This information
    is based upon the Form 4 filed with the SEC as of June 2, 2023. Lisa Higley, who was appointed a Director effective July 20,
    2020, is the daughter of Edward D. Bagley, and each of them has previously disclaimed beneficial ownership of Common Stock
    beneficially owned by the other. The share amounts indicated for Ms. Higley do not include any shares held by Edward D. Bagley.
    The share amounts indicated for Ms. Higley do not include 6,546 shares owned by her spouse and 2,252,636 shares held by a
    trust in which she is a co-trustee. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Bagley may be
    deemed to own an additional 355,257 shares of Common Stock that Carolyn Bagley owns individually. Mr. Bagley, however, disclaims
    beneficial ownership of these shares that may be indirectly beneficially owned by Mr. Bagley and they are excluded from the
    amounts reported in the table above. Mr. Edward D. Bagley has sole voting and dispositive power over 13,314,156 shares (including
    the shares that may be acquired pursuant to exercise of options to purchase 38,333 shares of Common Stock, and warrants to
    purchase 685,295 shares of Common Stock). This information is based upon a Form 4 as filed by Mr. Bagley with the SEC on February
    28, 2025 and a Schedule 13D Amendment filed by Mr. Bagley with the SEC on February 28, 2025. E. Bryan Bagley, who resigned
    as Director effective November 6, 2012, is the son of Edward D. Bagley, and each of them has previously disclaimed beneficial
    ownership of Common Stock beneficially owned by the other. Lisa Higley, who was appointed a Director effective July 20, 2020,
    is the daughter of Edward D. Bagley, and each of them has previously disclaimed beneficial ownership of Common Stock beneficially
    owned by the other. The share amounts indicated for Mr. Edward D. Bagley do not include any shares held by E. Bryan Bagley
    or Lisa Higley. </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information, as of December 31, 2024, relating to equity compensation plans of the Company (including
individual compensation arrangements) pursuant to which equity securities of the Company are authorized for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
    Category </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b><br/>
    <b>Number of <br/>
securities to be issued <br/>
upon exercise of <br/>
outstanding options <br/>
and rights</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b><br/>
    <b>Weighted-Average Exercise <br/>
Price of Outstanding <br/>
Options and Rights</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b><br/>
    <b>Number of securities <br/>
remaining available for <br/>
future issuance under <br/>
equity compensation <br/>
plans (excluding <br/>
securities reflected
    in <br/>
column(a))</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation Plans
    Approved by Stockholders </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">569,016
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.32
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,015,171
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation Plans Not Approved by Stockholders
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.625in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">569,016
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3.32
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,015,171
    </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHAREHOLDER
PROPOSALS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that our Annual Meeting of Shareholders in 2025 will be held in November 2025. Any shareholder that wishes to present
any proposal for shareholder action at our Annual Meeting of Shareholders to be held during calendar year 2025 must notify us
at our principal executive offices no later than August 24, 2025 in order for the proposal to be included in our proxy statement
and form of proxy relating to that meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 14a-8 under the Exchange Act, we intend to retain discretionary authority to vote proxies with respect to shareholder
proposals for which the proponent does not seek inclusion of the proposed matter in our proxy statement for the annual meeting
to be held during calendar 2024, except in circumstances where (i) we receive notice of the proposed matter no later than August
24, 2025; and (ii) the proponent complies with the other requirements set forth in Rule 14a-8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">APPENDIX
A</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b><br/>
<b>TO CERTIFICATE OF INCORPORATION</b><br/>
<b>OF</b><br/>
<b>CLEARONE, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearOne,
Inc. (the &#8220;Company&#8221;), a corporation organized and existing under and by virtue of the General Corporation Law of the
State of Delaware (the &#8220;DGCL&#8221;), hereby certifies that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. The name of the Company is ClearOne, Inc. The Company&#8217;s Certificate of Incorporation was originally filed with the Secretary
of State of the State of Delaware on October 25, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. The Board of Directors of the Company (the &#8220;Board&#8221;), acting in accordance with the provisions of Sections&#8239;141
and 242 of the DGCL, duly adopted resolutions amending the Certificate of Incorporation as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Incorporation of ClearOne, Inc. (the &#8220;Corporation&#8221;) as currently in effect is hereby amended by deleting
therefrom in its entirety sections (a) and (b) of Article III and inserting in lieu thereof the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    Stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total number of shares of capital stock which the Corporation shall have the authority to issue is 200,000,000 shares, such
    shares being divided into 150,000,000 shares of common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;),
    and 50,000,000 shares of preferred stock, par value $0.001 per share (the &#8220;Preferred Stock&#8221;).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the provisions of this Certificate of Incorporation, the Board of Directors is authorized to provide for the issuance from
    time to time of shares of Preferred Stock in one or more series and, by filing a certificate pursuant to the applicable provisions
    of the Delaware General Corporation Law (a &#8220;Preferred Stock Certificate of Designation&#8221;), to establish from time
    to time the number of shares to be included in each such series, with such voting powers, full or limited, or no voting powers,
    and such designations, preferences, privileges and relative, participating, optional or other special rights and qualifications,
    limitations or restrictions thereof, as are stated and expressed in the resolution or resolutions providing for the issue
    thereof adopted by the Board of Directors, including, but not limited to, determination of any of the following:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    distinctive designation of the series, whether by number, letter or title, and the number of shares which will constitute
    the series, which number may be increased or decreased (but not below the number of shares then outstanding and except where
    otherwise provided in the applicable Preferred Stock Certificate of Designation) from time to time by action of the Board
    of Directors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rate, if any, and the times of payment of dividends, if any, on the shares of the series, whether such dividends
    will be cumulative, and if so, from what date or dates, and the relative rights of priority, if any, of payment of dividends
    on shares of that series;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the shares shall be redeemable and, if so, the terms and conditions of such redemption, including the date or dates upon or
    after which they shall be redeemable, and the amount per share payable in case of redemption, which amount may vary under
    different conditions and at different redemption dates;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the shares of the series will be entitled to the benefit of a retirement or sinking fund to be applied to the purchase or
    redemption of such shares and, if so entitled, the amount of such fund and the terms and provisions relative to the operation
    thereof;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amounts payable on, and the preferences, if any, of shares of the series in the event of any voluntary or involuntary liquidation,
    dissolution or winding up of the affairs of the Corporation;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the shares of the series will be convertible into, or exchangeable for, any other shares of stock of the Corporation or other
    securities, and if so convertible or exchangeable, the conversion price or prices, or the rates of exchange, and any adjustments
    thereof, at which such conversion or exchange may be made, and any other terms and conditions of such conversion or exchange;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    rights of the shares of the series in the event of voluntary or involuntary liquidation, dissolution or winding up of the
    affairs of the Corporation;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the shares of the series will have priority over or be on a parity with or be junior to the shares of any other series or
    class of stock in any respect, or will be entitled to the benefit of limitations restricting the issuance of shares of any
    other series or class of stock, restricting the payment of dividends on or the making of other distributions in respect of
    shares of any other series or class of stock ranking junior to the shares of the series as to dividends or assets, or restricting
    the purchase or redemption of the shares of any such junior series or class, and the terms of any such restriction;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the series will have voting rights, in addition to any voting rights provided by law, and, if so, the terms of such voting
    rights; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other powers, designations, preferences and relative, participating, optional and other special rights of that series and
    the qualifications, limitations or restrictions of such preferences and/or rights.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
    as otherwise required by law, as otherwise provided herein or as otherwise determined by the Board of Directors in the applicable
    Preferred Stock Certificate of Designation as to the shares of any series of Preferred Stock prior to the issuance of any
    such shares, the holders of Preferred Stock shall have no voting rights and shall not be entitled to any notice of any meeting
    of stockholders. In addition, except as otherwise expressly provided in the applicable Preferred Stock Certificate of Designation,
    no vote of the holders of shares of Preferred Stock or Common Stock shall be a prerequisite to the issuance of any shares
    of any series of the Preferred Stock authorized by and complying with the conditions of this Certificate of Incorporation.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights of the
    holders of the Preferred Stock of any series as may be designated by the Board of Directors upon any issuance of the Preferred
    Stock or any series thereof. Except as otherwise provided in this Certificate of Incorporation or as otherwise required by
    applicable law, all shares of Common Stock shall be identical in all respects and shall entitle the holders thereof to the
    same rights, powers, preferences and privileges, subject to the same qualifications, limitations and restrictions. The terms
    of the Common Stock shall be subject to the express terms of any series of Preferred Stock.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Thereafter, pursuant to a resolution of the Board, this Certificate of Amendment to the Certificate of Incorporation was submitted
to the stockholders of the Company for their approval and was duly adopted in accordance with Section 242 of the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. All other provisions of the Certificate of Incorporation as currently on file with the Secretary of State of the State of Delaware,
shall remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness Whereof, the Company has caused this Certificate of Amendment to be signed by its Chief Executive Officer this __ day
of ________, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEARONE,
    INC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 51%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Derek Graham</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">APPENDIX
B</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b><br/>
<b>TO CERTIFICATE OF INCORPORATION</b><br/>
<b>OF</b><br/>
<b>CLEARONE, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearOne,
Inc. (the &#8220;Company&#8221;), a corporation organized and existing under and by virtue of the General Corporation Law of the
State of Delaware (the &#8220;DGCL&#8221;), hereby certifies that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The name of the Company is ClearOne, Inc. The Company&#8217;s Certificate of Incorporation was originally filed with the Secretary
of State of the State of Delaware on October 25, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Board of Directors of the Company (the &#8220;Board&#8221;), acting in accordance with the provisions of Sections&#8239;141
and 242 of the DGCL, duly adopted resolutions amending the Certificate of Incorporation as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Incorporation of ClearOne, Inc. (the &#8220;Corporation&#8221;) as currently in effect is hereby amended to add
the following after the first paragraph of Section (a) of Article III thereof:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the filing and effectiveness (the &#8220;Effective Time&#8221;) pursuant to the Delaware General Corporation Law of this Certificate
of Amendment to the Certificate of Incorporation of the Corporation, each [ ] shares of Common Stock issued and outstanding immediately
prior to the Effective Time shall, automatically and without any action on the part of the respective holders thereof, be combined
and converted into one (1) share of Common Stock (the &#8220;Reverse Stock Split&#8221;). No fractional shares shall be issued
in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive fractional share interests
of Common Stock as a result of the Reverse Stock Split shall be entitled to receive in lieu of such fractional share interests,
upon the Effective Time, one whole share of Common Stock in lieu of such fractional share interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Thereafter, pursuant to a resolution of the Board, this Certificate of Amendment to the Certificate of Incorporation was submitted
to the stockholders of the Company for their approval and was duly adopted in accordance with Section 242 of the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
All other provisions of the Certificate of Incorporation as currently on file with the Secretary of State of the State of Delaware,
shall remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness Whereof, the Company has caused this Certificate of Amendment to be signed by its Chief Executive Officer this __ day
of ________, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEARONE,
    INC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 51%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Derek Graham</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">APPENDIX
C</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b><br/>
<b>TO CERTIFICATE OF INCORPORATION</b><br/>
<b>OF</b><br/>
<b>CLEARONE, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearOne,
Inc. (the &#8220;Company&#8221;), a corporation organized and existing under and by virtue of the General Corporation Law of the
State of Delaware (the &#8220;DGCL&#8221;), hereby certifies that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The name of the Company is ClearOne, Inc. The Company&#8217;s Certificate of Incorporation was originally filed with the Secretary
of State of the State of Delaware on October 25, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Board of Directors of the Company (the &#8220;Board&#8221;), acting in accordance with the provisions of Sections&#8239;141
and 242 of the DGCL, duly adopted resolutions amending the Certificate of Incorporation as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Incorporation of ClearOne, Inc. (the &#8220;Corporation&#8221;) as currently in effect is hereby amended by deleting
therefrom in its entirety sections (a) of Article VI and inserting in lieu thereof the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<i>Action by Written Consent</i>. Any action required or permitted to be taken at any annual or special meeting of stockholders
of the Corporation may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing,
setting forth the action so taken, shall be signed by the holders of outstanding stock of the Corporation having not less than
the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled
to vote thereon were present and voted and shall be delivered to the Corporation by delivery to its registered office in Delaware,
its principal place of business, or to an officer or agent of the Corporation having custody of the book in which proceedings
of meetings of stockholders are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Thereafter, pursuant to a resolution of the Board, this Certificate of Amendment to the Certificate of Incorporation was submitted
to the stockholders of the Company for their approval and was duly adopted in accordance with Section 242 of the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
All other provisions of the Certificate of Incorporation as currently on file with the Secretary of State of the State of Delaware,
shall remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness Whereof, the Company has caused this Certificate of Amendment to be signed by its Chief Executive Officer this __ day
of ________, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEARONE,
    INC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 51%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Derek Graham</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">APPENDIX
D</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSED
BYLAW AMENDMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bylaws of ClearOne, Inc. as currently in effect are hereby amended as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
1.11 of Article I is hereby deleted in its entirety and amended and inserting in lieu thereof the following:</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECTION
1.11 Action by Written Consent.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
action required or permitted to be taken at any annual or special meeting of stockholders of the Corporation may be taken without
a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall
be signed by the holders of outstanding stock of the Corporation having not less than the minimum number of votes that would be
necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and
shall be delivered to the Corporation by delivery to its registered office in Delaware, its principal place of business, or to
an officer or agent of the Corporation having custody of the book in which proceedings of meetings of stockholders are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&#160;</p>



<div style="position: relative; float: left; width: 48%">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><img src="img004.jpg" alt=""/>&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i>ClearOne,
Inc.&#160;</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i>5255
Wiley Post Way Suite 500</i>&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i>Salt
Lake City, UT 84116</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&lt;Shareholder
Name&gt;</b>&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&lt;Shareholder
Address1&gt;</b>&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&lt;Shareholder
Address2&gt;&#160;</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&lt;Shareholder
Address3&gt;</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="border: Black 1pt dashed; font: 10pt Arial, Helvetica, Sans-Serif; padding: 4pt 5.4pt; width: 100%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Control
    #: 0000 0000 0000</b></span></td></tr>
</table>

</div>
<div style="position: relative; float: right; width: 48%">


<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><span style="font: 12pt Arial, Helvetica, Sans-Serif"><b>Voting Instructions</b></span><span style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><span style="font: 10pt Arial, Helvetica, Sans-Serif"><b>You can vote by Internet or Telephone!</b>&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><span style="font: 10pt Arial, Helvetica, Sans-Serif">Instead of mailing your proxy, you may choose one of the three voting options outlined below.</span></p>

</td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 20%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 68%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td rowspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><img src="img005.jpg" alt=""/><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b></b></span></td>
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>VOTE
    BY INTERNET &#8211; www.colonialstock.com/clro2025</b></span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9642;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">You
    can view the ClearOne Annual Report and Proxy Statement and submit your vote online at the website listed above up until 5:00
    PM MT on 5/29/2025. You will need the control number at the left in order to do so. </span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9642;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Follow
    the instructions on the secure website to complete your vote.</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td rowspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><img src="img006.jpg" alt=""/><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></span></td>
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>VOTE
    BY PHONE &#8211; 877-285-8605</b></span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9642;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">You
    may vote by phone until 5:00 PM MT on 5/29/2025. </span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9642;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Please
    have your notice and proxy card in hand when you call.</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td rowspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: top"><img src="img007.jpg" alt=""/><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></span></td>
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>VOTE
    BY MAIL</b></span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9679;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">If
    you have not voted via the internet OR telephone, mark, sign and return your proxy ballot in the postage-paid envelope provided.</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9679;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Votes
    by mail must be received by 5/30/2025.</span></td></tr>
</table>
</div>
<div style="clear: both"></div>

<p style="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">TO
VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font: 8pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font: 8pt Arial, Helvetica, Sans-Serif"></span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 2pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>THIS
PROXY BALLOT IS VALID ONLY WHEN SIGNED AND DATED.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
undersigned hereby appoints Derek L. Graham and Simon Brewer, and each or either of them, proxies for the undersigned, with full
power of substitution, to vote all shares of common stock, (&#8220;Shares&#8221;) of ClearOne, Inc. (the &#8220;Company&#8221;) which
the undersigned would be entitled to vote at the SPECIAL MEETING IN LIEU OF ANNUAL MEETING OF SHAREHOLDERS OF THE COMPANY (THE
&#8220;MEETING&#8221;) TO BE HELD AT 5225 WILEY POST WAY SUITE 500, SALT LAKE CITY, UTAH 84116 ON MAY 30, 2025, AT 9:30 A.M., MOUNTAIN
TIME, and directs that the Shares represented by this Proxy shall be voted as indicated below:&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The Board of Directors recommends you vote FOR all the nominees for director in Proposal 1, FOR Proposals
2, 3, 4, 5, and 7, and EVERY 3 YEARS for Proposal 6.</span></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 4%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1.</span></td>
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Election
    of Directors</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">For</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Withhold</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">For
    All</span></td>
    <td rowspan="4" colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">To
    withhold authority to vote for any any individual nominee(s), mark &#8220;For All Except&#8221; and write the number(s of
    the nominee(s) on the line below.</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">All</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">All</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Except</span></td>
</tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Nominees:</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
</tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1)</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Eric
    L. Robinson</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
</tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2)</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Lisa
    B. Higley</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3)</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Bruce
    Whaley</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Abstain</b></span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2.</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Approve
    the amendment to Certificate of Incorporation to increase Authorized Shares of Common Stock from 50,000,000 to 150,000,000
    shares</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3.</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Approve
    the amendment to Certificate of Incorporation to authorize 50,000,0000 shares of &#8220;Blank Check&#8221; Preferred Stock</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">4.</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Approve
    the amendment to Certificate of Incorporation to authorize a Reverse Stock Split by a ratio of between 1-for-10 to 1-for-15</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">5.</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Approve
    the amendment to Certificate of Incorporation to allow Shareholders to eliminate the prohibition against stockholders acting
    by written consent and expressly authorize shareholders to act by written consent</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Every<br/>
1 year</b></span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Every<br/>
2 years</b></span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Every<br/>
3 years</b></span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6.</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Approve
    the non-binding advisory vote of the frequency of the advisory vote on compensation of named executive officers</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Abstain</b></span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">7.</span></td>
    <td colspan="5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Approval
    of any other matters which are properly presented</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38in">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In
their discretion, the proxies are authorized to vote upon such other business as may properly come before the Meeting or any adjournment
thereof.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The board of directors recommends a vote FOR all the nominees for director in Proposal 1, FOR Proposals
2, 3, 4, 5, and 7, and EVERY 3 YEARS for Proposal 6. This Proxy, when properly executed, will be voted in the manner directed herein
by the undersigned stockholder. If no direction is given, this Proxy will be voted FOR proposals 1, 2, 3, 4, 5, and 7, and EVERY
3 YEARS for proposal 6.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 27pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 60%; border-collapse: collapse; margin-left: 0.38in">
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 44%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Please
    indicate if you plan to attend this meeting.</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#9744;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 27pt">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 27pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Sign
exactly as name appears hereon. For joint accounts, all co-owners should sign. Executors, administrators, custodians, trustees,
etc. should so indicate when signing.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 27pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 90%; border-collapse: collapse; margin-left: 0.38in">
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="border: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif; width: 29%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 2pt solid; border-right: Black 2pt solid; border-bottom: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif; width: 15%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 2pt solid; border-right: Black 2pt solid; border-bottom: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif; width: 29%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 2pt solid; border-right: Black 2pt solid; border-bottom: Black 2pt solid; font: 10pt Arial, Helvetica, Sans-Serif; width: 15%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Signature</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Date</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Signature
    (Joint Owners)</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Date</span></td></tr>
</table>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 27pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin: 0">&#160;</p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img001.jpg
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*1111111117__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!1@*\ P$1  (1 0,1 ?_$ )D  0  !@,!
M       #! 4&" D! @<* 0$                     $  !! $# 00$!PL(
M"0$' @<" 0,$!08 $0<2(1,4"#$B%19!49'1,E+389+2(U-4E%655@EQL4)R
MDR34%X&ALC-S@R4U14/!@F,T1!@9\&*B)N$GPF1T$0$
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M[]5^0+Y2^;0/=^J_(%\I?-H'N_5?D"^4OFT#W?JOR!?*7S:![OU7Y OE+YM
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MOS2_7G?LR?\ X70/?FE^O._9D_\ PN@>_-+]>=^S)_\ A= ]^:7Z\[]F3_\
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MJ/WJ?-H'0'U1^]3YM Z ^J/WJ?-H'0'U1^]3YM Z ^J/WJ?-H'0'U1^]3YM
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M@]8:>[TG$1/5#I%>Q4W)4ZE5%]!!LJ;*F@CZ!H(+_P!!/ZR?S+H+%_\ +?\
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M4VE<(W>M7%15$0Z014[$)-U4U-1V1555]'9MH)L1Z=^W??0=M T#0- T#0-
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MIXW;"N<6ML( @C"A']8$%0(B'\9H)J/82_&4DQNZ]F6]13UU?BV?.RG'<?\
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MJ7XS,_DV'9-M!V%DD]) OW.C?Y%5=TT$4 0-]D1-^U=E5=U_T^C0=] T#0-
MT#0- T#0- T#0- T#0- T#0- T$%QY&UVZ5)>SL%44ON^KOU;)\>@@E-;'J7
MI<40VZE$=U1%[$+H3UE%2[-]!R4L0V16SZR7I$$3=5)4ZA153=!W'MW7L30=
MV) O]>PJ*@J"7:A)U+ONB$G873MV[:"2LT3\6JK_ $7$41'J=<3U51MM$7=>
MLD1%[-MM!I;LZ]SA#DYBVD85S918=?<Q1FEEU/FFPJWQ]JTRBQ)M;)WCU@I%
MY&K>_7MAH"$V*]J:#=!7+TNJ"N"ZI-D8GZJN$VA @&Z8[=9.)V[[(N@J;_T$
M_K)_,N@L7_RW_,T%=QC_ +4W_P 4_P#;T%QZ#"KSC9]Q_C/'T[%\JD5\ZZRF
M2#F.X_+S&?A!RIT!1)N<UDE0Q(GUHURDA'T@75MMH,7?*/><X7&7C&K?,5CO
M+N#4$R)[W8//Q:WFQ</JK)HTAQ\6Y5FLQG\LR"&^/20FWOTIN6V@SUYVY-LN
M&^(LTY#J\?L,KM,8JI$B!C\-"<<?DON(T+\CPS9F4:&I][(4150:0BV7;?08
M28EY_+9_BCB'*\@X\CVF<<EY36TTK',4RF':TM1B\B>W7O9](L13OJVOBR'4
M:)AX <-]%#;?07/R-Y[[' KZX=<XJ?M,+D9_><+\?Y)%OVSM,AY2IH\9UR!9
M533)^R**<<L0;E"IKL*JJ)MH/7,<\S[D;ACDGDG-\$?Q[*^)KJXQ3*L/J[1;
MB.]EE:U&=C1*J\-IGO:RR6<THON ")U*B]J;:#S"7YQL^A5KV/2.'X(\WR<U
MJ,4B8:YF(EBLB'<XJ&:0[@,A\&*A%]B.B)-J&Z2BZ?1VZ#GB[ST.\EY5B3+'
M&TBGP+*LM'CE<CDY CEQ#Y"AP7Y%K6ICX1";<J(+\<V4>!Q>LU1=MEWT&Q:&
M^#I.FAJXOJ])(I*)M=1"!(/T1+=%143M[.W03I/L@NQNM@OQ&8BO_P#$J:#K
MXJ-^<,?VK?X6@>*C?G#']JW^%H'BHWYPQ_:M_A:!XJ-^<,?VK?X6@>*C?G#'
M]JW^%H'BHWYPQ_:M_A:!XJ-^<,?VK?X6@>*C?G#']JW^%H'BHWYPQ_:M_A:!
MXJ-^<,?VK?X6@>*C?G#']JW^%H'BHWYPQ_:M_A:!XJ-^<,?VK?X6@>*C?G#'
M]JW^%H'BHWYPQ_:M_A:!XJ-^<,?VK?X6@>*C?G#']JW^%H'BHWYPQ_:M_A:!
MXJ-^<,?VK?X6@QX\RG=R^+<U:C@-M,3'WEB4\=^:CMDZ3@[5AA6RX\AYJP'<
M2$5W0=U]&^@U 6J20FR6[ '\6]W!)[)H,=B\D#Y.6%N676+_ !Z+&E ,T+(
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MKU;;:#";EK^(_P"6#BYR37Q\R]^\A:W0:G"8ZW2J7P#X]M1@=J]G8XOIT&-
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M6_SS-V!R4 K(.%8K<>P[&VQ&:$<G;Z1.E"3D0"!M'&A7=47LT&PS#+Z#E%+
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MQ.RBA+1O=6Q<(T%M5["(>@A7<DT%-]QL4_4\?[]_[70/<;%/U/'^_?\ M=!
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M_4\?[]_[70/<;%/U/'^_?^UT#W&Q3]3Q_OW_ +708_\ F3PS$8?$V;S7( P
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M0/<;%/U/'^_?^UT#W&Q3]3Q_OW_M= ]QL4_4\?[]_P"UT#W&Q3]3Q_OW_M=
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M1-0@1T@%78H_5NR96.2KR8/#%I=L5197E^42[6 ,NGYX8>E _&PZ0\!*)2D
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MP8;T'&JVUL9G%.,V,N/[T<29(<RI6=E_+KCU2<F=B+LMWONF8ALH) /K*0D
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MD"3=1W(-[Q(+$\ E3Y#"B;XQ^ILC<ZA%$104(RP9SL['FH>-0;"^GT\![C;
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M>*Q=R)<J]Y1FRK%R/#DTJJKC?B1Z>I$78D5 0-'F<C)CYMR,DF&D*7:<AYW
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MI8W?*C:ITHW^-T&+-B.,^&GI*:R1S#_:%>G+3=4Y3CFBY[XNS]GO</J@]ZF
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M&1.2J@TBJTNZ!LB&$[$DV064J:UE<(,P=II-?/Y::G>+Q2ZP9S'H^_#4%/9
MLLYS!:5(HN@!/"ZO5T*OXM A;, -+#APK&EI*2?82..,3FV+X7'EONF[6 )Y
MMR83M;(.;33B(G )5[M +I151>H Z/=Q(:R!J8S-MX%_+CO\F8]!DRF9_F3G
MMWD@&<@XL,JX_#5<$A1UUMO9# =NI$]=0\ZYA?L)N&6EA97K&0VZ8O44]3G#
M*=>(8QA;D-YJ3PWD,$&JR+,S.1'%L6QD.QW''6R7OFE1!(--33CJ'CZ])LOU
M\JN&"R+A-G%9]N98@)'FQVY2TGJ]BM1V;?J]!."FZZ  *Y6Q(;'<"P\,.2[%
M =T?E>YEN9./0AGMP$(2[5>*<#B[;^$1?5T$%TG>ZE2D=>[RQ<M*V7,<F/%*
MEA[$PY/#@Z_#\99PD^!B1%KH_P#_ +7PZ"H #;%BZV2$@5-_-)A5:;;6(\G(
M2JBU[;+DQW'I'Q)$*YW^--!M _A#179GF4S6+%F3(13^*X\IUR$Z45YQI+NV
M53,FVY:V#G6N_?2RA.J7_P!.F@^EMK%WT:;1<HRA51L$W*4TA?13Z2(*(B_'
MH(GNN_\ O1DWZ6U\V@>Z[_[T9-^EM?-H'NN_^]&3?I;7S:![KO\ [T9-^EM?
M-H'NN_\ O1DWZ6U\V@\0Y^I+2MXTRZ= RRQ8E,5(FS+LIA-!6=,EI7+1PVXD
MT9+40-]V^Z5=E7=41570:JKN0\LS(#F//6\G)%%ODFUJW#\'YEV(UVP,2KX?
M1NO=&%.C-B+3JM;-HH$*$J?C$#F0_9.VE$3%LU1Y#"K:N+@F=K+>=QSR_P"/
MN.6'>X#G:>S6VER.:VBL=\\B$KA=J#LBD%'DL0_8#]$UC601L/9M0NY/#_M*
M2]FKV8CCKKZ<O-V)5Z3?<0Y:)-04%&5#9515_%:";ER;!V[OICMM$MKB?#DP
M\RSJ-*?:Q[GC&8_L8?\ *_!F$K"ZLNC"YW?>,FG=NBNR&BJH!@QYYI$IBCXA
M@Q[<HV,PZCE1C&^/W+60.2\:UKC+"+C.7,C12'["P-XE-%-QI.[W%2Z?QF@P
M2-LF7;E@>A&X!VIMB@L1FXKAVF"*CM?%*3(;IW=E7\?#DVKG;LK0[KL'81!V
MU1GNT=]IRX:2T=9%YZ609QD*B<^.Z[#&_<#;U#EO4G2G:@GZ-!*>(=>;@R#)
M5<BQ:N(V:JXRY%!O&;\0B1IA1BF,A(^B;#<67'1.SQ.WK:"%);%FMD0R1P66
M::UGI%?&-T,OGA^.*1L0V9)-,N)NJH^U.E/(O:D/?U=!]'7\'JM=NN!^2'SN
M+> ;?-^4DW[/DH1NAW#(_P!Z>=C0Y+VVWI>C1S3XE].@V\>Z[_[T9-^EM?-H
M'NN_^]&3?I;7S:![KO\ [T9-^EM?-H'NN_\ O1DWZ6U\V@>Z[_[T9-^EM?-H
M'NN_^]&3?I;7S:#!'SAP&(N-X3 N0R'D+'[');/OL AS#8O;EV% ><K[* $6
M-(<?3'9 ^(>W)I.[%5];Z*AA04RU2PDV*937RLPD8_*AV_*WM!QS!\SPM<:C
M@G#5(VM1W;>=,Q25A#%.]5]>I$4O4$*9'(695%$@1IU-54-S,_RTHKJ1*=LO
M+79/7-<,G*^54=K72?JG@7I:%XU; %V0NA5,0C*RQ/;OH[T&PO(%S/;+DC&H
M-E/<O?,C:):318RGC&45<!+2U9@CJLM=+2-)MU;()J$\V]:NRX]K[U0%RR'C
M<>EJ^6U>-<)Q+"AQ^>J\,7#1P$23GTU@>Y121'C)%)>DQ1LPU.>9T:=GGNS]
M@8[=X37Q*[C@(6/7DE]V_JS>K,D<EN1Y[D()U-7V$DB? &HE@) :;N-_10,=
M0:WAU\$P;7O8(3VX[01$CN/#@DTW),B&,YN#*EJ2;I)<GM227M\(J^KH)UPW
M'V?$JX9^*9R!E]2>-QQT6JW"D%F<\Y%C/V;3>_JQWXU>V']&0>^Z @NMI-%S
MM!*JY4VG&VW5*.)\CRTZ(#(HZE,AKZ4AI<JOP].@E*YL71:9[EM!E^R))@@,
M+"D/+$R567)M6LEJ--)27UI#TV$^/P1U]&@^RKRHX[.?\N/"3CM[D,,?\KL(
M1&6'VV6!<]@0^\&*T2DXD0>Q 4E[4T&0ONN_^]&3?I;7S:![KO\ [T9-^EM?
M-H'NN_\ O1DWZ6U\V@>Z[_[T9-^EM?-H'NN_^]&3?I;7S:"FV]!*AU[TH,@R
M24K*MF3!2A43!#'KW5L5,$1.WJ1%Z?3LN@U9^9"$Q5<IYK"8;NFX%UCF+#R+
MCUK,D%>>8)F19,I!I>-Y81I*M2*ULNY,@Z.KI(20$_&:#QA9M@LRFG1<A9@Y
M#25E=7X'R'+G/#1<(8],:L8[G&G)PA6 U+R4F@6,)N>LKG3OLJ)U!2'AJ_8'
MLI,:R,,0:EM6R\3E8RESIO-6J%QYCEUV0E4+X83!EHLHNQ1[LT7IW_%Z"KNR
M);\C+)4VX&;?7U?*BY]G$&P?C8WS[CL:;1MMX)QP\-6XU#R1I@U:<6.'>$X)
MIL>ZD 2E.W8-66(3XDF/0RZ(HS?&DV8^:5/E;A'D,EF;3\I,'"1)$BU97^[F
MZ2*9'MZJ>NH:2\Y-V1FW(QS'UF2(W(.=S'YJ((QWYHYMCW?7=5(';V#%MR]=
MM^.EF\J+_P#+IH+=A[2)QB*(HS9=2Y)Z^Z>;>0LUR7UY'B?!CD+JHO:X^[4/
M+^2^#00-S$&IAN/=<2/4P6I2R7&76T+$+<1:&6,1Z;#A_&RS E,[=BRT^EH(
M5TWM'M&#%M6V:RR>%H66EAMNKB6+DK\6 W+<C0Y"EV^);F2WB7UECHJ]*!Z=
MQZ>W*F$$3TV*MMR!1LO/L/N-3"[OE2KZ3*2,5QRS0U3M)^-4K\:E\(?;$&-2
M7 $SR7)0(DW4!F-*@_$B+TIV;:#M[KO_ +T9-^EM?-H'NN_^]&3?I;7S:"J5
ME2[7J_O9V5IWJ"G=V+XJ@;=FXFB(BK]S01; 6Q9,%)[O7![MH@)5=;>420";
M7;I%&=]U)?@[/AT&HJ)Y%>5,DYGY/R[)L\I,*P?(KIJU;K.+(,FO#D*3#>9D
MUTS,<9M#.D-:V<VBR31M"D].Z[CV:"Z9'DFYAB8AB&+4W*^,W-FUA>3\89S8
M76+I"CR<.RC(SOVY5!%K28B1;"M)P@1$3I5%1=O1H-H.#T;6+XS28Q%==>A8
M[3U-+#=?1>_./60&80*X2D2*I(QU;=FV^@E\]7)_=ZP3#7:EC)TB2#H9%XR\
M_4QK,0V8D6#<<VWRBMB1*?2J+MH-6<+S?<@S.1:/CG(^<.*H_>9=45-@]AG$
MO([X6(A)*#-I(N1V,AS'6 L9PJRCIJB*:*B+H-LU>KBSI"=WW30,--]'4"=)
M!MW8DV@;B0-EV[$HZ"K/_03^LG\RZ"Q?_+?\S05W&/\ M3?_ !3_ -O07'H,
M'?/9,QJ!P3D[^68Y6Y10NW&-Q)D6\OY6-550Z]; K-U9VL%QN<%9$/UC!C\<
MO]'08_\ DWXUXKN\\R#D*IE<97F3XTU6@S8<5\BYQE12([K))$B7[.2NB+D>
M,G8T!(2#\";Z#:VQZ[#:N "$2=9@B;B)JJJ7IW[4+_7H(G=M]GJ!V;;>JG9M
MZ-NSX-]!U1AA"0T9:0Q55$D;!"%51154+;=%5%V_DT'8FFBVZFVRZ24AZ@%>
MDEWW)-T["7?TZ#D@ ^GJ 2Z50AZA0NDDWV(=T794W].@ZHRRB"B--H@?11 %
M$'MZO53;9.U=_P"70=D !^B ILFR;"B;(GH3L3T)OH.41$[$1$3[G9H"HB^E
M$7^5-]!QT!]4?O4^;04B]1!JYBBA)NP\A=T"DJHK+B;%T?C!#JVW4/63TIH-
M#GC$61(M$S6Q;CP[8ZB7SD\SD?CN&73?MWG.*V8\LDGS8UP0"VK[NRB3P]7;
MT:"A$P^AA7Q<&E-DTR>0_P"2+SV0(&..>[[,D?,+7RB477[HFU<E%%3\:;Z*
MB?CD703;SKLAZ'-AV5CDD/))4JGC<@.1;_;S5/,6<(0X[GPQ4/9L+NR[MJ0*
M]WTMDH^IUZ"8D&\V$HULY]&SBCC,2=D#35S(?\F[[UV^R.(53;2H5NW<I^*5
MQ.H :-%7\7MH/->6VFHG'V04[E"[BLR=545FUQ%)28[ S6M6%.DKSI<2;="B
M-G6NAWCHS%[CK='O=S0-!IMAM*+F-"R>ZQI,!VN=B@X>ZG>97WS^-LQS;L9K
M7:JN%1$,4.U3]&@D&%(*N$(*$>.\VT9R29K)%8Q)]T+?=UIYW;&#O75](R4]
MJ[KV;KH)U]=V[$A%PWW6K-AZ*;=@5CT>P\.WD7PRB&_8A?#_ -04JCXDVT'8
M=PLE-%'O(]V81G!5EU9 KR*J*&,.0T;23M_2'&D0OK*F@VF_P>C,_,[G)1>L
M^OB9DYTF&KX-,2EOK<1;E'%Z8K,I4['!LNJQ545-_3H/J,C-B,=A%$-T9:1=
MAV3= '?9"W+T_&N^@C] ?5'[U/FT#H#ZH_>I\V@= ?5'[U/FT#H#ZH_>I\V@
M= ?5'[U/FT&.GF:0@XKS/N:M^X5ZA=CNP& LW'9+3C[0E7QAJU!]L[3?NB+=
M/57THB+H-0UB<EF1,9&-(QY<8 ?'5=>5R^'DTA.70"EW"<C)W=U$>ZD>;$/5
M4'BZ?Q2+H(489KKT: M!)MW+^/!G0>-GG+P6?-"P+L_O.7+R2[L560,IWZQU
M]9$0>KLZ-!+'-%&_:XY5.\.K"T#?.R,7BS&9,?'GT:\M1P.I9ZU_C1\$,M>T
MW@3M[]=!47 DA-DUAXY.Q\<>&79GQUT7CK?EP;):A5Y;J9JD(3O'*9.HTB=0
MHAHVNW>:# SSSH^D7C.:M5*LF;.JY8?C<M UDW5S2RD>.RN826HAA&AM0]^X
M$9"(T3>ZK^)WT&!A-MDDYLP:=2._;$RK8PB;E'[5P1>FE2MZJ=^8"_T<?Z9G
MI4NU"T$PA=5G8N.$/7+EP!DONGT.Q^C.LA[L,AD3Q6&U*';8 R8%=^+;LT$N
MI(9P4-B4!!353;#+B6)V"-IC%\CEC"1K?)7:\1[?^F_]((?0G3H.\H&4@/ "
M17FF:VS-EUIBO<AB^N$X[M)CR&S3&$M.KT-04]L(:^LJ'H/I1_@TL'_D-R-+
M+J-Q[G;+&I(22E++]2.QL],2Q3VXW*3?Z$W=S9>SLVT&Y/H#ZH_>I\V@= ?5
M'[U/FT#H#ZH_>I\V@= ?5'[U/FT#H#ZH_>I\V@= ?5'[U/FT&O+SD2? UN!6
M2W;N!Q6<EOFSY3C1ISDK$_$U;K05+L:'^+-K*'52-WSVP]1)T>OMH,!6XSS;
M9U 8:_XJ+"D7#O!77<#&P)(U%&E-\[A,$^IV>I$M@3"*CCSGJ#^.0M!'BN2W
M7VG6;.PR9O(WK*/&S1(ELTGG"[NVB"6)S&7'.YIHU4IFVN_XON>I1W!"T'$.
M09 <EVRG8VQCLQBNDYFK5[U>4(V["6C.'5$8U%ZVB2P7H)T_Q)MFF_XOHT!8
M[BMG4O8*_P!Y(@,W"<&(]<=QG+;E5,,O,1(LNI%8D1W@1YR,OXQ'3'JV=Z-!
MJL\U<KQ?F*M)I9G/Y#=9I..H4;,"BV<2SNF&X.2MG#HF@Z\GEP*S;PYK4(C9
M(&[W;U+H,949:*KC,"D$6A9;< FPJDKV23!9A(PZLU4Q5NU[/6!]%N$7X>K0
M5&66[$LT%X2>:LP=#_J"/1P]G89^-N0F;VS5:7I$[@EK"'Z&PZ")7FJ3ZX47
MJ!B]>5EIDE:\7U<CS$4L:*-N_+(?A]VNE/K=F@H[32(P0"@JT3U24A9!P8[(
MKX;)7 "[=L$'&6;$33\6$]"M'/0BHN@^UOR?/)(\M'!I*?>]/%.""I$! 2$F
M/P]Q)DDV95$_HHJIMZ.S;09+= ?5'[U/FT#H#ZH_>I\V@= ?5'[U/FT#H#ZH
M_>I\V@= ?5'[U/FT%-M^AN \XH+T@K9$3;G<N-BC@[N@XB*O4WZ=OA]&@U ^
M:A_JYFR64M_(NO8-#BSECDD>/-25Y6&I5@V(92PL$D6U6W'<SW'J!ISUT[G?
M0>"/(])<BUSF'2K4\@:K;*'Q43UR$;S.QNF<Z[S-.DJNT*PI7&QFDT:BBD@H
M:+N&@CR)SAP2MV<PL);!--UKW/3L.\=F3WRHR)?+^E:!B^;,^2*0UDBO4#J)
MZ7=M!WEM3U*RB-8_+HI>,L2+27QBVEV[%\JWX^F<:Y)J$;)"N9=B3RR6VVNI
M11P^G8>\T$A7OS9<FH4:J7D29)/8:C4,ANW;_P#O$8"^=&1:3G3_ !5,Y1"G
M?*3J;$TVB%LUMH-)^9ATYGG3!PPK%9Y'SGN*ALT="#+#-<=%*BE15ZI-E%VV
M7V)_?DV]=4T% 8: Y;H&WT?]8@^*;DE&EP6IOOIDJB=ZQ,)(D"QW^BWD"E)W
M^CNN@E&U(GHLIQ'2?"OK& Z&YR3)@EA]NG6V$<UR9VO#X4@J-5M]-.G00[@0
M&!9@*QD;;KK(VW-Z]:IQWW3Q=58K#90<:*T0EV5NN_ZJB]B^MNN@]4XW)5Y=
MP)5!]W_^X="<MUIN;&EK_P#W4JE2'DSH*5BT#2_[H;W=2V3H^#0?<RB"2(72
M*[HB^A%^#L[?N)H.>@/JC]ZGS:!T!]4?O4^;0<]([;=([?%LFV@X417TB*]B
MIVHB]B^E/Y%T'"M@2[D *NRINHHJ[+MNG:GH7;0.[;1!1&PV'Z*=([#_ %4V
M[-!V04'L%$1%7?L1$[5]*]GPZ"U<JE/PX;K\:&]8R @SBC5S9BV-A)  -F K
MKB(RT<Q1[L2)4V4M!I?Q8'.3,GP''7?+U?<8Y;3<CSKR]Q>7SKC-=6^RHF2O
MV9.Y)C@/.VUR<.9_>XD, !4(_3MV:#=C )7)KQ[]0^':7;MZ&NM=T1GXQ<$=
MRZNU%3051_Z"?UD_F706+_Y;_F:"NXQ_VIO_ (I_[>@N/08,^=F%1VW"^01\
MCM[2D3WPQ$\=ET6-UV174V_A6R.U5;!I[62-7-\7)_%D4D@';=-MD306?Y2<
MBRX<OY'PW.3LJW+JV#06+V-6O&^)82[#K+-">C6K=AATZR8LA5L?HO*BBJJG
M9H-AD(P<C-F"H0$IJA(76A>N7K;[KZ?]6@FM T#0- T#0- T#06]E*HM),!3
M$$=:<;5215515ETB1OUVQ1Q!%5%2)!14[530:*W6;4\EJ:R-C-*6;RG"EX3Q
MH<:M#C[-<4#VT,S.,_DMW4JJC9/#:5PF&E<?<4Q392ZE4 LMDL==J8\F+=7Z
MX,MT_"J.00JHY<CV6='0QFW^+[^$E^\^?%_C@!D'R,6?#KTJ8@/>$%SS6C"X
MRZ+808=;?U+,B3RQC%;$A/T/#-"5E 5S,N'9278,SLH'U27N ;525=Q$AZ##
MB*PGB<.&MAQK.PL6T7A.JG18:UG.].MU(*;=\UJ[<M-QI]>I$\VKRJ7>INB*
MJ]V(>9<G,P1X=SF12R[&SQJ%:T<:XS&5'1G+\5Y!88L!9PC' :E6\X^.'S0F
M.^C,S 8:1!1EW=7!#3<VV!^R(IM(XT4JKDWT5P!0SD+>Y630^#=D1XUDF_T3
ML)E \G]%@]!*,D?@HSS*-+81JQ@"!)SDAUFK7#[=$:D3FZWVJVTB+MX1FKD1
MA^&Q^'03!""0YD1I32*TQ9RX+'3&1AZ2M'ARFS'@L2I+%4 JG_SC%A;22_I0
MP]&@Y9(CG/$J)M-OB"UZ#,NS_,5>@73D,,I;?%M8>[R?54M!M6_@]*1>9W-7
MFVVWWV>(6ABO%W;[C$<+^W3I>?[R)[*=[-@C,L6#+GYU\8?4-&)3CL$2$A$R
MV2H8(V>Z@BKU FZ 7QI\&@CZ!H&@:!H,>/,XR#W#^=@\;K,5R@>9G.QXK,F6
M,-20WWH(2;*M8.3%$>L44T]9$^'0:;06(43$G <>N*:XF2O\G+&P@L-3N<YB
MY*).5_-C;MM&=JQC3U[!DH:*#0DH"2=VH1D6G2ER%^=;6T'%*Z36L<MYG KH
M99/Q5E S+$&<5XE$;]9;N%R9VP&40D:!OJVZD)1 *@$:8[/2,5'3,9TN+A.:
MX_&'7%QE[A#B+_5RX\^5X4).1CI_QR1%<[]7U4-]MWT"2%BF6'1S84^QL\8M
M+2T9XSRJR@QRRSE'+_&50R<#Y18.\.5"PAIX!5EQY5:Z-E5 %!%P,$?/-'K/
M'X@Q+?EQ\P@L<GCFF*1JZ!,Q'CR\*%'=;H\'DN9+!%VGG-HCKKT9IX!=]9&N
MM.Z4,'GA)YVU>5LW79;ML%@K2');:CA:8)^+6<\,"5<B6VZC.B4;(>CQ"]FX
M0N\1;4W&"$EB3(;=9'!P(Y/BN=9"BMB^R,WV(B_"L ,A#L_WB;]@0^[9;2#&
M<!MN ]#IY4IIJ,"QGYPXU?DK#$.39#!LY(E]*3(L:Y_X? HOJZ#M-*>=:_)(
MG"-ZFN67I+C[K[4B$&%X\*0&I[=9&GR9##:;E#=K8<=43I&>2>OH/I6_@S;%
MP!R$U'-?#M<X963"H#;!>'6.SZA0&'YT2M!#] !,F;^GKW]5 W(:!H&@:!H&
M@P%\X[CSK'&[5+44&19-(O[U8&(9(+/NO=,L4LD[6?82'9T5EN93Q$5UCU'C
M)Q$38$]= UP1)&.NX[&FA=W7N++LYC5!R842.QGF29^E%&9=XUR*)[5\:QQV
M$A$8;,C)EV-V)TBG>D$T(S6[O,FKBEA5]I2B^?+5;6,QGZCA"F]M0)46^X7-
MFT%JUN)PHCCGA@!TG.PA$Q[L@FV(;SLO$TA0:^PNK<$E<14ULQ$8H>8:!F?.
M??N.8S9NGFH>1N(1&PDGO3!Q.P=U4!"E].-+C4UYRXORP!BRB1KG-_ BG(%5
MG\BFL6H_&V.1$N5D/<=MGNVXX+G<JRG3L0JK@!K(\V\:TA>8[(H64X_1XU-*
MFXO&UIL?:K2H482LR+V7)A18]BU4RWYL3H<>\18U)-NDJ"#JINH8T;O-0H\O
MI[AX(;,1MTW)S38Q#P*8C;*V ULRQ;(T[$CA6O1=^Q)VWK:"+):!N.^R@= 0
MTM'XH'%!HQE'78:I$+3=A)BU>Y>B0Q)MGR]*PP7U=!$B;N3(S3BJX$^]<*Q%
MQUMT6D'DB7M(45&&&2=7H49AX\H;;HA+V:"5AJ:MQW6D4W(KM2S%1IXDC,1?
M!Y+UFW*:B3[:$!(FY,-P9[ KV>+1-!]J_E(Z2\M_!K@=!B?$F ]+[2*K+NU!
M%_W;J[=YTJO;ZH[?ZD#)#0- T#0-!3K8T""\JHA*70  2;H9F:" *FZ?25=M
M!J4\U+,DN=8#;]=7A=3J/&7.-*BN"*[ Y7FQ;1I)M?S$K[\(:^FK"1495T#1
M>E%!2/9I0QK>]B)6W3]A;6T/#X4ZMA\CYI55\<\QXPRM';(H&"\4QUM^^FX=
M-EFK+Q1U1I&%[$)5) ".XU9++*$[0U#>?K0>-=XW:*N+CMGCEO&3&3R2R\EH
MW7ER/#KE[\6543&9^)Z^G\=H(;35,_$Q\XLNQM\:LK>=&XERF=%8')^8\F5Z
ME63A_+K#UTVY78KXP4%5DDC;@@))T;"#@3H18#,V]&YD2JUFNMX,;EZ96Q8Y
M6G"-H[D#SE:UPHD>Y)+&DF2=FWTB=2)NI]!+NT@:.\Q>8+,LZ.-)E3H#^>Y?
M$D3I#:#+G5_OICO=OV*FG>65BX/:4:2M,R*_1E.:"B1D49C;+8M+X2TB>Q6F
MG'R?;K_?3)5=?7N6)3U6B)OV06[UKXW@].@D!%M4C-N$HQ'XD.0T"C&-U9;>
M*VW=M-5SDIB%8BXO_P!4[81)(;]D0E[-!S>&XK%L_MT2GZRS8E(+SP$D4<4Q
M@5;.S?A))L$%.SP[M;7L)Z/&JGK*'I/&XMM\M\?(3B-M,<B4PU"2VVXZ-O?Y
MJU?>H8NS!9H0(OH+!?O$=_I*WOV!]SL4S<CLFX)"9 BDA)LJ+Z%[%55[?]>@
MCZ!H&@:!H&@:#R3F_DVFX<XVRGDN_8>EU&'U3UQ81XR@,M8C3C3;ST<W$Z$<
MCB[U(B^G;0:7\6?XPRCDC&:&KYIXDE8]><D0>1H.3G@UTUS^[93YJ6K6+O96
MD5&'8V[Z,&1.;*VFWHT&]VH=[U^0OJBJMM&3*(AJ"GZ"-]O9HS,1151.U%7T
MZ"L/_03^LG\RZ"Q?_+?\S05W&/\ M3?_ !3_ -O07'H,!?,]D]99\K<3\#96
MSCM=QUR8%Y=YC?YA,=@A;>[1#(J<4PJ>CT8*[,#G%WX/J8$VT*(*]N@LKRKP
ML;P3FOGSC/$PI,FK*Z-1Y+7\@5]Y89->E"MFG.[P[+K^QGV++MK0&!=VRTX
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M=G>&4>\914,N[ZA4,"'',B;R.S%RQQ;WR?QAY[(<B:]VV^-CXWAXPP+%-CK
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M&6(CS&;X[X^XBF")'&M4]_#C<I-@H/T64T%L01%9\5$W>:&?"*&V)O"[+_\
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M\JO7W)D:98LX_P O/QHT:,QDM/":J9#3,)A@EC* $TVJKMOT;N(&"Z_BW+)
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M>+_T[=J>^6^PFF@AMJ][-KB<;D#)""R+$9QF:LI(WN?;I[2@5XRDOGX9HO\
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MR]R)RKEU[RI)P2RXV>Q.[P[CBJH9EW$NL H<CI3@6UTQ5!&[NXR6RFGL<LC
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M#0- T#0- T#0- T#007_ *"?UD_F706+_P"6_P"9H*[C'_:F_P#BG_MZ"X]
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)]'P]6WW=!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!/@*\ P$1  (1 0,1 ?_$ )@  0  !P$! 0
M       #! 4&!P@) @$* 0$                     $  ! P($ @0&# L'
M P,# P4! @,$!08 $1('(1,Q(A0(05'2%54689'1,E*2(Y/35)0)<:%"@K(S
M4R255A>!P>%B<C5%0S0EL6,8<T0F@R<H\,)D-AD1 0
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M+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M>
M>KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_
M9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M>
M >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,
M_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M
M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM
M,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]
MM> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >KM,_9+]M> >K
MM,_9+]M> >KM,_9+]M> >KM,_9+]M> ANVY2RG+EK&:D@$%>>9/# 4CE-]O\
MSY_(:LM&9U>]\>>> J]M_P"TM^PM1'L=; 7'@& 8!@& 8!@& 8!@& 8!@& 8
M!@& 8!@& 8!@& 8!@*<^_P I927$M')UQ&HGEZ&AJ<<=5GDE*4C/P # 8:HV
M]NTE?N-=O4/=>S:K7C*<CKM^G7-3UR5O)7H<2&5KYB9C;B2"RDYY#HP&<622
MVG/IXCB"DY D#,',Y^/ 1< P# 63>MX6S8\!RX+PN6F6G0(;0,NLUF=&IM.9
M4XYH90[+E.H;!<<(&D J. IEG;B67?[,B79%XVY=D9@),J3;E7AU$-/E).E3
M;#[RT=3CDI*<QT8"^4DJ;25K=4A*4NK=STE1\#>E)&61Z<!:=VWO:]GIIB[J
MNBD6XBM3T4ZFIJ4]J')ERI&268U/:<.J6^I1XI ) XX"YX+H6\3S2LN-%02'
M>8%I0H)2Z1I 0I8/1@*K@& 8!@& 8!@/AX@](X'B.D?@]G 6/2KQMNOBJN4&
MY:36#;LQZ#7S3:A'DKICT<*4[%J;;:R8<AH))4% $ 8"HT:O4NY:>S4Z)6(5
M:ILYM:XLVEOID0W]!*5(;DM*4C,$<<C@(CD\,I;;=E,HE/.*899D24,K<DH&
M;K4-)4#(<0WQTC/ 4RK7/1:*]3858K<"DSJW/11Z )TL,OU6IEKM'8XS"E N
MOED= !)P%YM+YC:%Y*&I(.2@0H</"#QSP$3 , P# ,!:%U7'0;:$)^OUJ'1F
MZE,BTJG&;*3'%1JLAU0A4^+J4-3[SG2 ,R,!-6Y<=#KZ:FW1ZQ3ZJ]1ZD]3*
MRB#+3*--JS62I,"3I42TZUF.J>@8"Y< P$I+66TH<U$)2HY@$C4K(Z!F.(&?
M3@*);5ST.Z694N@5FGUN+#E/4^2] ?0^F)4(ZM,J$]H4K2ZTKI!XC+ 7-@&
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M ))\. P/0_N]=J[:W%I5S-W3?TRQ[?OE[="V-FIU9/\ 3JW[W7(=EIJ].IY
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MZ*LAGF".'21^++(8#YFHY9*2"H9@</; Z3@/2=7$* X99$>' >L P# , P#
M, P# , P# , P# >.6CIT\<R<\SGF>GCGGQP$,QF5%)4@**#FG,J.1X\<B<L
M^. AJ@Q%9GD("E  K1FA9"3F$E:2%%.9Z,\L!$3&822I+2$E2@I12,BI0Z"K
M++5E[. \B'%'+ 90 RHJ: S 02HJ)2 <AQ. \J@1%*UEE.LJU*4"0I9SS <4
M#FXD> *S& B*C,+RU-)X#2,LTY Y @:2.! P 1F!KR;2-9)5T\2<L_#P'5'
M<,!Y,..23R@-6CWI*0-"@H: " CB..66?AP'T16!G\DG,N*=S/2E:_?*0>E&
M?L98 ]%8? #S86$E*@"599H(4DY @'B, $5@:LFP-2DJ.14,BD) "<CU4Y)'
M 9# %18ZL]323FG2>D#+5JX $9'5X1QP'TQF2<]'Y?,X*6 5Z=.9 5D1EX.C
M !%8!)".DE66I60).? 9Y#C@/)B1BD(+*"D)" DYY:0HK RSXC4<\!Z3%80@
MH2V E0(5Q420? 5$E1]CCPP'TQV%%1+2"5A(5F,]6G+3GGTE.7 ](P'WD-?
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M7OH\ ]>[6],1?BO?1X!Z]VMZ8B_%>^CP#U[M;TQ%^*]]'@'KW:WIB+\5[Z/
M/7NUO3$7XKWT> >O=K>F(OQ7OH\ ]>[6],1?BO?1X!Z]VMZ8B_%>^CP#U[M;
MTQ%^*]]'@'KW:WIB+\5[Z/ /7NUO3$7XKWT> >O=K>F(OQ7OH\ ]>[6],1?B
MO?1X!Z]VMZ8B_%>^CP#U[M;TQ%^*]]'@'KW:WIB+\5[Z/ /7NUO3$7XKWT>
M>O=K>F(OQ7OH\ ]>[6],1?BO?1X!Z]VMZ8B_%>^CP#U[M;TQ%^*]]'@'KW:W
MIB+\5[Z/ /7NUO3$7XKWT> >O=K>F(OQ7OH\ ]>[6],1?BO?1X!Z]VMZ8B_%
M>^CP#U[M;TQ%^*]]'@'KW:WIB+\5[Z/ /7NUO3$7XKWT> >O=K>F(OQ7OH\
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MB%+:4AQM0'%*DD*! R. UGMGN%]VBWK4I5JQ;*<E1*74WZF:E(JU3-:JBG7
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M"P2>/' 3& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@&
M8!@& 8!@& 8!@& \E(.>>?$9$9G(X#ZE(2,DC(>+C_?@/*D)4<SF%:=((.1
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M[6_2KD@Q*A3X=6CF0W!K,!ZFU:+P&;$R$\2IAULYA0. NA_]7^<G](8"T_\
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M<D+;2$J>=RUN$?E*"0 ,!X7&2MTNY\2$I(4"1H'2$]8!).?3@/*X:5Z<G'$
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M7"E&2@%%M0!^40X!F0XV<B@<.G 3> 8!@& 8!@& 8!@& 8!@& 8!@& 8!@&
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MV&1U>6"59#,X"]:;4VJFVF1&"'(KC27&9+3S3S$A*N*7&'&U*2XTI)S"AP.
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M+:RCI"L\_#@-\(>79F@,L@"$@9G)() 2=7'4D<#@)K , P# , P# , P# ,
MP# , P# , P# , P# , P# 4^0C4]QTG)*5(6M1 :(U)ZA!X*43T>' </-R&
M;<5>>ZL!JEW"BR*C=$%6Y5MU%QAJ^+LK"'9K=/G[7K?0)C5(84D%\-JTD ]
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MK5V*[(=JSKD4QYLZFP8K<" VA6D)<458#N12#UD#FA]X,AN:]I#7.>2A"E2
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M%A2%H*DNH=!!"DYC(X"HX!@& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@& 8!@&
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M.7# =A(.Y%OU2GP*M3&JI4:95(;,^GSX4%4B-,BOI"VG&'6EJ2YFD\0.(\.
MF4WU3E'(4ROY]'&DOCCT=). C>N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77
MOX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[
MY6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >
MN<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T
M77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX
M6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6
M >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<+T77OX6[Y6 >N<
M+T77OX6[Y6 >N<+T77OX6[Y6 @KOF V"I5)N'(+2CA273F5 $$=?BD9X"\([
MZ)+#;Z$N(2ZD*"74%MQ.?@6A7%*AXL!X<E-MN):4%ZE'($#-.>@K )SS!(&0
M\9P$$U*.%%'6UA8:",V]1=* L,D%S-+NE7O3D<!$;FL.(4L%2$I<+6;B>7J6
M/?)3K(U%)X'V<!#<J45M.HK*@4J6G0 K6E'!6C(]8Y\,AX<!X35H2D!8<(24
MI7T D(6H(0LI25'2I1'X,^.6 FV)"7]>E*TE"BA05IZ0<OR5*R_ >. I=PU.
M#1:3-JU3D"%3:>PY*FSR'%=ACM#4N1H:2IQ00!QT\<!P8M^Z=N-TM_)=[PJI
MMA06$;JOQJ9:]>@7N]ZU)AU0(\_LP<FJ.JHR'$"2@NH*>:!^' =[*?'?06W'
M%H6CD-A.A 2->A*2I(_(;6D9A( R\. J#_ZO\Y/Z0P%I_P#,?G?WX"?MO_:4
M?ZU?I# 7'@-3>]C3&ZKLQ=T&H7+5+2HOG*ERJI5J3$G29<F#'J#3LNEM-48*
MJ914&TEEPI&:4\<!IGW#Z-;,/=?=>/9]?ARZ=#MZF1V: [*NYVMSX,F>9,:L
M56GW9DFFR"'2PA;8R*4C =4*C;L2X*2[0ZU!B52BU**["JL*<RS)CS(;C>A<
M>1'<"FU*5T$C 6C:NS&W%E6MZCVS8-KTRTR^N7YE%.B+I_/>>#SRW&.6HNN%
MQ(6DD]4]& GI^U]G3;A<NB19ELR;@<@"D"NKIT5RI>:EMF*Y3W7'VR%Q#$44
MY#B$G(8"WW-AMM_-MLT=BR:!!HUIW#ZR46BTM@0*=$JICNLKFN--@=L6X7.L
M',\!/-[-V'&H]<MF)8UK1[9N&4[.KE%138BH5;ER%!3DB>A;>KM#3HUH4G@.
MCIP$6/LYM_"G6[5(UAVKV^T(_9;<DII4)J33(ZNMRH3J6ARDI=)7FK,E71@,
MEPF'VEOJ>"1S5Z@>:XZX3F1UBKJ)&@#(# 3;H=(3R\NDYYJ*?P=& @:)7C3\
MXKW, T2O&GYQ7N8""^X]'9<>=TEMM"EK/,4 E*$E:E*)&02D)XG :K?_ #'V
M<10;AN=55J#E'MFX&[9JKB8TGGIJSSRF&T1XC@#LF-K0<W4 H'CP%P)[T^U*
MKCF6JNH2FJK!M<W>_FD&,:*(HF*4Q)_4O3 P?U /,SX98"E,][_9211;4K\:
MMSG(-Z5SU=H.J&MEYRJ:DIY4YA:0]3F"I67-="4>S@(T[O;[1PFK^<D3Z@RC
M;.3'AW<L,ZNS/2G TRFF\LJ75]2_"P%98"Y[4[P=@7E=-!LVBU*6]6KCMIJ[
MJ2AII]^.JC.K4E!G2D@MPI2BGBRX0X/%@,[Z)7C3\XKW, T2O&GYQ7N8!HE>
M-/SBO<P#1*\:?G%>Y@&B5XT_.*]S -$KQI^<5[F :)7C3\XKW, T2O&GYQ7N
M8""IUY"U()]ZG4I04O2/$DJRRUGP# :7]\OO8T;NV6.@4S37]V+L;-+L&S6'
M5NRY51F M,SEQF@IYM,=2@<R,LA@,3]Q[NK5VQ'JAWAMZY@NC?/<X)G/29S1
M=-I4N0VMYJDPB_J7&<90X0I2<L^C :R[F.4%Z\MTI8K-S2K+9N.*QN+=TYMW
MUTL"J*=F&G1=L IU$R339^21($;(#,Y^' 6Q'C5TU>%&31+<<OV3;7.I5BNM
M1&[&JFWB::XL7W5W"\8#>X19&OEJ_>"OAGG@+>YU#=HL.0BLU^19CM;EILRZ
M'XJV[WNJ_P!EF"AZR;S:=>$X;?1GCI;6]\@IKH&6 K%0$I-2NMF9$B,5JGH:
M>W>CT]N.JC[:4M-92['G;/--O!N55GTK(<5$TKS2,^. S3W>501O%MJFJS9U
M+[917G]LGZ&T"WN!;_.=+M8W94RXH-7*A'%"96;@5T' =B4:E+/+5F5A12I7
M4*T)5I5J(3FHI5D!GX,!&T2O&GYQ7N8!HE>-/SBO<P#1*\:?G%>Y@&B5XT_.
M*]S ?%-RE)(S3Q!_+)X^#@1D1G@,2[L[,V=O=8]6L;<FB1*Q2*DP^A3CJ65R
M8+ZFREJ927E)*H+K!XC+IP')2F79O7]VG>$"U;\FU;<_NGU^654.YF69<NJ[
M=\US2(SKIYBV(T=))4%=5:1PRP'8ZPMP;2W-M2CWC95>9KU K;")$&I4^1SF
M<EIUAN24DJCO)Z%(5D1@+P#ZU'2%@JSR U. J/\ E!2-0P$QHE>-/SBO<P%.
M>J26' VXI0S'5< =4TI>8!:2H)(+J0=1'@3QP'I4\(25K<TMI<#2G#S="7%'
M2E)(23UE< 1PS. ^IG*4'2G62UQTC7J=&7$L\,E];J^/5PP!$]#B6U)?2>:
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M1T56EIVQIS59G"(VWVQJ-.4-2*L' 0IUO,ZL!T&AR6'RV&U\U1:U<U.8:4I
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M"F,\^TYJRRP$<]X[="2J558EXUB/;]Y*=IEC4N2S 1<UL5N.(<=VJ;CL ?\
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MRQY,1)5<4++LU<F(;0W-GL(R :;>>25  99' 7X_^K_.3^D,!:?_ #'YW]^
MG[;_ -I1_K5^D,!<> TQ[XLFVZMM;6+0KNXU%VXD56=%G4*=69!4FI5:ARVJ
MBU"--96W/JM-D<G2^S'2XLC :]]RJZ)^[6X^Y^YM6K@N&:NV*+9[%4M>UJO;
M5@SF:"X4.,P#7%<^75TE&DJ#:2&QD<!T^B26V([#<AQ#;BM92C(@A.:E)"\M
M0Y@1D#QXJZ,!':J$1T9H=X Y*UH<;T]75FO6E.@9>$Y8"*9<9.1+S8!RXZN
MSZ-1Z$YY\,\L\!Z,AD*"2O(D*4,PH A !402,CD#@(:9L5:M*7VU$=)2<TCA
MGD5@:$G\)P!4V(@$K?;1D<CJ.DC/+(Y'(Z3GT]& CH<;<XMK2L9!0*3FD@YY
M$*' ]& ]X!@& HEQ@*H=5"EI0DP)FHK.E.0C.D:E $@9@'AQX8#@8TQ3'#5J
M:W:U39M.=6C4+CV54](;NK<ZY!,F(8W+MJ4ZQVA%!HZ0'5)S2A6CCPP$7MM3
M<G/51Z[H\VY':**3)WA4M0M^LV@J$I4C9)B(B&EA-Y2&D<H.9 A0)U<0,!Z
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MB3(%7H45$L%<)E;-(F=E;>F E02M SR. Z#4.F1J,U'IM.IT:ETJ)$;C0:?
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M9P'6!%CT=[-:'*JTV]I<);J+S:7%)2$APA)U)4O/,C+ >_Z?T?ZS6/XM*]W
M/Z?T?ZS6/XM*]W /Z?T?ZS6/XM*]W /Z?T?ZS6/XM*]W /Z?T?ZS6/XM*]W
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MM /@P':.B\T-PPI#2$N4]AYUEHJ 8DNH0I] 0K/)I+F:4#/J@98"MO\ ZO\
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M2DGBCJX#OBUTK]_TCBK+23FK/2/!EX<!&P# , P$E/!,967+]\DGF:].0SS
MT=;5XO9P',7OF@/WS:%/37)$@2Z&PAK:E2)33>[[QFM96N_+0H*9CG/-1)
MP&H3@25(F.5IRW446='IE0W$9C3R[W5 LNH.WU/C%1\XQ7L^7SDA617G@((B
M2BMVE)L]?:W=-2B[#1B\\B[8++3BOZ]R9A7I:DE'[\6\]0/#+ >@^EQJ1/%W
MOUF-/5V.+O"8TEF1N_(6F*P]L/*C@APLMI^3#I 2.&1S"L!Z$8L]K811Q1%V
M]-3(F6TUVX([H:'9H NFF3.9IJ3E83UEH!5D.D8#BQNDZT_N5N3(%P"Z&57M
M>"Q=2VFHS-UZFHFBK%Q*!2GG9!.HHBH1,&?%6> LEP@3G$CJEM]2I 5I# <\
M_P!/ZS++V<R([_GJ9<9]C 0TI4J134:5J==[*MA"0ZI]QOME9S6WV92'I$;/
MI,#0U[& ,%(A15M9H;;Y3>84PWRG#2I@4B0Y*2J @$]")"53#T)5G@.M'W/7
M#O$W:B2"?_PZ.0A*5AX#L<0@E#V=1#1\&:M.7@P'Z>F/U+67P$_^F BX!GX/
M#@& TQ[]=HJOGN[W];R;2N2\T/QX+RZ7:+Z(UP1W(CO:FJE$3)^0J#4)2 M;
M'$K R\. QKW"J%OE0MH;4%[4BVK.L\1WA2+33;LFEW0ZQS,F:W5V&B(D&?4D
M9+<0D :N/AP'1".H*"U9*&:L]*CF4C+@,L@4\/!@)C , P%N771XU?H50HLL
MR4QJG%?A/KAR'(LUMJ0VIM:XDA'ZJ2D'JD\ <!SI7M/:\2KU7;N%WUKYCBDO
ML1JM99N.@/5ZGQJ@X6XU,F59;/;HZDE90@A84.CIP&_]AVK3[(M^C6M3)E5J
M,2DQ.RIGUF:N=4)FA*5<^3*>)=DJ63GJ' 9X"]'_ -7^<G](8"T_^8_._OP$
M_;?^TH_UJ_2& N/ :<]\MZFM;#W\*K9GKY >=IT/S([*GPX4>9(J3*F:M/?@
MCM;=)IA >D*;Z-& UJ[A=TVE<%?N./:U+7+ L^!,N2Y(5PW-5Z7$KD:J/0EV
M]"]90$AHH8#J-&9T$8#<;O"T=FO[';DTA^%7Y;-2M:I1I;-KK4U<,.-)CJ49
M,5*1KEO1 WI+21FZD:1@.#VU=!H;FU%JV%,V/W %3K5RRO5/=UBVZU"M^@V\
MQ(;%4N*1;:'6U4:\FUM%IO4D:W"59'/ 9MWRVYW-G7?=E*M"S-P:ANH[>-!K
M=&W"8:G,0Y&QD*VX46I414UV4E/:I\)I\.Q??%QPC+/ ; [>U%FT=L-ZV[-M
MV]=O[2W>JXLS8JU9M-E19T>ZF[7,:MR8$-U3CE(:K,EM:42%9)"AG@,%4NRZ
M@+(N6;1=J=P8.T%%K>T;6Z%HS(,L3;LJ%NI>C;A2HU'R$BLLK>*5K>0-+JDZ
MN. M_;7;V\6KE9:D;=;BM7+6=U[0N/N]U.8U(5$LC:.'5)#E5A2IOZNC-K;=
M"^RN$*(\'# ?H&II/,?25A2FD,M/%*NHY(TZW'@@9]9S5Q/AP$"O2JQ%;CJI
M$*/-<6XL/ID/<D-H"04J22H:B5<,!;B:G>Z^"*+3$'PE4Q1&7BZBB?;P'KM]
M^>B:1]K?\K 4JN3;X<HU5;<HE)>#E/F(2V'UNA:S'<*4J0XZVG2HC(\>C </
M4JIBH-=J#U=J/JE#KY9N;<MQ"%[AV%=?:928VWEH-=J#QLJ:Z0EPI!3DH\<!
M/F'6!4JI"7;E$CWBFE.521MNRS&%CTVQS24Z]VJ:5RE,_P!24L9NY E>L\!G
M@)8B$Y2J')@U295[>J-:<A6!>\QI NK>*XRXP!9&Z*G%(FBUN8%(/."&M"1Q
MP$Q+0&47*N?R*0S0I,<;JRJ<E!=[O;ZJA^[PMEPW,*W(,UOK/<K5QP&N?>R#
M,?8VMM55Z91*D^FS9UDTFF1VDQ=R[917E.-;A7FEA]Z,+P=&1)<'.&?O2<!R
MT6TXB22ZAO*<26.<&TQ5*-85K4XO6I3DC+I$E$).?058#PR<Q#6.(@-- %O-
M8;',J8/)+@#K0(\,1,A/LX#Y2XL"<^Q3GIC$;)47M49II<I45J=0U=@EJI2<
MV%I*\OWKM 7_ .U@)^HU02X79W345SEL2X-P)GQ5TN,[-HLR$U$5&CMH[7*4
MM!21VE+*#\++ ?IS^ZK?N.-W0:$U2Z3#E1/7R^\Q)>0DATU!K,%"5K0G)7Y(
M) \!P'2(3[\R'_AZ0G_+VM[J^QP5EPP#M]^>B:1]K?\ *P#M]^>B:1]K?\K
M.WWYZ)I'VM_RL [??GHFD?:W_*P$C(J5\)6I(H-->=5IX=N(2XG0H$,(6H*Z
MG_4]C <<+\=I3EW[B5'UDKCULT^X8+.XE^MH_P#S39VI.&=V:C[7I<=;==H]
M24I*9)0E8ZRL\_ %M0X=Q>>H-.1:]N>M;]O^<*9MR$1'-O:Y9HI;BCNI5B_(
M=CIW(Y7RA 67@OH!P%"#E#=I467!K-5>LZ74IL"V[^D,A5X;A7HW'B)?VQO7
MFO,RT[>L3-*$%:0C1T*\. K4]N>W,NAJ33*; JM)90]NE1X;;*:3L;$75&=%
M1VD4)@0Y4)+0ZW+U'JC@.C 8#[SJ(\?82\/.,V91FZM;%'G;>(@--KD;O4%%
M>CJ5=&XVB2M2*ZSEJ25 KSZ$JZ,!RA*C)F:FPIYN8\Z@@MK4[)4BYJ<%-/*E
MB 7&FR. ?$1(\"C@/;"TERGZRE79G8$?(J= C U*X\F%Y,%QF.5#CV=N8C/\
ML=. EXS4AN"PTZE"07(\E[E(9">6BVIBD$)9G*97[!6^VZ?V6?# >VG>:W)E
MLJ45.Q*HROF%\!+7J_2!^[N2.3)+A\(7&0UET.GIP'Z-/N@)5?A["[AQ*- C
M24)WEN$J7)?ZP*HD4DN);4MMI/#I0XXK/P# =;>WWYZ)I'VM_P K .WWYZ)I
M'VM_RL [??GHFD?:W_*P#M]^>B:1]K?\K .WWYZ)I'VM_P K .WWYZ)I'VM_
MRL!R_P"]2Z\[NA/J%<=%/HD.A6RB]+TI[G:;BVI9,Y\0YEE GMQGU=74?#:2
M=)P&O<2)7)-0MV!"MNB5&\9]&1.LBP9G*]1MQ;30Q55(OJ^"[+3IO%IC-](6
M4KYO C 4M#M$11H=4\_5!%D*J;]-@;FJT#<";=J:2EM>VU3"%+J'J$U-S89*
MD\HM  D(ZV J/*F,52X6YU(ATRX:9#4_N19L".PY0]D[=6(:HM\;6J:F!IV[
MYK1"W0WJ(*S^ ARS[SW<EM2M7?=7>(N^^J[4K7K[,RL6;3%+:CUJ_:'2'$Q)
M<NO5,*6NB3P\M*GD/:>>.#0U<,!J)MW:5)VU9K<2G(E51-4DOO15294B)&H3
M[$B ZTJF1,A+?GPHLL)2)1;0LC,K& O2I5)EV2W)J#<J0W">G%NO0FV_/5';
MC5!#4>H3*8UGYY>F2G,R(_:@QEQ)P%2I]"/8<WY,1<5Y422]74 RJ:(S#E1>
MU5R*E:)*;EJDAXI81FP6]/%)P%+F09%$"%5!)CJ7$CM,S'7TNQ9++5O*CLPW
M*LT@LF2$ :HJD-:3TJ/3@.Z_W+#]8B4GO",4ZFQW@F[J*MQ"WS$;:4NEQU)2
M&VVY+0"D'/,.*S]CHP'<8S[YX<NCTA*2G/C/=<).I73I0T!P_#@/G;[]/12*
M1]J?\K .WWYZ)I'VM_RL [??GHFD?:W_ "L [??GHFD?:W_*P$O)G7VIL)52
M:/D5I!!ER,E=/5.1/!71QX8#GOWP6KA?KD&?7+>HT&B4ZVF'+IO>"['=NW;V
ME=O:_P#+6:TMU$ARI)5EIT@G/ :F):F.U2W&XE)AU*LU.(B5MU:TYEE-O;W6
MXE^27;QW2*I@0F[FV0I: LI.I(X8"GYTEJAS:@JOUIFR6JPU3ZKNM$;0=PJ#
M>JDN=GVUHJ1*YJMOI;V41PA)0&P>. FW(E9;JE9@S+>HD*\(U)5-N6P(26#9
M%B6B6(RSN!:*A,+9O7L><@A*BKG<,L!+,F.N+0%Q),RI0JM55-;55.:PE%1[
MP%1;J($RC;S'M)4U3:4?^U*PG/V<!QNW:,IK=K=<U6EQ*3/5>5XPYU*IDE1@
MTR8EJ*':/$5V7FJ@,*ZJ0MAEK(?K2.. Q\CC)0I'6,)\A#C6:E0D^L%/X,J<
M 6G+Q11)& ^ H!8#BE9S5L<KFZD2%L^=:N%&0V 8ZFB?RGWHCG_MX#R=9#4I
MH]5M+#(6HR@KE)I$I*@AU"5S2H?DI3%6T?VN7' =5/NC'JE&W[N]-*;*W%6L
MIQ,62XVB*X%4V"4K+413S':%9YJ)DA>?2@'A@/TFLU"_"RT?-%)'43P5*D:N
M@=.:L\\!%[??GHFD?:W_ "L $^^<C_X.F!96,W&Y6K-OPG):LR<!?$9;BV&E
M/)2AXI'-0DA24K_* (Z>. CX!@& 8!@& IE36E"&=>827" X%+S:<*3RW TV
M"MPI5QX>]Z<!PE?VUMFK;]W7(L^K;EU[;JIWTF'>J*%MK!F&7<$>X6JG4V7+
MVEI%0<CQZK% )3P0CA@.Y=*>1VA,1(6E,:&RVVE22$I:"4EI"G'.L])0SES-
M/ ' 5Q_]7^<G](8"T_\ F/SO[\!/VW_M*/\ 6K](8"X\!J-WPF+_ '=D[T8V
MU149=R/"*F7#ILF'$J\VWWI;"*S&I-0J6FGT]U$ JS4YPP&E/<^KEUV/O!4;
M1MG;3<9K9^YZ120I=PW-:]=1:=VI?0B=69GF9;DAN'/;!TZN&8X<,!V%BI9+
M(*"ES,K0M9&HK*5J"P2H9E(5GD,![3&C(;Y*(["&=17RDM-I;UDZBK0$A.HJ
MXYY9YX"*4()"BA!4!I!*1F$G@0#EGD1@*=*IM.E.1ER(<=Y=/6)$/F,MJ$=_
MCDXP%)/*=_S)R. GD)0M&9:2G6"%)*1D<QU@1ED0?#X\!Z#;:=(2A"0D:4@)
M2-(RRR3D. R. ^A*4YZ4I3GEGD ,\N SRZ<A@/I /2 ?P@'  E(Z !^  8#[
M@*'<H4:%50A.L]@E]7-"2H=G<U *7U0K3T>S@.$TH5I5Z07"[;AW& E>HSNN
MFC;95G*7.146;\>2CL3-Z!K4&$NCFZLB,!;2?,:;=0TA%=.W8N-"J>E995N(
MC=8Q@1(F-Z1-.T:7^)=43&Y7^7+ 5V:NJ(J5Z>=)%+7>*J:L;L/TE=/=M*5:
MBG8XU;1N(1R)%W<C2-,;)X*SXX"6;4IMZS32@A,EIQ*-BA4S"[,S"7+RFM;]
MZVRF-*=<_5=LS.7LX#7OO/\ ;4]WW<YJBB$S13>%I-[ABJ\D5GU\\]K46]M3
MD)3UC+626UQ2&^C+C@.5P^4=RS1K0X4NOCDZ<A659)J:@-.H>#M_,&?1@(=.
M9#RZ9%"V6"M$/GB2M;;D5M<RJI1.;0\KM3\9Q70892P1T#+ 3CLF*S3C%3/"
M:M'8?MZMR*?35P6WETVG*FT]0<=2(G.*<@,QSLO#@*=*==>?EN.K=<64RUJ<
M<+KCJB5T\DR-)[6R?&J:5-^QE@/U7_=, ?\ PXH/!/\ _O-]GARR">WMG,*;
M ;5^%/#Q8#IH.@?@'_I@/N 8!@& I,[25E)!*<DAWAUPDI5IY)'6S)]]E@.,
M6ZINE.\<U<D6J;Y9FJ&U+D1Z FP8U-)FBH.;J.E)C-UA3>H1TR 5E66G+ 88
M;7;@MR8RM-R*V]17$NU:&CDHW"<W.5#7F]1&@GM?],^;QYB,H_+\&6 K<KU@
M16;B7(<MIZ^W* IF^U-+IZK!5MJJ#"4RU8;X08CVY+3'!UMKY?F99X"GK[%R
MK0534R3345)3>S4JH=G17FZJJN-IE?UL8>276:(H! :5+S'!7AP&&^\<Y4/Z
M#;VBDKIK2M%"&[$BMJAC5<8N)LM)V;*D:I%LNKX%40A.7O<!R0<<6N<[S%++
M@ER0\V^2E;(]8Z5RFGW9VO@I/'.5K0#T8#PUGS(!"BE1<@!M>E\+0/.5Q?\
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M#+T4KS6.4IML#B7%E3I<!R.8Z,LL!.X!@)68HI84H)*LE)S((24#/BL$^%.
MY?\ ?4<IIW/V^)%11>;5)6Y80D9&R$U43V B3?[RQV5ND_\ ULT9X#3>>[ \
MV78J4B8[;RJNR]NZW34LFZG+Q3(D<F1LPVA(>?M#G:>8J+DT&\SE@)]#USN7
M3"[.+<3N&NU6U4)Q]RG(VN:VU%/6J:Q<$C0*<C=)<7,LMK':"]T<<!2H[E$%
MN4EJ.*T;$<N-]=A,2TLB_8U\H9845[@(*#.:L/MP!!>)9Y''HP%6D/SNTWFB
MIBF*JY5$.^;U*$15&E4E4X"E_P!"UM)")%>:)!?3#R7GTX#B=N6*>=R-S$4=
M=9\UMW1=AI+-93,1<B(7)B:'JV7E><53%)]^F0I38/@P%GC(2V\B0>>4IRZA
M3_\ D%/_ .W"NL^YGX(&AS ?" M;2B%*:;=AJ<;&?+"Q,K!UU( \G7X?WX+<
M]G 18RR40OE4I<=CMG66I:Y26Q1Y>31Y2A47D+ ZJF5".D99C+ =7ON>DC_Y
M"78&VSRQ:3#@;0/W5"S#B9J6&LH"I'PB4\PGI.> _3XP266BI6HE"25#+B<N
MGAPP$7 ,   Z!E^# 05>^/\ 9_Z8#VCH/X?[A@/> 8!@& I\]&H1UYJ269"'
M4E'',HXALI'64'?>\.C/ <,J936;3[PUW6]<=-D3[GK6\4FX(C]&WRD6_2.P
M5*8R]$BJM>*>P=HA,JT.QCDMQ6>?AP'<"E>^0%-+;4AA.392E2&<\@4ID))Y
MY/PN&K+/ 5=_]7^<G](8"T_^8_._OP$_;?\ M*/]:OTA@+CP&B_?\ER(O=MO
MEYAA#JDUBW&THDNU%JG!+E4C(>57E4LB8JD+3P4AOWR>!P&/.Y*_3'JO>BJ>
M_L4\ZY1Z5VS^D[5=8J)2VE(0FN)JC:&BRR> T9K!& Z11 !';RZ.L?!D<U$Y
MC+\D^#/CETX"9P# , P# , P# ,!;]T.*;H=04VH)=,60EK4XIM*G3'="$J6
ME#F25'QC+ <%EMT1,2L0';6JT:S9EQEZZMHY$B6N^K[NQ,J8IB[[8DB*7T4&
MG+R><""&U-I(/# 1U2JVFHJFKN.F/WDNCBCRMT4KRL6?8 @A+^S=.:$/LXW!
M<:4&PL#7F#D<!*+##5&HL2)3)=%H-+JBW]N+*G./&X]E*^TIER=?VX#O9.;,
MM>6M6IIM[- !X# >ZB\M;-SF4ARJ(KLV&_NI%BONI5WC9+,@"/+VE4W$U08<
M1OJN\G3QP&N/>T6F5LA7GZE'DW(]!>L]BT:M +RZ;MW:3U94W&V[NIA+,<2+
MGCNY)6IU:5G(YJ'3@.6VA6;26DN+[$\>2E;;"DL..UE0=Y2BZAFB(:!Z<YY4
M!T# 3R'(T5!2VY0S<<=^3;D_L@>J51<A36I<J%)>0LB"5-GBA6I@I/$# 4U$
MF1(2M^9*<<FJB)"I3KR%OJ;\Q*06UR"@N*20.CLZA_[V \/#E]I (:#+KY2H
MITI.:Z<<F&GG"B"?\Z79G^CP8#]6_P!TT=7<\H2N)U7W?AXJUDYU%OWR^6UK
M/LZ4Y^(=& Z8X!@& 8!@*?)&:SQ*2DITZ4ZE*6I"@!_E3PP'#_=!FCIOG<JE
MBU*W$MNI5F,N_P#;)Y]]%W[NU-#LM<"X-OGPTX6*;2@C]Y2VI*3EQ\&866S+
MK J4:KLW;28MW*H@I5(W,2"[:5O66FFKSVDJS+L(M*OM4?Y(O+3S@YT<<!38
M[-*-+CQ4T&KQ[6@UB=-M_;IN1)5=VW]Y!B"N3NQ<ZE12XY8TYTI6A&9;R2=/
M', *G,7/74+A7-JD*IU2HAB+N96X:W?-O>"@FL@QJ7M8E$0HB3(D=>@\@C4M
M61/'/ 8'[T;;#VP=RM5"G3KB13:#1H>WZ8#KC<W9>C*N!OFVCN,GLR&I=74G
M@%.D*5\)/3@.3;K:$O%!3J,.?+,=M#2XY;"KCI6M+7)7,3%UK.>L&9F/R1X
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MER6EJ6@.$H*^*?!@.GL DQ6^*E %82I125*2%J"5$IX',?VX"<P# , P# ,
MP# ,!1;AXT6IC2A6J%*&A:'%I<SCN]3)K)8*^C/P8#@Y4'BB7+JK=[J6B%4)
M45WO EFI%K:9U3LU"MJQ32LJDNU-*N4'P#EKZ<!2U1%,Q7Z8FRG&60XJ>-D"
M]42JB-,TY#@[P299=TJ<@D\\L@ZE!6668. J*E+D,RZF*V[<*:HZBGL;G%4C
M_P#DR%N1T.[6)9:(CTYR&A.A#R4I T].>> AK3I4M2&G+?-%?:(G*5-4.YXC
MSCFNFR0ZX457SD!K_*\?O,!J=WE[XLFM;$WRQ0K^H%/G2+EM9I=K0:D[->WE
MJ:*XXB5N.X X&8+A''LKH#69ZPRSP'.MQN/%7$F2*?2S58%8?IZ>TUDS9%1I
M=5EN\I;=%IN34=,58_\ M-*AX<!1V'GWF6I4J7KEN/T^*Z^VQ3FX\I#(J3;;
M#NM'FAIQI"  9Z5R\A[[/ 2R,]"<PI3AB@:#V@N%GS(K-80#Y[+7LI7V#_+E
M@/LATCF.ZVP7.V! +;11)4':> F,E"1#0X",LZ>E#WC.K ?JH^Z74K_X@48J
MS8/KU?1*%(GI*%=O;S)[>I;@43TZ\SGT\<!T_0<T(.K5FE)U<.MF!QX<.. ]
M8!@& 8"2>&;IS4HA*0 E)*=.I*P0L9Y+"_!XL!Q+W.==<W(O.6;_ !,73*RR
MVUO$&9*!W>5%4W_\3=;S[-4#< 6<E9$)U<?R<!C=,0.-MTXV*XXMV.[.3L>I
MVHJ]:&DTQ95O^Y+YF:4ZOEPSGX>C/ >"YF>WHO-3PJB5TY6[*FYCJMW%-181
M_H4AJ,I+<(4X)Y?/2$I*24YZB<!'=94B3)9%%<MQ5%7)D*M)2Z@XKNEEVLM*
M=N14@.Z:JBK)^52A)(3EP&GA@,'=Y@!&P^XY;J2K814K?HTU*7VZG(3WE&TW
M QJW(0D+U4Y,?I+2\D@?K 4X#DSP<DHTYJ:7*?0RH$)$S*XH!6J&B-I2V62G
M2?-G+5\+/C@/+(2&J<L%*N0]#*I +">S+\Z7&$ID.O TLJ(/ U1+KGB.> ET
M)/9X[8"M1;C.AD=K#^2[9EE2FW0OSER7A[X,*3$(Z$Z< 2K2W(5J0A+BZFP5
MA$?00+<H_P BDA*:,M;9.9$5":AGTJSP'Z6_N96THV(W/2&^7IWGN+)*N<%K
M AQ,GSVPKJ*0KP)>43XN& [%X!@& 8!@& Y)=[92/ZR&6]4EPQ3:=0'#N0EN
M2K_X].3);Z'*JME![-/%QHZ0I)T@\>K@-:(\5*6(E,59KM73,D-RT;*H?GH?
MWX6W'J;C6[D6H!813&XY_>%-$C,#)0.:<!!ANN\A-47>3D=A_GT=_?D"8D7#
MII*$'8\0%**VU1W!YO+^02I2=0.KC@(C<97,5'%#=HR:/VZ<O;LN5!2>[$E0
MBJ3N&74. 5!^HI':"E6I.75 ]]@,-=XA99V(W1EBK&GIJUM5-0N=**EJ[SK:
MJJR7+J0T%Y04T( + ;"6@<RH%KA@.01R/)6<E)69[;:U&*MHI6JA L1FHJ4Q
M$*6!Q$$(EY^'5@)AXY2L@-?*>DI<;(4$Q0+B0$]J;>)D* '1YWYJA@/C21^Y
M*2DJ<6W#6@I#Y4\.?7<U,(@E%1#20/\ [ HB_"&6> @,-MB/#<"$G-I*>T!4
M8(01:N9T+(\PI=&?')';3\+/+ =]?N2@$4WO"HS "KIM\J>(4@O'S1'R*FJB
M5U=.7_N**3THR3@.\L0A1=&I+@&G_IN)(S*\\RYFDYY># 3FA&8.A.8SRX#P
M]/MX#R&6AEDV@ **@ D :CTG(<,S@,8[B;.[8;G0%P+ZL:W;D9>S0I51IL1;
MX!0I)(EJ:+R  >''IP'.:]?NM[*@U.3='=XW-O+9:XTK[3&C4BH2Y5![5Q4E
MLQB]RTM*7ET#@,!8KEY?>9]VE 1=-IT'O(VA /,D5.E+[+<*X;(THU(0@+<<
M".*AF<\!@_=COJ[9[Q7C9_GFW*OM)>$:*S0HMS7>N;"F;25U;Z'W;LC4_2&Z
MBU&6@I259I(Z>& A4ZITJY'.52FHUV-520T9EA1)TC7WI'V%NM(W%5)YG-I,
MJ*H*>5%.601FKAE@*D) _>:MZYN<N,$4T[]=FJC:+4R9<C(V0132OFNF<G_Q
MX>R(23JZ2#@/(A%#;T%VSU4;L.JJ.[-!=26O9)9;CZ=WUR4.9U)3S9$OEI)4
M ,AQ"L!$2'5N2GC57+@77)+;$BXT]N;;[W++4T<NUDM)6&Z?YH XD!).?6S&
M XM[I-M)W.W& H@M5D7K=T9NV"IIQ-+4&H@]66'D 4?F0O>ZH:4S.'%6> L9
M"$\]362DI8F2]<8K'[MIN&GE)DA[.4M:?AU4N->Q@"&T*5"S07%EV,\UES>:
M2FJ5<!Z*[&4E]+:0<M-.*&LO!@/*"%L)6I2=&3;:G@&4-ZO-,P!@J=!H;;RO
M_P#*0J9GT*SP'5K[H :.\%=;1!8RM1)U.DO26P($ I2%+)K(1QX:E\CX(RP'
MZA(W_;L];7\FCK\.MP''J\.. CX!@& L:_;%MG<:WJO:-Y42%<5LUN$J'5:1
M4&4/,S&E9Z4H*P="DJXYC(@\<!A>C=V?:2UZA37J%;<>FTB-93NWLJUHZ$*H
M]4HK\CGQF9T50Y<B9!6M2@XL%2<^!P%=;[OFTT>%:=.A653:93K&K]1KE%IL
M-"8M/14:@VIB3+J,5OY.HB2RL@\P*Z<!.CN_;*N4)RWCMS:0IB:V]7U033(K
MK8JDM04[)!4V3I= R SR2G@!@*[5=KMO9ETT>]I%H4(77;\(0:9<'8V#*@1
MRJ,PS&>"-2%LMK/+(XHRX98"H;7;;6_M;095O6Z9+D:95ZE<$V5/DKESI]4K
M,E<N=,D2'"IQQ3CB\LU$GA@+\G'-MMOK O.H;2L-J<2VHD9*7I(*!GPU9C+
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M$GKDU(<VGI,9"G$!YS(\,GT1D_YO#@/U0_=/2H,7NA41+[\:(\+]OM"F%R6
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M#H$!/A(1F<!^C_[FRBTFK;![DKGP8\WE[TW%RTN(CEI@=DB AHP%*I"AP_\
MMB?9. [ ^IUK^@X'S7^. >IUK^@X'S7^. >IUK^@X'S7^. >IUK^@X'S7^.
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MO_,(0 .!5\@H>\X98#]02 4H2"2HA(&9Z3PZ3[. ]8!@& AJ:0LZE9D\,N/
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M/U:TRE)(X\M'1@/T\1W5J8:4H!"E(22ATA+B<QT+2G,!0\0P$;6?A-?'/N8
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M7&F30855JU80]58.N09=9=0]* ;C\N.AAM:/DTA/ <,!G 0[U  \^T@Y<,S
M=!_M',X' .R7KZ=I'V%WZ3 .R7KZ=I'V%WZ3 .R7KZ=I'V%WZ3 .R7KZ=I'V
M%WZ3 0%TR\G%ZU5VF'AD4"GNK;.0(!(*R H9X#7FN]U"GW+>U-ON?<$9%0I_
M-YM,8H,--$K"G>=\I7*<$(8JKK(?/+6Z%J1EP(XX"Q3W#K=\P3K=3>U7;CU"
MN&NOU!J*E-822DI\T,U+7VEN@ '_ +0*#.7#++ 5YWN6T%ZLUZM+N)(77;;]
M6E4Y%%C(I-+8[.S&%3I,!.3$*M%+(*I*0'%GI)R& I[7<<M]IBSF#=T]Y5F2
MU3(TER$GM5;49:)B6;E>"]59C(<1D&WBI)!S(SP%NW=]WU:-XVEN!9U4NV::
M?N3,B2JI(\V1GIE#,6:)R&;34^%HH,?F#(-L!*$=( . UU>^YAV34X=-_P!Z
MJ6E:G$=J>;E&<MR;'GJ367'-2ZFPEV, E+I( /C P'U/W,6R#;D9T;A7T@0P
MROF(?0S+@/L/39"%4.<WIE4AHJGN)*65)!2 /'@("/N8]DFVVPF_+PY2'$!A
MK1'5%>08+M/>D386DQY4YUEW49"@72L9YX"7/W+VQJ7'4KW"OT@I>091D::E
M*1)AQH284ZID*D3:6RF*DHBN$L@DC3E@-X.[5W4:?W5[2K5E[>W&9,"O77.N
M^8*Q&*^S5&<TVTZB"B,&F6(NE R1EEF3@-D^R7KZ=I'V%WZ3 .R7KZ=I'V%W
MZ3 .R7KZ=I'V%WZ3 .R7KZ=I'V%WZ3 .R7KZ=I'V%WZ3 .R7KZ=I'V%WZ3 8
M&O[NQ-;CWK;]]UVXV$56WF&H[,2-2VS2ZDPU(5);:K,1Y:D5)IM:NHAP*2@]
M9("N. QP]W%;>?H-:H"[RJ:6J[78]?E5%F(AFK0WF%2B8%'GM+2_2:6\B44J
M98*$:1T=9685AON64!JO2J\FX@3*H0H1HYHL44%A'FY-,-5CTH?NK=;6TG4J
M2$\Q2NDY8"D1NXQ;<:G6K357=.6+0JTBK0):H23-J[LE:7%1KED%?,K<!)1D
M&7RM  '#@,!1;O[@%KWK;VY5LU2Z%]AW/:2Q5U>:(RW*"TB<F>VFT@X%HHX2
M^G/J =8ZO?<<!K0Y]R_LBZF4A5_WTI:NT:7'GN8[*$U,'M4>I.J.NIP%+@IR
M8=*F\E$998")_P#\8]DW51W1?EWI#!6%H"&$(@(,T3@U;S.GET9M#@R 8TC(
M^/ >T?<O;'H2DF_+Q=0E3><=],9V).;:5*6P]583B#'FSVERUGGK27.">/#
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MX<P #UOQX"H8!@(+_P"K_.3^D,!:?_,?G?WX"?MO_:4?ZU?I# 7'@& 8!@&
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M3@/JDZLN.66 \\OV?Q?XX!R_9_%_C@'+]G\7^. <OV?Q?XX!H_S$?@X'V^.
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M:;>,=]O/0\T7 ="TE2LO%G@)V/&$<KTN.+2H)"4+.801J*U ])+A.9P$S@&
M@O\ ZO\ .3^D,!:?_,?G?WX"?MO_ &E'^M7Z0P%QX!@& 8!@& 8!@& 8!@&
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MY(*<\LSD,!?XZ!^ ?^F ^X!@& 8!@& 8!@& 8!@& 8!@(+_ZO\Y/Z0P%I_\
M,?G?WX"?MO\ VE'^M7Z0P%QX!@& 8!@& 8!@& 8!@& 8!@& ^$!0(/0<!X4A
M61"5D9C(9C,#P>,># 2R802G3SG5=;5K6HJ<''/2%9CJ>QXL!Z[+ED$N*'6U
MDDDK4<\\BHDG2?#[& ]+9<6A0UI2O\DI"DIR_P R0KK'+ 0.PDCKON*/P2I7
M+R\66K5D/PX"H8!@& 8!@& 8!@& 8!@(#S'.T]<IR/6RRS*?" ?R3[. A]EZ
M>LD9G3U4E)Y?BS!SUGPGPX#PN'J2 ES)2>"%$**@CCFA9U=8'/C@"8>C04%
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MFE.@+<R"]24(6YD2H)'#IP'D;Q[=*<++=V4!;V:DI;%7A9J<2X6RVD\W2M0
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MO(JCU!O(".&5QZ;%U(82DE(4?%@*A7>X!<$ZD56GT:L6Q:JJA(W1<=<MUJ7
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M]S -:?'^(^Y@&M/C_$?<P#6GQ_B/N8"GEA6M2B&RV">6QD @:R=2R=.>O^_
M?#$!*?E5I RX#+@$AP >]X_K/Q8#PJ.YK7I#90LA*B3D2VEO('WAR4I?@P$R
MVWD@!0Z&TC3J.06.GB /PYX#V$) ZH2@'WXZQU\/">!Z<!\+;>:04-J3X<PK
M@/R0 >! P#2H*!26\DYZ,TJX)5[Y.0X=& ]@9>%K,=!"",AP/ = .> ]H(3G
MGIS/24@C/\. ]ZT^/\1]S 2LAKG%&2\M(6% C-"@H#,*24DGH]C 2QI[/42
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MT^/\1]S -:?'^(^Y@&M/C_$?<P#6GQ_B/N8!K3X_Q'W, UI\?XC[F :T^/\
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ENOZ.I2D:LQE^]1?I>G 4?5([7S= \Y?5=0RST_M?U71_FP'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img004.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MEQ!+;L5C7'FR.JC@"OYM?VX_#_[5W_!03]I7Q)\4/'_PK^,%_J^O7+O;VO\
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M_P"#)>.<_MP?%QDW_9U\$()<?=W?;H=N??AOUK^E2@#^+[_@NA^QAJ_[#?\
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M<@9(_>7_ ()+?\&[GP7_ ."6=W'XHC:3XE_% 1[1XJUFR2(:=U#?8+;+BU+
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MZAM.T+1[*'3+*#DM++?BUDB+<86.(.V>6V#!/QN/^#JWX3_]&#_!W_P96?\
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@U>>/3K31-,TR&[NKBW98WN;C["TSGECY@+G>6  /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img005.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  M # # 2(  A$! Q$!_\0
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DV4M"_9JT%]/T.[U*6.>3SKA[B7>]S)C&]VZL<<#T' P* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img006.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  M # # 2(  A$! Q$!_\0
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MO$5W96\KP6U@XA;RVVM,^U6)W#D*-P  P=ROGC .9_PFU\H_X^;@_P#;9O\
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11]V6)RS$]2Q/)8Y)[F@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img007.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  L #(# 2(  A$! Q$!_\0
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4SM@%CC@>@X&!0![1FB@#%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>clro-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9aM5s7xRiXhun8uCaHNMOaiBSbPtxpd9WelBvm1wbTk6/y4o0vuV4S/Uf9UWkewJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:clro="http://clearoneinc.com/20241231" elementFormDefault="qualified" targetNamespace="http://clearoneinc.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://clearoneinc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="clro-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="clro-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="clro-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>clro-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://clearoneinc.com/role/Cover" xlink:href="clro-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://clearoneinc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>clro-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember" xlink:label="ecd_PeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoMember" xlink:to="ecd_PeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoMember_lbl" xml:lang="en-US">PEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:label="ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_lbl" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:label="ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_lbl" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:label="ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_lbl" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:label="ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_lbl" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:label="ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_lbl" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:label="ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_lbl" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:label="ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_lbl" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="ecd_AwardTmgDiscLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgDiscLineItems" xlink:to="ecd_AwardTmgDiscLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgDiscLineItems_lbl" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>clro-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://clearoneinc.com/role/Cover" xlink:href="clro-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://clearoneinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember" xlink:label="loc_ecdPeoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdPeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:label="loc_ecdEqtyAwrdsInSummryCompstnTblForAplblYrMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdEqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:label="loc_ecdYrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdYrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:label="loc_ecdChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:label="loc_ecdVstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdVstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:label="loc_ecdChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:label="loc_ecdFrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdFrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:label="loc_ecdDvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_ecdDvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLEARONE INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000840715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 24, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_80D_eecd--PvpTableTextBlock_dU_zCdGZOumUPA8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAY
VERSUS PERFORMANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_988_eecd--Additional402vDisclosureTextBlock_c20240101__20241231_z5vbjxqxEUcg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 953(a) of the Dodd-Frank Act and Item 402(v) of SEC Regulation S-K, we are providing the following information about
the relationship between executive &#8220;compensation actually paid&#8221; (or &#8220;CAP&#8221;), as defined by SEC rules, to
the Company&#8217;s principal executive officer (&#8220;PEO&#8221;) and non-PEO named executive officer (the &#8220;Non-PEO NEOs&#8221;)
and certain aspects of the financial performance of the Company. The Compensation Committee does not utilize CAP as the basis
for making compensation decisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding <b>pay <span style="color: #252525">versus performance</span></b> as
of December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_zKvkjphnUBCe" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
    <sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
    </b><br/>
    <b>Compensation </b><br/>
    <b>Table Total </b><br/>
    <b>for PEO ($) <sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    </b><br/>
    <b>Actually Paid </b><br/>
    <b>to PEO ($) <sup>(3)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
    Compensation <br/>
Table Total <br/>
for Non-PEO NEO <br/>
($) <sup>(2)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    <br/>
Actually Paid <br/>
to Non-PEO <br/>
NEO ($) <sup>(3)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ClearOne</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder</b><br/>
        <b>Return ($) <sup>(4)</sup></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income (Loss) </b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000) <sup>(5)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td id="xdx_987_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEpKDIp_zKZkMbQt60Vf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,053
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_fKDEpKDMp_zrAJkg0U8RCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,654
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEpKDIp_zaUFirdKEGL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,016
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDEpKDMp_zRToSV5od2zd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,567
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--TotalShareholderRtnAmt_c20240101__20241231_fKDEpKDQp_zC0vievn2Urc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_dxL_c20240101__20241231_fKDEpKDUp_zk0Umzwpha67" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right" title="::XDX::-8983000"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0028">(8,983</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEpKDIp_z7dZGVZfxyX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,047
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDEpKDMp_zefMaHFoZlWj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,476
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEpKDIp_zS0qesyw9Wh6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,940
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDEpKDMp_zH6KK4rf15p3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">324,129
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--TotalShareholderRtnAmt_c20230101__20231231_fKDEpKDQp_zCdLGP4yhkok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_dxL_c20230101__20231231_fKDEpKDUp_ztJ0gyOHgeQ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="::XDX::-560000"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0034">(560</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEpKDIp_z5chmf2WeW47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">557,277
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDEpKDMp_zk9KQNqddKW5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,457
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEpKDIp_zGUJQibgNuSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,000
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDEpKDMp_zoJpt6h6OjSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,409
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--TotalShareholderRtnAmt_c20220101__20221231_fKDEpKDQp_zRpuB6tx2Kg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--NetIncomeLoss_dxL_c20220101__20221231_fKDEpKDUp_zYtnSTDvfPCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="::XDX::-20556000"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0040">20,556</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEpKDIp_zJrYtK1zF6ge" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">418,750
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKDEpKDMp_zOnO9sOKd7ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,848
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEpKDIp_zdGI7hg4Rjsk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,625
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKDEpKDMp_zfELDaCihS59" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,684
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--TotalShareholderRtnAmt_c20210101__20211231_fKDEpKDQp_zBIxb2JNU3Rb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLoss_dxL_c20210101__20211231_fKDEpKDUp_zGTbYnMA4MBe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="::XDX::-7694000"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0046">(7,694</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; width: 0.3in; visibility: hidden"><span id="xdx_F06_zz3oS2A8Jhpg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F1B_zejlcHmtQpPg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">Zeynep
    Hakimoglu served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. Derek L. Graham
    served as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO
    NEO for 2021, 2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting
    April 17, 2024. &#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F07_zaAaXyETk6Bc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F15_zNjgxfPMlYag" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#8220;SCT&#8221;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F04_zoHHm6RBVyW6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(3)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F11_zfUjOVmZwz4h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F06_zEsHeG9JWfxa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(4)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F11_zu3zMLy0CcNi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">Total
    Shareholder Return (&#8220;TSR&#8221;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"><span id="xdx_F0D_zN7vWGotiKVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">(5)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"><span id="xdx_F1E_zYSQZBxFL9D4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. </span></td></tr>
</table>

<p id="xdx_846_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIHNkDeAmKH6" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in">(1)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90B_eecd--PeoName_c20210101__20211231_zc8nXPLn9QD1"><span id="xdx_90B_eecd--PeoName_c20220101__20220524_zW16YPtlQJk8">Zeynep Hakimoglu</span></span> served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. <span id="xdx_900_eecd--PeoName_c20240101__20241231_zDhwQLISGaU5"><span id="xdx_90D_eecd--PeoName_c20230101__20231231_ztC3eFAM8tTh"><span id="xdx_90E_eecd--PeoName_c20220525__20221231_zX92O3nknRK6">Derek L. Graham</span></span></span> served
as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO NEO for 2021,
2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting April 17, 2024.</td></tr>
</table>

<p id="xdx_856_z3BMs82CEOYd" style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#8220;SCT&#8221;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. </span></td></tr>
</table>















































<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Shareholder Return (&#8220;TSR&#8221;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. </span></td></tr>
</table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_846_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIHNkDeAmKH6" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in">(1)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90B_eecd--PeoName_c20210101__20211231_zc8nXPLn9QD1"><span id="xdx_90B_eecd--PeoName_c20220101__20220524_zW16YPtlQJk8">Zeynep Hakimoglu</span></span> served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. <span id="xdx_900_eecd--PeoName_c20240101__20241231_zDhwQLISGaU5"><span id="xdx_90D_eecd--PeoName_c20230101__20231231_ztC3eFAM8tTh"><span id="xdx_90E_eecd--PeoName_c20220525__20221231_zX92O3nknRK6">Derek L. Graham</span></span></span> served
as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO NEO for 2021,
2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting April 17, 2024.</td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 283,053<span></span>
</td>
<td class="nump">$ 366,047<span></span>
</td>
<td class="nump">$ 557,277<span></span>
</td>
<td class="nump">$ 418,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301,654<span></span>
</td>
<td class="nump">366,476<span></span>
</td>
<td class="nump">532,457<span></span>
</td>
<td class="nump">378,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_840_eecd--AdjToPeoCompFnTextBlock_dU_zktbON4pGhN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_895_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zw5UFPqMe3Dg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_zjvMQTE3PX8c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b>&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Compensation Table
    Total<sup>(1)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEp_ztIEVFc6FXAg" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,053</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEp_zFPmHf2vIwqj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,016</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zs2jyxiUvAid" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,047</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEp_znd71MrwH95c" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,940</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zCqWFJsTt7R9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">557,277</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEp_zkQD2Vnx0Co9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zVTwDOePmla1" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">418,750</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEp_zhYv502HjhBj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,625</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(-) Grant Date Fair Value of Option Awards Granted
    in Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_znKNoIZXEsub" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,336</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zVc01fFMYQPc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,560</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zq34aOVQdG94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,900</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zGd3guyWU8Gl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zIANvmwVty55" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0077">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zAIi2qc9MMa1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0078">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_ztwx085tLj71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0079">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zvvIvGUGwn7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0080">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Fair Value at Fiscal Year End of Outstanding
    and Unvested Option Awards Granted in Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zZxr8Fsx34qd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,466</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znqZFeJo54Ih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,111</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHmKunO23AH5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,637</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znuQY7veDSDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,697</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zy7s2t0gBNna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0085">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zBKbaang0jij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0086">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zqrafkcuAcH3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0087">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zIDYUORb0Pjg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0088">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Change in Fair Value of Outstanding and
    Unvested Option Awards Granted in Prior Fiscal Years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zwoVAV218org" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0089">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z2EIQc5WZRug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0090">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zIgiQtYUlTme" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,309</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zqfSUrmqcYpj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,926</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zvdjqdD8nBZk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,059</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zkX0zoAL3LNf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z4V364rvF1ye" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,666</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zNnR0wAjszf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Fair Value at Vesting of Option Awards Granted
    in Fiscal Year that Vested During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_znrA0X8DAk48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0097">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zlx3MMLgiKu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0098">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zdrOO2zhcnU8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0099">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zV6tkOMW46Of" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0100">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zDI6thyn3B15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0101">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zgcSl3baLeD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0102">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zYcJbkfnMQih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0103">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_z2QDDjF2SUPh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0104">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Change in Fair Value as of Vesting Date
    of Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zysPhLGdjCRf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zrcLuTUJm3a8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0106">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zm6kMphRlx5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0107">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zFzkm9XlUjjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,588</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zAcF1aiDI3O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,761</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_z0GLaxEzulb5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,991</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zDu1oRGQ3MLc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,764</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zGohn6Bl0isf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,259</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(-) Fair Value as of Prior Fiscal Year End of
    Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zotxkpBz5QL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0113">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zleyzy3NohWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zj6ZlravDgui" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0115">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zLfrp7KWOThk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0116">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zeUVwtb205Rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ztozsQZraVr1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zJOtatw5hSt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ziwbjX4D5jX5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0120">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Value of Dividends or other Earnings Paid
    on Stock or Option Awards Not Otherwise Reflected in Fair Value or Total Compensation for the Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zJi6E5UgPrMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMNENFfHkyia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0122">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zOT8D8xZCAG" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0123">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zc00AY3wS4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0124">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zwY27UfvKNL6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0125">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zbL6TbuFEaa4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0126">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zvLNBkFrSD77" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0127">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zP7UBF0gL6X3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0128">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Actually Paid</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zhs5glIOxzo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,654</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_ztgmL40trfU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,567</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zBOPWg0YxqNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,476</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zVKATGF2znuh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">324,129</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_zgGURNbWeN4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,457</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zA1NR0PhJkL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,409</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_z4I0ZThw5uDi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,848</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_zZRQn6mBJ7b3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,684</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span id="xdx_F0F_zO3McgkuRBwj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1C_zk49F7torW5c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.</span></td>
</tr></table>

<p id="xdx_8A0_zHdolzGOK756" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,016<span></span>
</td>
<td class="nump">364,940<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="nump">251,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346,567<span></span>
</td>
<td class="nump">324,129<span></span>
</td>
<td class="nump">222,409<span></span>
</td>
<td class="nump">227,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_895_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zw5UFPqMe3Dg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_zjvMQTE3PX8c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b>&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO
    <br/>
NEO</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Compensation Table
    Total<sup>(1)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEp_ztIEVFc6FXAg" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,053</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEp_zFPmHf2vIwqj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,016</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zs2jyxiUvAid" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,047</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEp_znd71MrwH95c" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,940</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zCqWFJsTt7R9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">557,277</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEp_zkQD2Vnx0Co9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">230,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zVTwDOePmla1" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">418,750</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEp_zhYv502HjhBj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,625</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(-) Grant Date Fair Value of Option Awards Granted
    in Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_znKNoIZXEsub" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,336</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zVc01fFMYQPc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,560</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zq34aOVQdG94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,900</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zGd3guyWU8Gl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zIANvmwVty55" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0077">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zAIi2qc9MMa1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0078">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_ztwx085tLj71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0079">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zvvIvGUGwn7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0080">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Fair Value at Fiscal Year End of Outstanding
    and Unvested Option Awards Granted in Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zZxr8Fsx34qd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,466</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znqZFeJo54Ih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,111</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHmKunO23AH5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,637</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znuQY7veDSDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,697</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zy7s2t0gBNna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0085">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zBKbaang0jij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0086">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zqrafkcuAcH3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0087">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zIDYUORb0Pjg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0088">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Change in Fair Value of Outstanding and
    Unvested Option Awards Granted in Prior Fiscal Years</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zwoVAV218org" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0089">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z2EIQc5WZRug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0090">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zIgiQtYUlTme" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,309</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zqfSUrmqcYpj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,926</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zvdjqdD8nBZk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,059</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zkX0zoAL3LNf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z4V364rvF1ye" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,666</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zNnR0wAjszf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Fair Value at Vesting of Option Awards Granted
    in Fiscal Year that Vested During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_znrA0X8DAk48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0097">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zlx3MMLgiKu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0098">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zdrOO2zhcnU8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0099">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zV6tkOMW46Of" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0100">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zDI6thyn3B15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0101">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zgcSl3baLeD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0102">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zYcJbkfnMQih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0103">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_z2QDDjF2SUPh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0104">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Change in Fair Value as of Vesting Date
    of Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zysPhLGdjCRf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zrcLuTUJm3a8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0106">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zm6kMphRlx5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0107">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zFzkm9XlUjjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,588</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zAcF1aiDI3O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,761</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_z0GLaxEzulb5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,991</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zDu1oRGQ3MLc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,764</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zGohn6Bl0isf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,259</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(-) Fair Value as of Prior Fiscal Year End of
    Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zotxkpBz5QL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0113">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zleyzy3NohWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zj6ZlravDgui" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0115">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zLfrp7KWOThk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0116">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zeUVwtb205Rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ztozsQZraVr1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zJOtatw5hSt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ziwbjX4D5jX5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0120">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(+) Value of Dividends or other Earnings Paid
    on Stock or Option Awards Not Otherwise Reflected in Fair Value or Total Compensation for the Fiscal Year</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zJi6E5UgPrMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMNENFfHkyia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0122">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zOT8D8xZCAG" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0123">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zc00AY3wS4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0124">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zwY27UfvKNL6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0125">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zbL6TbuFEaa4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0126">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zvLNBkFrSD77" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0127">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zP7UBF0gL6X3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0128">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Actually Paid</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zhs5glIOxzo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,654</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_ztgmL40trfU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,567</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zBOPWg0YxqNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,476</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zVKATGF2znuh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">324,129</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_zgGURNbWeN4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,457</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zA1NR0PhJkL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,409</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_z4I0ZThw5uDi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,848</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_zZRQn6mBJ7b3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,684</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span id="xdx_F0F_zO3McgkuRBwj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1C_zk49F7torW5c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.</span></td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84C_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKG2IF5OZYmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between CAP and Total Shareholder Return (&#8220;TSR&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Non-PEO NEO CAP and our TSR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><img alt="" src="img002.jpg"/></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84E_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zDtRPUQV0v12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between CAP and Net Income (Loss)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Non-PEO NEO CAP and Net Income (Loss) <b><sup>1</sup></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><img alt="" src="img003.jpg"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
the amount of net income (loss) reported in the Company&#8217;s audited financial statements for the applicable year.</span></td>
</tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,983,000)<span></span>
</td>
<td class="num">$ (560,000)<span></span>
</td>
<td class="num">(20,556,000)<span></span>
</td>
<td class="num">$ (7,694,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Zeynep Hakimoglu<span></span>
</td>
<td class="text">Derek L. Graham<span></span>
</td>
<td class="text">Derek L. Graham<span></span>
</td>
<td class="text">Derek L. Graham<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Zeynep Hakimoglu<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 953(a) of the Dodd-Frank Act and Item 402(v) of SEC Regulation S-K, we are providing the following information about
the relationship between executive &#8220;compensation actually paid&#8221; (or &#8220;CAP&#8221;), as defined by SEC rules, to
the Company&#8217;s principal executive officer (&#8220;PEO&#8221;) and non-PEO named executive officer (the &#8220;Non-PEO NEOs&#8221;)
and certain aspects of the financial performance of the Company. The Compensation Committee does not utilize CAP as the basis
for making compensation decisions.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,336)<span></span>
</td>
<td class="num">$ (21,900)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,466<span></span>
</td>
<td class="nump">26,637<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,309)<span></span>
</td>
<td class="num">(22,059)<span></span>
</td>
<td class="num">(43,666)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,529)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,761)<span></span>
</td>
<td class="nump">3,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,560)<span></span>
</td>
<td class="num">(14,600)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,111<span></span>
</td>
<td class="num">(8,697)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,926)<span></span>
</td>
<td class="num">(4,600)<span></span>
</td>
<td class="num">(26,200)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,588)<span></span>
</td>
<td class="num">(2,991)<span></span>
</td>
<td class="nump">2,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#8220;SCT&#8221;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Zeynep
    Hakimoglu served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. Derek L. Graham
    served as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO
    NEO for 2021, 2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting
    April 17, 2024. &#160;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Total
    Shareholder Return (&#8220;TSR&#8221;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><p id="xdx_841_eecd--AwardTmgMnpiDiscTextBlock_zHfIXq293Jp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Equity
Grant Practices</i>. The Compensation Committee recognizes the importance of equity ownership in the alignment of shareholder
and management interests. The exercise price of each stock option awarded to our executive officers under our incentive compensation
programs is equal to the closing price of our common stock on the date of grant, which is the date when the Compensation Committee
acts to approve equity awards for senior executives. Performance-based equity awards are also granted to our named executive officers
at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Compensation Committee establishes the criteria, and directs the implementation, of all compensation program elements for the
executive officers. The Compensation Committee considers the Chief Executive Officer&#8217;s appraisal of other executive officers&#8217;
general performance and looks especially to performance against predetermined goals before making its recommendation to the Board
of Directors. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_909_eecd--AwardTmgMethodTextBlock_c20240101__20241231_zJtJubIV0rEh" title="Award Timing Method">The Chief Executive Officer recommends for the Compensation Committee&#8217;s approval the stock option <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--AwardTmgPredtrmndFlag_dbT_c20240101__20241231_zFbkr6XPFoPa" title="Award Timing Predetermined">grants</span> and
compensation related to achievement of non-quantitative goals under non-equity-based incentive plans for other executive officers</span>.
The Compensation Committee did not employ any compensation consultants during the year ended December 31, 2024.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">The Chief Executive Officer recommends for the Compensation Committee&#8217;s approval the stock option <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--AwardTmgPredtrmndFlag_dbT_c20240101__20241231_zFbkr6XPFoPa" title="Award Timing Predetermined">grants</span> and
compensation related to achievement of non-quantitative goals under non-equity-based incentive plans for other executive officers<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>62</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="g084805_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://clearoneinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="g084805_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="g084805_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="g084805_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>clro-20241231.xsd</File>
    <File>clro-20241231_def.xml</File>
    <File>clro-20241231_lab.xml</File>
    <File>clro-20241231_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="g084805_def14a.htm">g084805_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img001.jpg</File>
    <File>img002.jpg</File>
    <File>img003.jpg</File>
    <File>img004.jpg</File>
    <File>img005.jpg</File>
    <File>img006.jpg</File>
    <File>img007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="108">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "g084805_def14a.htm": {
   "nsprefix": "clro",
   "nsuri": "http://clearoneinc.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "clro-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "clro-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "clro-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clro-20241231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "g084805_def14a.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 9,
   "memberCustom": 0,
   "hidden": {
    "total": 44,
    "http://xbrl.sec.gov/ecd/2024": 36,
    "http://fasb.org/us-gaap/2024": 4,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 62,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 102,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 108,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://clearoneinc.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084805_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084805_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084805_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084805_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084805_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084805_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r41",
      "r51",
      "r61",
      "r92"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r44",
      "r54",
      "r64",
      "r95"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r88",
      "r96",
      "r100",
      "r108"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r106"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://clearoneinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://clearoneinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://clearoneinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://clearoneinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://clearoneinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://clearoneinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r41",
      "r51",
      "r61",
      "r92"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r48",
      "r58",
      "r89"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r96"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r96"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r96"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r96"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r96"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r55",
      "r65",
      "r88",
      "r96",
      "r100",
      "r108"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r111"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r111"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r111"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r113"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r43",
      "r53",
      "r63",
      "r94"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r56",
      "r66",
      "r97"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r56",
      "r66",
      "r97"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r38",
      "r48",
      "r58",
      "r89"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r49",
      "r59",
      "r90"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r50",
      "r60",
      "r91"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r57",
      "r67",
      "r98"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r42",
      "r52",
      "r62",
      "r93"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001753926-25-000783-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001753926-25-000783-xbrl.zip
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MP(L4/]FO!>8_9MOMOL?G.^_^U?8-NT?KU8.OZKLNSM7L\"]02P,$%     @
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MUATZA8"V9UC1OE7*1;A5I<"#0&'7*;:5PF($^3<_HU=B =S8KL0V$@] 7&/
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M[1<LLD<\'(HXYJX-^Y@QMO=?\)<O6B]?5ORY9OSYQ\IQY3'O"5_@G7JE #>
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MD6B5:OW6_@W]O/"SO;VMYLX5M[IWQ?:ZNP\><[[:+9C**/"$:\@AZO8QG+-
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MXWFEKIZWLG:$@=82-!$6&Y1-?L4)5F1BR2<K1R/^2)?C^<GE'AQC0HD@4<X
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M^WN"=4&EQ4+F^UVKA(KF&^-*Y&"8R-\[][ @?I];6#85?FX>[.Q2UHGV^+W
M%W0HM'H8:ZRJ*.B7<J*S$Z=FF!L\$5U'-'&%G!*\S 8BT2N+(/EX-<XMN3XZ
MN!K4G;+GJ+8C1\@TU0XQEWXNY;%T3+)2K"*5.H@B,J4?FD;K\=.8G8X-M;\>
MS$5Y4^6BP+#?_*BY*&73NM#($-W%?!'AKBXN+Z[;9];Y19T <)N+E.3Y#V'Q
M1LA"IKUSUCFZ.;TXMRY.[./3*_AP<76]:+MP'6=_2;K_(@FM!PN\4U'7L<?N
M(GVJD<<,-)!*/%)R_R9S1SK2J?8K8> @RI3,ZM1@/OB5Y8/)8 \YUJ*-9-JK
M+NC\@.,+K52=A*Z]]++T.@R7-G)YSUG^]@"Z,=5DK9ZXYVZA(F[&VQ33[:5L
M"RG#GS5R M*0/LKO1X)PU<H!&>TV3B&_%4&"E>SUY:EK*7-)A?H90_=(W2M?
M3=Z]LE)3&YXX#VYI)NW67HVLX)I]QD(XN?T"5ETHG*^13$)3 Z:YL7)S0XL+
M/]W1N1!7CRK+*V?7MDG35<:2G%TU8A]85:.$H=&E)F"HKB?P6@4]61EX,(F*
ME)GM4&4"(_[1)YAU0[>:%F /1T2*@.G4(9(26=]T0L8K95TN&*:=]4,N[72<
M/JLTS')])7IC5-/OW"*(,/*_TH%+1UJD_/(I A81?8^/:\0N5T$7SGA*;>$7
MOX,^XF,)=Z*90W&K9DM@)'0)<SOQ8^$5&=G*<F_N4C!,7Q"A+I)-:%@)':4U
M/[L)2+MB:J+K;V@6]"VR^*D4?0FLA>RIPPH%(J6A6]G2Y-7,#=!D$KV\,81#
M#BQ,G,0\C5T4Q/4U=0S-0 J ;BU7X7FM:>6UIA\HC[=LT!-<>=PUW9HN23Q.
MDD)F<SS4\V:N"3E2KV,E=L_GQ+[YI6-]N&A?'=M9B\S^?-X^/_UT\?GZ[$\;
MOKOX]*ES?GQMM^W?+FXZ^D2>(X1(==$;28;#(;  R FN^M;[%+-!G]^U'8B]
M @FF9_O\XM/I>:=S;9^W/W6.[5\Z5YW3\WKE.&_,'0:@^][(MH5JZ5S?<Z$V
MT3_-?^)7?8X7SAB@7JT,1A+IR8A+V$:PYK#&"KI?LZZUD/?5Y2$A_Y$1[6>7
M*]W;HKSM6A9!" :GXR6%YB;W5O3G"3]1*6'2T[\<>($JI?J;&4W2*S29EU;P
MO77)]]9,?6^S][CXK0<]:I+^K)+YCL2OY:;7K=-4M_O53"]GIB^#2)AR6-5T
M+WJZM9TBQ] -7[VWK@7ZX8M3KY(FEYO[6ZZUS5ZQ<_#3PN>H$PJG3B,X2T_'
MB\FR+8RN^=,ZICLW&XM?D[TW2CM4J_" <+Q9_$(<#9@ &ULJ:SP#:75BOXN2
MT?L7S9<PU&0T%QV^02NU;'EI-9I[$Q*S4@I]P1-P)B)&1'_0[LZ%*H^UXL-%
MZ^K7"]?5ZS+=2V+VO$E7S?M2V+S5:#5^:!7[(4P<>4965T85YRV'\U[O5H+^
MG IV:8;NNJS"<M1M\V":NOT!\=6FE=;]?M"UI6"7@?C,48<MF-A/%"!$Y*EX
MYH<#M&OTK0&I-M_;YLZ047R$^:$^&U,O_G)__<'*,&"2_'>I[XZ*#V,H!L51
MN/E BDS>(&4N1.0*_14#4/ ,34M&H5%4BEQ[/S0?R)@/X=LGO!LFF.\#5F&+
MXK LXSJ,1GA+B"%Q,1:T'7,6$@[**!2WL@(<UBAS5(1'FBG$0%F%/L;II+>/
MW,/ %]4&/8^I$3XWQ=Y*D9$\=F?WA S$H]CR;A+Z]G^Q(:CMZQCT4,T^.ZKG
MPH%,3!V^:RCL!4X2R>H:D<DBJ&5IU@DN:88^55UC$N.KC@%Y,BJ'13 G&/M#
M8RG$(N%J=7&R,/?+$2/*E%49K!2(\TDX87 9W,' /WI!EWGVF0!90@!!IM=2
M1PE&?"A4NF^08JK4[(O/5_85CYQ$P4[)%#6:4[4R>@7J=CO.=%D,G')4J8^/
M'!8"2#D*$C_B7LV2Y4XF:I6H7#@3RX.M3Q!#-5=B6N3?+G'ASG@?FFCW>L""
M4;U  J8C#9E0"3N(^7MGI7R%$,'(^]2:(ZF391C3^$TY:8*2<17(#/=<A>30
MIY%1J!:(@7 P, E;Q6Q;'M+8,(!58[D5!" 3PIF*H$-SDZ86!;J."^S3 WB8
M:T)KR&J9 C QAE,EH:2Z3?%C1RS4TT8AK2B^%HCOOHHWPX2CV\"##]A(J$*Z
MJ.B*#P_[F/[45+4,,"2,,A,H]:54)%RLQBAK*J;]J_!2EG9D(3A>F(QB9VR/
M>$QW7#+$!_7(",%\FDVM23[7K^OVA_2%H\"EU"_21$T*36V^05<62"0Q@EE=
MJ1PPLC4(OPJ=@&F6$Z4 UL;789[XXRCI>L*AX6I6#[#P-KQ-"UXNVTK3$*(2
MK'J?J\QRYOR="'F%!\]#P[#S49P&=P9^X 7]L:4K+]94T5)B;.*?+-/\PNU^
MR-R$HNUD;#+.C(]U+J%]2JPC?4:#& 2^3.BG=-,/.'\NQSA5PIB21305+I6%
M6L"L*X) L4@']!Y=MFU^SX;VB\27M'/W91DMOS%<NJX _9HA277_:_VX;M]1
M<=]!]LT+-/HL@TQ*L85NJC&8_8GYK(]D=L"BD-L1/GH&6O>*(_I)?5(SELM3
M3@>G*RC9Q<I(?29Z5T$=3$92>YAZB(5'T_C-FMVIV\<,*UT"HZ)'M0I"7*&!
M@.%#/N^LO[O['DT7-AH%,H-ZTNS1?,!!_&4HKC)]*!:^4<^$"Z>;,O!1;]OL
MQL3&*$5D.EE*G38.ZO:EX5/0X1@@K\IA'9U<R(@Y)J*Q?6R8[I*-TNJK4N@^
ML= 98'.OE2K_E?G*SFH<U)3$8=M#E"/N6IA+P2BNV.1[.P7>SJ6S9C4%!B1C
M&H;.92SB?63FHCB4&QCUO0(*8?(-BP;0!@7K(;7[M)VDPTE)IS625!C<(QQ&
MAL[B@$RR"4ZRT(F8+,[2:%&[&.W?@]?8O>G#)TBTWT6$M<:NP6H:U.PK, IA
M[J5)".L6.7!4ML_.+N4R9,S;QBYVE@XKQR)@RF$6"MI_'Y@SX)[DM&M'4*:?
M\#= T!Z;^WE0Y7["L ^JW,\EUX,JRL&3JW^U4PTYQ2B[@!."RB!!;(!/']KR
M23+6KC''/_."-+/-9L+D4["!6/+LC2HFIU1$I! ^D_X@EF9_QT5H(/NXKBP1
MB<6$T;_2N)X\I$LSJOA>!D<(3@S!'9R==@_J^XV?]/XHHBA1.2A!$E/F%,Y#
M%F5HA:R@V=9SU4R>&</YNNK"25XVD5/G\=:-W+>:^W2>.JAG$YZ0(PG>-<('
M$9HJE+N6VD9AJ278%0%C^;#5@:%$'@R7.\SE4:XUD<F7-'CIZ MQ%>S@[\)#
M>U[NN,?L5D0UJGK?E_C9\@540^2XZ3)57AK].U8!=I!.*T:@Z$0RV;KR;#4/
MWL Q\C/94MH::>W4LJ23,X&0WY$>H(433(<ZV7'*?,"SIK;]LL\ P>3KPKGW
MW#L.9@P>:K&>:K8'*B:@#F EY[LNC^]P*,V#_3<D>\V#UTUYKHD35X"9-R1?
MG82HB#+^,>-U8NY0^ (.EV0FU0H'0F5;<9HY5\BL37UJTV<Z>9JL%W;ZM=T/
MYGS8.+JXNKRX:M]TK(\7OW6NSMOG1YTJYVAITW^:YKI85PAH.0&O_Q&1D'U9
ML<//)"_G4A>K%7N^@P0""4Q)M4\S^FL*]EO#(9$"\SR5INWQ6SS.]5*'F@B=
M9(AVBH-=4VKZ)]"'Z#$VB>$UXTXB7:Z5<H@'-)>/. TX36LBD".5OY@^X'"=
MF"B0WEX6?@ A@9%0LI=@@'1R/6]?'[?_B;FR(AV@9&#<QX>PA8+B=QBZ?A\@
MV<Z0K)*=):(KNA\'8B2U=Z+2\F5./I4^[^%Y6V?_BQ#+Q88.'(+1.Y<=]U^)
MVU?X:VO/8C^"K$ /W[J.95,N9&OJ)J;L3K8F(2L4+@>6"4 D:^ T,E-*!:7B
MF!4:R$,<XP8C D<8L##F80H67<9'A<O\:5?XJ-(B)Q1=C8_)DG@0A&#5DHXM
MNA;A:?3+*_!(Q6DZ3" +XD(PF2,$($]Q #,E%\IJ+4@?H1J;I8Y"WS.TFCI,
MN01VTXD'PHF4Z. 50EJ_ ;$+&%GSNI2#I9^2J('I)44_M4Y2]#Z\'$*_LH9;
M((B64.T<>#;2,'0:[-@-8+>CKJD6!($R&OQXX4OH4+KIQ.-"!A=4H7G*BJD%
MT$_INW@TH&<&.UY6+G=AT2-K%IS/M1>V=;6B)9K/&6>(3X+&PS7=1B8AKPSC
MY^,F3/>7JEOAI2ACCG2*1 D%;8C68H1(66;Q(KUX]A!TE2=?@L>'J#Y3'Q!>
M#X,%G3.5LQ NS,5^(HL")'H>OQ=4#F@$<HMZ6MV@2OTA8>?O!IS4&V&UC%@H
MD85);\MK<7S(N"5)"5/T0^>>.PG1I"-#7B@[^ZASH6%#+7UZDT6'E)^$T<!+
M[1"IF@E$1I\:,"P!$=CENWA<"&0,TI!]E3I0@T1E@HUJ".-J$1J9C*V!\4E(
M'8U\, *K&D^AOF-J+Q4OEE,_6HVJ$WG<[:L#*6AZ'C)"E=(OE\]*W4H7)T1X
M?,2D->NBPE!PJW)E4 OP04!.VI+-)N41@FE3\5OIH2;+".C#TRT3-Z#=('(M
MRVM'@V";Z6A$\+0\4FXK?+HO-"<#*PVQ%@KN)"EC$DP_[JZ( &8:1L@CBS8.
MB6E1RQSEY4BQ=$%.4$2L4:KIA#1D]V*8#-6<H05"VQTN.3G-#/L.TMVLP+#6
M-(;%?1<FJ4O'/T0PT_P/+Q&6DOZBENO&M)VB:3._E)L)T]BW=/F":K=<H8&@
MH@X#;Y)=INJW.[KT5BPQ&3F)/.+G UZ^$7R)X4TPY@'ID/( 1K-!U'+:",E,
M-5*)^A($]I[BEV550^J@L50<$P*_\"@+\J5%$4<@I/%..Q9Y(R3>/%TKA786
MXT^C]A4>+6XM>MJM6::]$IH5&@@*S51MJG;-4O>"5.:NP$@]M?MJ #W)2I(G
MA*^WFS&PZ2WW@I'<1F[T#FM-=MR5L7^*_;<)AQ)^R5V#X>Z$'V,1D3;'$C1E
ML6/EQ%,/60&T KKV =&MY=O6YZ\XDM"IDU()/<!:A>.L1)H=4#U00H)&8S4[
M;DH"RG^ZY=;40JBCG!(\9>P]M'9&&..@+S<['9Y(--X-L/3CD/TE'0-YU-2\
M^[6FJ967WV1]PFD6Q;_+/+(P]"U9=K!3!F08*\,0%H&+2D;94 7Q8%Q.LU$%
MYL"PFXT?-3+GF2Y=9P]W(/OF*B!7EGTEHJ_VA1;OYW-/;'*,2>IXR/F,Z>BE
M_+<J/I/T+.?:V9O1M,J03 ,1T $JDS8*1B:=KXTCF(K\@M1LPW^LR?;T%JCC
MMQ_8A.A0:7[)-!5S-IR*\ V#E%D>& E5'&Z(S%?8K[^=!V>S".].HGRJ5"_Q
M>L*C.E*X54]XQJ$_2U&2W\Z(" S<CR*SI]%W^;.RJ4(O#\K2\2Q[=U)OO?$7
MQRSZJF'!M=ECY<<+)/LR?\D>)6&4,.E3CA6\>3;06 W<W"S@X74$$^.01UH[
MLA.OX''",!HP#J0[@^"UT5T3))&="SG3[GA,'I.N%\6 >33E:=37I 6IRA:I
MHE7%Z.AT,BWD%V6:45RS)Y'0]95PI@BVO.*0U01E%5:P'4= $C0C/?;J$57T
M" V\HKF%B5XHQ-"->LZB:^&8)A*F(U+7MVJD="12?A6G9@<C'JK(ZUH:.EU3
MV3*FG"+.363X=P265';(=#T$[5*62N"IRE_XRO-92-E-:K6P9#$*R'"EE3V5
M+SC&I#I73L&L1'5L35/'! E-6N<;:AOQVTD,0LI H@>Q]D*"Q<Y 961BZ706
M6J22R0*'NPDZSTE2"P>0[$%%IZ"9G 0EE*93[.COA-2H-U:7C50F(4V+,%=H
M2IF:85DS[D;Y#?#AK6F<[OMZ0Y+7 (Q^E.,#7:1/=OF) A6'Q,F_C";,S>"&
MGL'6<R!H"3XL)6;#E/6#Q[:;Q#)[EM(Q%1MK S%R8'^27.S""8LYIDJ@\/7>
MFD]93-E<;49PM,JWF;VV2%M+10QCB:.8*NCEI8WNN$4X?"O="K=Y(F5+UJ-:
M,I/!Y)RA'4+67+&+'N?13+1:#] JJR?XV[(S7<X[4D6*B].DG\*2)A,_!A1!
MC,1*$3:N(;3=K8DEHJ:T/?562;)NCU(0S*JE$I[.AK$[E$VH74J9L:8A<\@$
M*OW=J[3#2@T$M8.NOS03(@@=-Q"7PC[+7&V\T.["E[KFT%4]6W8(&J.4!Q7N
M6+<[>/\L.];FEF1))XU:$^D!2%Y&2#3Z5-1D!CK)^V1X9@W/@=]^VIJMCJ11
M"W3B4>*2UI(<2=Q^%;F,0:-4Y5?Y>O,#RYZ7\N67\O&RTFL[,=6"X@35Y7JA
MZ8S02A^T"6R5>>2A2XLI/;GF,&>5CTG7#>T<51*[0@.11Y6TMGV)43P%L^=!
MYT\M5?\J(,YL4GDOC%,(M+-DXAE% O1#-E1^(I6TH@+H)FY6P'*0=_?H!*:S
M-IU?J9R%NA^/,+D'118-6.6&J)G&)L=O8S5C[8-*@Q;I<)UT,PZ3C!^J9)9D
M"G(Z7H7F,>GR0A )X8"X@%5/6@23C>G<+Y5GYV+BD)^;NUS@N!PZWH/AWW>#
M@/0L1JQ\DQ)2)T4E/@VV"1K-*N)9%'=1 U7:8(4&@K'!.:[29B!7PC3)/>0O
MQ%^Q"DUTN &3L"&%7N:">;?8J5T8DOB2P/K^ZS\/]E\?O%T@Z.@R "3C0&+6
MQX0_I PWJALU$/V!-TZ+#*(!#"<V-Z&8=#:2=?EZ.E@2T:.H^*L?R[.YZ"9R
M-]+ET ._OTV%3U5=0WVFQOZ5??NVPK&LQ+<2WT>++V8'IO9O;A,GWS'5@)-Q
MOO)F*!^D;/;Y2OXJ^:OD[PG;)W:@W,\R-E6[<XW1'*4UMM/X5?50KAXPW:Z:
M*+OT9C;D=]HKE8JQ3E"()!F$G07_=J47MA+F2I@K87ZL,(>\YY&3A0).O(2L
M7$I&5>?>]))+93)I<%B0G:\\'GE,!0:CQ*L8=T<[6"I,ZWDY+\7[2Y5-1)?[
ME^;2_4K=?2'P!V8!7_CIO63.F74IW8R8'DP9Q:!7T7Y"[UK(9;H.N34I,2[[
M(JB^KX1"A&X1X QKPC<B-3@^'O6$#E?&D%"\F8<F,"_(F%WH,'4".#_]6][
MP9NZ>B_WN,HB[A7<I2'%.B,*1I0(E8NE63<-AY_BT)&0TXCP.O(XQ2TAEA+0
MZV%"G'3LT$V@+VO.ZZ"[O&F)A$J0WWM..2=LB#=V\K;E-IL AW#6E$P\$,[
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M)58]\ 8FG"OC71(<2#B[;)S#NHE4F2(0]X=^X)\G0XY1%802=1]?\=[/6R?
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M&3(\@R"(%3_R#%2<NMC/(/HBVZN#'+"ZG%*\%I$U(0E>ACR96>Q8DFG@V8C
M8 H8<S%H9EA'2S65Q^=#69.[7&F6FH8^POGV"L-F"HA&8\&FLMS%,EFY<K/(
M N65&=19H$P\3'R%DBI7"WX$>D=)OR1,@_8H+..<\&FB+<(K+<C7].W0=\UR
MN3D4_PD^+,X+YPK>$?F)*[>)A2GM= N9J<4":E2YU6NJ)"J)!<B*!LA ^ [*
M0,Q?P.&LF1=$J',3-/:@\=7#((SQ8,E2?06Z<'ZE-X>E2JO:QE=H(&#-7DO5
M:]U@Z6WFY \^TJP]]8&/;^7Q!8\NM2D,*PLK8J$4U:A=VF@M4RR%"M:C96A=
MY:KX3"1F%ZU!9"ETMBCSLUY4-D2=436H]X#!5<T^C1R3"1NVF*=*\LK</B=1
MNR%A8LLHM.SN3U&0V4T6(=J*$.C:WXQF1#?680%4F"GM3-=(MPHETNTXG3NU
M[<&,T?:)WC=0QVCWIU74@Q&ZNA-?E6/_"XL=VK? -@BS4Y,!PUU5#3A*<:Y4
ML79TARLP'EV!0UTDD18%C3L2_C8<H0OIL>D,*_68P[,S6%N;*O4/!UJUJD K
M#+1J58%6BROA*/]=WRFNXMQP1154B3)=/DF;80%8;8L:R*KMU;-1/:TJE:RV
M*@,\X)<#;<01+!FY%6&K3FU&4T"UQ^]D!+9OO][[22MQUN^'$M !OG@A7F:B
M1^ 4J-!C3 ]3@?MD:LT+4=* G6V J$?[75X=%1 C)MNU AT>31E 9E2R8+W<
M^3.'M3N>*:6K2_Z5'LP,9 1- LV1OB-.W5G6%"-'Q;.TI1']*3,[U[D#-9 #
M>@Z.F*A05+)$WK%';F_J7?Z>M\NMR< X>5!#CW)-H^#%=!$=2VPL!I82Z\+H
M5=PVQJ\0(1)YAB*WG0%W$P00S=K_T^??'(E<1C87P=4]>'Z0QY:,6Y#\+<H\
M*)W/3)%?+#*LIM;ZE+:?G=D5,B4V60.=^E9JZW\#M8H$>]<(^H,A9/3L3N'9
M4N<V/0DB;/2'1D5[\'1A%U_;!'Y9@ZIBQF XUHZMJC3:+(9-@75V]NJO:3KG
M-J;?N96K-'/'#?JWKH@A(:8H<C-U2Q;WRE$8]#C!M6'9>3BJH*<0=R+83QSM
MMV58,8?'Z+,E%VT?57M8LY@JYM7GTF$_)F\CU7W'386.G)E\((F6JCW?",6!
MV!DZ6-. :7 #KTTFQU#<XV:!A_L1'G\S_D@J)6*%7'F "^[?C!%1[A)._;U8
M58S2T%@F0+_<N% 5@(R_VIK2]D3Q.EVT*RUYI5KA=C=P4\=W5FU*W5Q2TSO5
MIQDGOMT- ^;"<OFRI%&V1$PML[C%&8QDJ%BVR'2FIIWQ?Y;<:#)_;*687JDM
M9VX=YZRFGUOJ-@\U"1K"P?R\=? $&B<=# O9>Y!6L__8GQBHB7O[!2,SM#T*
MA6>W]BC\8N^EG=N>TM3CQ\]1:6KV9(I]J;>GF7I[9N].<<NVQWO(N_-E7)C+
M&]2F1/ZY.<09=74X,7%ZH(;GLVGNAFMVMN8_$0OGJEV5O__##%B/J!*-1T%4
ME'+"^JW^"1\RCS^>Y]=OI)]^D'&>!_[V!S##PO$*C/9N(&*^C;8/D.@'=W 0
M6,(4' MI%YR#]8YI.!Z&$WVD<\G2;8!'&W6[;WY:_'XO)^/P00[1?6EC\Z>M
MAWCF"<;K3XMFA>8WL7C6=VP[&SRVQK.-[<TSC&UU--"BM<XQ'^K@32+R@_$Z
M//*(L6*'T:=9B17U%?63U*^J-F@UYJL.VKT0<9*)O#9EP""P1ZB,S75=S^D[
M5T5]1?UFV 5SUP0>B[XJ37#.9.)>J/\RJF%SUK6BOJ*^T@@/:H1(*'VP.6M7
M45]17TG]0R/_16!3RC4 %L 96 #^_08M9$5]17VE AX:N33ZB;I?V!T30OH$
M+IF,NCJ-/*8N<39E92OJ*^HKG?!@,"M>(:_UVDV_AEP'ZJ=?-*X#]974KZ?4
MW]P%^ASP"<'VKAB&(L.GCHHTQTCQS5G6BOJ*^DHA/#3RLX\?;O[Y?S=L\2KJ
M*^HKL7]HY*6AG)DXHDP,T0:M;D5]1?UWZ85Y55-L[F*6G,RLFR^,2;[E^>);
M21A3J[G_@KVT/U"N*V6/7Y@R %><"NG(Y'.5W3[WY.5%#7'5T 6>/)#\0BE0
M"O@R">7YKG/O#"A?M>W$A$#?/-C9)<Q"";F'J)%_)R+D41YEHU96=0'36C'I
M%;&P[@8!UH2PAW"TM @BI=D@B!2&N!DBPJ(/K@3H-C6,);)7E%(7!P@RR=.2
MQM>=(UL@&A>P6D@,)M\V7!?X6'%R:.\H2%-ZQ))XF3#,XM/3.E;-1/8NM;-7
MUZCH42T[!Y1\324\%0P,CC$'^P=_6FH&"5FDEX2^B 9VHH DG6 D)%7,\VRU
M6K9<+3U &/B8YJ$.6S$BJ$6!Q[TQ$LDRL&M4QEF]HKJ10(9)"N#^$'8V89KD
MDMH)/T4N**YG#5%:$*4[%D-309) 9'I@-L"*4.L21T9/4LTR%9" A&ZJ*&@1
M"!LFH!J@*8-,%-P@?$T$4Y;0FQ/S!%,CB_+0-,LR"1GJ+%FN:(40*U9*+<UY
M9S@*7*J"U(G!=%P HM6J3^<J 4<S-Q@1JBB(D"MKZ="JJ.I<(Y2J2(,WE^&Y
M3NIXJ?,D8C_BCIJ:(QG80NM(]29Y '':1T&4@8>XX]U(8-GCV+Z[NZL[6#PY
M\'D=!+V2TJ5(Z:F$FD!\4@+:U!6N;5GA.G"XBPB7E?@N37R5#%'IOF*UE#>J
M6HI:M9O0U>N%2]664OYPY93NU5]7-_==O_6U92JGJ.;L;S"!K3J8I9R*ES@M
M[^O__G':_^V77P?_^Y%*JORSV[H?_=GR/&?\8= =_K/_^9=?;_]L_?852ZPX
M=^U%EU@YR)98^>8<;KU7:G-JO17[.@:+3]=4N90X-5<$3)X_[DB#I3C-9^PN
MLE^@-::0[$O78?R2M+25+2<URB[0*%V@/@'3F'K>20C&;H1(\HR*KOON*X-,
MZXH(=#%AX48;(#F/1H_=J=!C$3UVIT*/S7%I"LZ$(#]!>"C3ZN<,*[O8TMI3
M,*334ZW5'6</K[EC>\&B*U=)J2_ *>@X/)21/4GHF+8'*JYFAXG'=6D11,J4
M93WRR@J(P(+1\ PJ*T*]3$_A2LT-1!=!R;])NL1:XWZ?]:EJ7![M6Y4BL*;/
MCRH##<^IP@P*96O(J("?AQ6R9&G8;%64!R<LJ[W_3E@(#7ECJXM:)4AB54C7
MG%95H0W5A/"_L9YD6*OIX2[1@6!FQ<:['*;#;NXAV"B^((+0TABGOFLJ;*HS
MO*)2SBQAE4GTM&#$?8UKJ@A40*8]$489B'*"-.W%JFB+FB_8=B*ND<OP>%@<
M55K='=@K\4RA0^A=4]0CR'0JN:0I@+ZHTC/>CTBLO/C;S&NILIHY)OK*QQE&
MPB-1EP#I1B'?-F7M).+:!%=ITRVS,L2)9:N7&@>6KK.75K@I)US7%DUA>%65
MT5/<%,10%? [,3.H&EZAH]1L"FQI]OSWX'>?&P ^:Y'GI JN>PNFVM)>6P*>
M[G*.I2-< U"9,8%A:Y-2@OZ%G <6"RBE&(JFWLM4K\>&%\&=:NG,U;] T,;6
M-&CC)8G+4@;[K**UE!$6O1,,-KH1(T34;R!8XP^9<C)4Z:A3K$&3K5=84LX0
MJYOF"A:2N56&XH^5FM(ZPF0Z3'0FL$%][F9$O<',S]@@LMJ6JB5';$PFDAP'
M-H*K,.*T%&@!,,>!<V/&'$Y-X5(C&"D_;U\?M_^9PF]WCIY+\ZRMG,Q9:77^
MZ!Q]OCG]K6-=G)R<'G6NKG]8_^="79V]P/.".SH!DHA@T26T[O$Z%,0.S>YL
MU<G0>-;HKG:R[OEZS<"&8!A/!KE)7\\W<4B[WX]#JIMJUENS%[;Y+L!'-GP8
MV/()1XE%,50)54M=@87 3;;[U?P_JP1<JDN#:A6>40J48T<.K!N^>F]="[0Y
MYP:X^CU!RN7;@=F$=@Y^6CB?'O.0?Z41@,W_,60#-GP0XG)N@T.0S&6R\G=%
MHB\39G3O]=3@WQ]X$8JB481$78!HD(^81M Q!K1V0%>K\R#ABY>25J/5FE_Z
MR2*4^(*Y\UH,E6GQ(:2:BHM<V77A0U+5BV6\W?V%J^=UF>TE<7JJAR?NZPK5
MIJZY$_*8A>-J>:8LST(4\>XT13RO?)^GW@BM9X 609*C59ZUR+OOA4PGD3?7
M$Q8)^O]E'L&(2LYA"'.47G=W+M#G_HF-,6VA16*##SN!WQ/A4#Y,UX,<KQ70
M10^O6/#*K\Q/4*"P'BKU@?7<N:LS#NB& Q]+/'RFL8,-G7'FVAV_C[>&,@;A
M"/J!(<FB\T=LR$,6410"O+);LP>2]%$8# -9L]Z\CO5G+TSU=AB!S_HX6OGN
M?NF[^H(#KPRN>,192#5M,7_CEGO!",,0=0NO2UNXAAYT*]8,K1R4MO(;+(Q]
M&7*,4)"!C]]HI]F<:,=2U#RRK7B &:D4N&*'@8?L1CQ%;6-I0"R<APY47)U>
MXN/9O ;<RX";\"]9;8]X3 :?X.V5YW$/8X7TPB"1_9 -57"\C$*!H0,_1(GC
M\"CJ)9[MIJ11A;],]4:,R_"A4V@8.#!Q14 =W\(8 ^)-S3,U2WX7Q2$'J4(*
M[V!Y/ R>&0HG#$:#P.>89]076( Q GD%/I'C<(C?L&,W<6+@.SD3>*]%0:Y(
M\"U0APSCV\T=&"N6,88'+VG^XL!"IB?6Q;#["^Q)MD$E7K,S@OT-B4=IO"9N
M%$."4!@]LUNAFUZ%*S$LF$R1,C0%V8'371Z\QG& 8U \SL /O* O,.KL4V@4
M!)#E4];"!^8 49+WKQVJE8C==#S@980L]K*259-7;P/1'_ HMJ$+DZ+%0-0P
MX<PD*!SS?L@?:"N-W_G( U"A#$-S8A$GLJCWC:9\O$(Q-JMXC;3TO48>).0A
M O>9R5UD2K 4+JL6"%ALIX[,H8H;4FY<%_F"+J' -+%;>Y3L1HR>%O+$=^0E
M,J]9@5'TD@FA<5>E'3(0<A!V(P#C&LI9TF-.G$A6YML4L!)BX=>N"/!)V8H?
M^-NH=42,X684KX(;64"%3+G<]YQ".HXB28J"XP2)3VFYH"D=11](V8CBZ4+<
MA4$Q@=+H4Y@CIEI2 5,J5JLT0#I3J'$Q;)#NK_IA<!</4DV3:A@+I5L=[7!%
MCDXNI+5[<2%S"FU<GU#&5<E 2SU*E[L@G6H3XA@8AV5Q@=9! G.&L7BX@%_Q
MFQ>P4DT:=?,M+MI+.670F06=P'X#[Y*9D<HOJ)P@&<D%A]>;;]+7F_ ZKAF%
M8F(6)D;]R>%CA7D=V:@FFU:!>5$@U2@.D+8J'-YY$'9!)5EG9T?4R;[II/GF
MI8Q]E1&)V84ZO<DKW-^%AP$,4E\%/N9585L[:5O[LBU$:Z U#L>84(5/-0[2
MIW9>UF3-VBB6P82@8P6_E0F4L',D>AUE/6/-Q!@4@1.-?&[TM5K1=&;D*K',
MHF7XS8&M 4\YL?6/RT\?[;.S2Z)MS]#6.'A9DQL.;188G:%*%;NW(@K <$-V
M0P4OF0.O3#V!NUM-19Q2J"MM;@/8$56'&/QZ<'! 2<UZEP?1LC+BP&![(Q8)
M9)WA2P_LQM@^#F),2<.EQ6BRR&PD5/DT'9G<8[*[51N3<%&#I ^].$J&]AF,
MBK^DG<J"Q@3L4?C851(A'G>Z[7SV3;U5:.USS.1RT#9_A$>C'N;#7DH6;*>#
M>'%TV7Z)+9I7SODM<YDB\6A H;3PZD<OZ#+/^I1N[[E6/GYJO]S0O>WA_)#=
M*C\$\T-VJ_R095:#78" 325]YDCG-!SJZ.+39>?\NGUS>G'^;'2OOGV[Q#@I
M;>9Q/Y*GKQ$3+B(LJ+-3=RPC%N61<")F*H<'$4T#A* =DGPE:S9YBU_QA2B&
MZ\^?/K6O_LR)FWW3_G#6V0RAJZ+<EAP3DXU<DSG= JSW$=CR.IQGW4)Y3!WX
MUK0Z\-\1UK-X 8>#\C=J1J_HO*\F5>O-#1<C$U#7OF.A&U5,43$%EI;O$!P9
M#>C4QU[0<D.7!&79&).OXI8?GEO:GD<CN2!LCXH[*N[(<L=-$#-OC:R-.0(N
M3[/2'WVJV-V;:]RB"8= NN1U9VU:%(3]+DI&[U\T7\(<)>C\FL\:KD%$YKH0
M^&;5"5SY&:P(K'BP(G#=":QXL"+PN0FL>+ B\+D)_.%Y<(5.</,<Z)^<R:3;
M*1>E<\G06$W6F2=5_V>.R499YTDH^H.Y5D1J[;RI[;>FUQ1=,7+GJ2C6A- ?
MDRUW:SL[\\S86Y/%7AM"?TBNI/#=UH^UT&M#Z _)D:U&K7&P+[WG.\9[OO)D
M_X#LN6!"UX=CW^S4&GO3R\"OUEEBA9 IEGC*VZGR\!="[3R%=!;4@ 68Y;NU
MYNXR@([61JMOZ  JML^R?;-VT)A>VW=-1E%Q?<7USW;:W5"&6?L!5!R?&4"S
M <?I1F,1Q^D-99]J !MR+-_9WZ\UEF#9K^AQ?;4O90W:"]*BD"BVI\*[2/75
MFG,L[6J*]>+SU2OBUIRXBMDJXBIF6]TIJXBKF*TB;N6)JYCM!R%N0\]056#K
MC^70:![LU-[,$?1_\Y=V-:E:&X;;;=3V]N=W2;CY*[N:5*T-O\WQ>F[S5W4U
MJ:IX;1-7=36I6AM>:^WLUG8;ZV*X_9BGI?D$B%9"MS)"5RGXM:>JXK5-7-75
MI*KBM4U<U=6DJN*U35S5U:2JXK4%G8\F*XKFBKQ,EG,I% 3="#Q]&.L<8#H;
M]=:<*P>]:+Y<R=-V"A^:5E1]L%1JH$JE[M;2<JE=CG4D\P52\<%?@<C6?DT5
M2%W0D?Z[5GRN2]Q:S26>"&O-K^_4"H:Z8&%S3][>_@ KN+.:*_@A\).(1T1*
MR'M8LT_5V>.Z="P6FA.P<"B$O0#ET.'VD&,M4EKL,+B5=7RP3$\.V1L^#$4<
M<UZZO@LJ4ZT!JA=8D7HQ118^WUS?M,^/3\\_6IU_?CZ]^=-N_]Z^.KZVVS?V
MR>GU4?O,_K/3OMKNG!]O1I6=M:S35U;N"D5 N!SK*)* $/,'LLHPEF.$)ZG^
M:A0'SE<[&,E2F4IBIA2^BFQ9G'@BTF5#BQVNHXV8V5K"X X'LQC\_6FY3VIB
M3!?->FLTUW-*MBS3U"BXDJ%_UX8].:Y&_6"^XY+\-TLYA?TE+&?IF&DMEU'&
M)4'M0@/'VN6@A4(1"VCE73=\]=[Z#"H@],:HZ_07H*I"1T2@M"Z4)MLDUJ#T
M*\,9TQ)(UW!@L_,\C&FAZNQN(&*^C5H>B/.#NY"-'JGCEEOS2C)^1[$]UJ8#
M _C%_WFY)+Z?-A,+XI ?8T!+8_85YNN/(9;0EMQ]S&)>\?-:#*CBZIFT]4B$
M\B"V= :?LI^_WELT>R_,<;;0ZF+/Q3-J0\=CY\,'G$=/YG-JMK4B=B/YRIR0
MIG+6"D4=&@?)SMY/RU!:Q9IR<[JM-54CGD?Q_L"$-Z92OG"T)P1[FN.-_]HO
M147X#\/\<P7W6^HRS.9?6^TQ5#*P"C+0JN]5^K\B_(?D_69KN[F[W6JT*@&H
M"/^A!6">5::>>3E6RBVP7OQ84;ML:A<MWWMS/MUOPIQ7U*XY/[]3!]ZY'7NG
MSSR""#=?+FP%Y!!^>*Y9+VH7S>/U1K-2V16U&\+.C?WMYAX>,>97[6XSYKVB
M=OUY^F#->;HZ*U?4K@VUZW09N GS75&[MKR\WWB&<W*K.B=7/+Y$(ZR^>U"=
MDRMJ-X2=F\WMUFL\4^Q6/%U1NSD\O0\\O;/N>OH'.R=/ -*L[\K]V-161^:*
M.S:%VB66O:[.S)O#-NM%;75FKAAD@ZBMSLP5EVP:M=69^5%GY@KT^ <!/2Z%
M0)PGL1<^WXX'(G0US!KB/D8#%D(K20JPQIDSL+,8D; :4:R!)'LBA _,]P6L
M4<3"L6ZH3S ^+N*;(&(R?A7R(1,^MJEZH8;XWPGSO+$D AJQ&4*ZBL#%EEJ[
M]A#H'D1V!MURMFY_ /3>.>(O+YS;VIZW:#X+0CL9P?/,=@;,[R-H*6@>/PX#
MC^#=G &_U:""CI.$D6SU01C@)^O9_]C>MD\$]]Q#^Y+U^5N8F+\3[B.X7'/O
MK?T;\Q+\T][>5FOFBEO=4P%MY .AC;12M)$L)?NX@Q9HV:>]Z,D8K&J(Y; D
MDP.GSC+#U0-]:]^,1S#&=LBZPGEK(V:GG(SS (?=W,N^]4J_AC_A'+Y[!3,R
M.3<C>'^[&W+V=;O+>T$(33+OCHVC1T]+!G VNW;9?K/T(>&T6JL/:UQ>AGN9
MB,PSJL+N^XO+F].+<ZOS1^?JZ/2Z<VVWSX_MZYN+HW_8OW6N;SH5J'26YD7B
M1X?<NH-_V7Y@:RS5<GCHJ=#0;A*B(E\<'/12D9\7 F$]9RF_#&*8$,$\ZY*-
M$1D_LC_C#GC#PZ'PF43\#NTCN1T*Q+ZG[7#10K6 T6X,5/L[\;XS''D!K9?5
M[H><:AI$:(:(]^U(&S9CSL(IE3)W:R"E/MDW01).%TBL>S%B83P&FQ5L)YN;
M?I$K(K2&L&R"Q301<#**!W8"U*/-3A;9E,;IJNKUVRC;)G:'YI=OXZ^MQEL6
M;]\)SZ-/33@6LDA TU@U1<0QV7S0'5AD283TX*#3?H#B6'$QMP>"GH!GL_W!
M[@^=C>%<P2+)Z/@-Z"_YQ:9"TJ_E0(#KVX[#/>"XF+O6-6TJ$A_3_@WL?.2&
MS])X+]%6XGW=/H&U!<:+X0BI#PAD^T?(*F6%"H"#71%R)_[_V7O3YK25K5'X
MNWZ%;IZ]GW+JE;V9;2?GI I/B7<2V_&0[.Q;MU)":D"QD(@&8_SKW[56=VL
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MTY=_V#1-22.@A-\&ONKUW(@3D?*@)5_X6D.H6LQAP)-QU%:,RUOXL.#)B/.
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M&K&U<''Y%E\16Y)B%=^:; :VHU);9N0V&C8^T=4.<V!I&^X/Y*%'/T I:AC
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M6*#J7@7P 9>N\$([-*-?Y].TVG0<$-% GK@-']G"B>OUX.2V/Z;I?09RE?Y
M141+SL(>7(DQ\SP YAMZ'RX_\$*6#HW4JZ^285?XEWE\SXP003MOMRT#SNS$
MN8:7'-APBJ]P$+7$L;U:0X:NI_WNAWGSX^'TP]GM$6OV/GZ(-=2I?LUU]FAF
M9D'.SQ:2_DER BYPZBSRE5$>LE\ZB),2\8HSPPX/QI[SS\4G9__+47FV%1+5
M#:5Z!4R7;^7&]XO _O+W[5X4$)R XE.B??7:JW0R(;YXEG63%4.E^C:.UDNM
M6\]<=]1RE@%#\:)WXW\GPQ-/X'H<O9)2QI6,CEEX..H.OGPZO7JOW]3'+_4H
M8X71!E$/P6&5G30_[P77W?$5CC/1HEZI)XI>'O[9KYQ7G5OG\F-CENN;.@FE
MWI@3,:8T;JOOSH]P@&;UO!*U^E[FNB.NY.GX-@G_TFBH/),O.NV'5I[!#SWJ
M@\Z6OJ-'F9"%=; 9JP>?_;W*X?'Y=W-$P!6B;)(H6UPP=;$N[#P!N0A("X?Q
M2CB,)ZO:[)ZT_22A5ZK[/Q["UL5%Y^#B:_EP+XO0XU@\<0RYRLB:_V=[&VP,
M9IMOU N] [;8%?L5,C#S 47VWJI?=3O$?ZK;VP*%3>M.ODS0M]23#VS=N%4K
M@-%DOD1Z-*G5#3351A3K!J56]!]/$BE]'1=.TH@!B,J\<2V>7I;8KMSH6_5Z
MV(<]-CV]91EO591O_##.7-QV>2_YJ[_DS_ K?KAP(N-GTX??;[<\IM]NMQC<
M/2RIVP-]Z#_Z6*(K36;MI-^;A \!Y["E+GWV_YO_0A+R19F NH>@V+7/FK99
M#[OW\[3.3YP(FFO)RT</M-4>B@\MQV2X:&FGOE@./Y(\-4YBOW.&O[NKV0IY
M$\ 7ZL!RU8&%QJ=621UXCFC00KS("\6<A>+*0H,OR\25(M21"G5L.%HN-+*P
M5+0L_/@3,GDGN [*>S\>*F?.W=G'JU_!V3P]%E=0+5L+3:RI>,QP 3ELBTM2
M0$="SH0$17:))J^Z-<'DC;QQK^E#,E:3)NC6J!<LLET5;KL2D_:!$N"GP/B$
M4&X#*;D#9,>$1NC]M8#!FLPW@$"8/PJL%C%@_B"LB31'#YMJ:\@E_?&AZH4V
M'D/@*A$#IN\.FQ=JVW-[I X("MY1CW^%5C!4[] B]540.5/8]DGSZD!M7AVJ
MN^6]G31.+#I^U:@D?:1-\^>U>\%<]'SD1ZVD SSG:8I5W0:M\[-:_WWW;)Y^
MY,]/CTL^]=K8J4<5FQ//?K^>//N\W] -#.HW)Q>_/K/J46<M;R"+(\YFZ\G3
MJI:J/QY^WGW^<GU<O?AG#Q.!N6>/OGZC'EF^ 0(3=#AU6[W0@4!]]8)Y5.F&
MM!A_O_+VHRRK606-*[\\*_HJJ8/!4>"3_WU5B4YYQ#O7(N]<.?;.S:>O<>_:
M0IE$"QMWU?[S5VMBM=2BMK.:18!/!%6!)BMV(06:+ 5-J@6:%&@R(YI,/_8"
M60ID*54J!4\IT*1 D]6 :NW1I%R@28$F+P9-%A@3RW/29"8C/?-!P!UB-E'>
M'<[IR9E[:T^ LA?'YYN!L05C6R*6))M__*?E_?5..2OPIL";@KNL"%3KC24%
M=RGPIN N!984W*7 F]7!FX*[%%CRHKG+$_B 9E]1)!952G\N<M/Y-8\$*:7,
M_\</^[QM OYCTK7*Y*<_7V4ZBN9.IEKHEO^8TD&Z.F$DW&B]/_6._O$0G!Y_
M/3$:)_\TY\FY$[O<_7.E)\!-;1/0F+M;?&6OJI7JU;&6\8O)W5\*$BVRF?K+
M!' :&>[-,MTIAQY/+GH?VI6[T\&O><:Z/3\]/FJ8TW3";,P]S:T,A%EN%(3Y
MD@"<E3"SY.-H-QM!CW[EY_#>NKEK6O-4Z3P_/<XB'Z<TNVGLSDV$C896JHT/
M5%EA%%IY'%]Y *<1X<$LTC&'&AUSM_S9&WS8KQMK28V/DH[3R')O?K*L:?NU
M\<'%*XQ4*X_U*P_@-++<GR ;$^W[DM1X^.O;R=_^=;![.<_\P>>GQEED8[)#
M8!81[L\]9ZR^JU5V"]GXH@"<1H3-661C#C7>?CFJ?'7N2X?N>E+CHV3C%++<
M+<WMT*F6-%B@(,N7!."L*FN6;,R<R??CX>OUX.B<7?1LO;R6U#B+;)S2E7>W
M/"\1ULI[VFZ](,(7!> T(BS/(AMSJ+'[_:Y>JGSXV3UX 5[5:619F5LVULM:
MHU)?-ED^^2S6%0J6+G*C6]NOL46-$ZA'V.SE1+<\WF(4N\6<]PG%F@/=,WW^
M6-R:]<3R84_J=Z9[,Z?2KV:"0LP^&LDV)),",3_HL6BTP2&<7<?UALU[RQ??
M 2E^IA9HXN]XR?B9XU_!L#F LSUU,%#M#?%[/W"N6_:)ZS7[=LO^[HE5'IR/
M9^[IO_\<^^$\0[R72BU;^4PI>9*3PCMQ< >/YD=\>OC7(\YIA(U59V=CV#S\
MOZ^VQ_A93:M6EQ,B6N05O%XU@-8N36D\ K0 +A#)Y,7R@J]&J=P^^?S]R\4\
M+NXUXP6C9_A['*'VVQRA5M+JC>78'05'6"6HQFW[,8XP&H)Z!KW@5[6FGW_]
M8K[?KVT2+Q@+;"U4+WA$+E>>7E#6]I?D BRXP"I!-8-U\'@NL"2]X+U9[83#
M;S=[[^W-YP6+U0L>D426PQ'*-:U1<(07Q1%R]8+1\-LSZ 6GS;.[WN!K,,0!
M=:O%"U(K;?O,V+;NM_FDT#<JG&S%NF]Y-A#E+M[#'AQA?!%K@R4%5/-05&EQ
M%+4D&=L\M2J_C/W/G^<*VJT&7>T5=/4BH(KIJIY'5Z/!L&>05,'@OK17#S[]
MW%U?BMHO*.I%0#6>AK4 BEJ2I+J[.[U[?_-^X.RNG)=X5KK:*RV#KHK@\8)L
M^O_O=3)BK ?)H+!Z[)@41 X#/]#CZ5 XXN3&N6,^3@G)C#!O:G3Y^&FCR]\]
MN($3#^[FO!WQC?>>$YBGSN&=9W[W\&I,I]-T3+@0/S EX_CWWML[\>^KM5_S
MU#,]4_K+0B+-\YY9VIFT-W]26TVK-58_VKQV8GLUH5I*XLGLRL3\#,+Y]>\)
M^]NMUTZ[&\\@LMS,"V(3<R?9[=:T<KE<L(F7 =4,&L1RXM#S,X@/O8^A<UZI
M-C^LGO-YN3'I!;&&1R2NC<2E&UJCNIR*L1=-A*L)U7AIYI,&IW]#@PB_?-^]
M8T=71QN5S3I[I'I!?.+WT]GVM,;^ZO.+(FJ].%:Q^[11Z_F9Q'#7KP2ESL&9
MHZ\:DYC9@5DO @,O JJ8O Z?(X0]/Y$=?&SINM,I_;3F*7M;#2)K%$3V(J":
M(?-J.?'L^<GKEZ>W;XVP:7RHKBUY%6E8+P.J&1Q-RPQNST]DIT??;\XO6Z6+
MG_,TJ%T-(EM*3E81Z5Y<I/NP"VH2H^!TNDHZ#G!C<)O G1[@OO LUTN&N?V-
MB7/GRN;EQ+D/NT[GU!%\8Y1#C/*1"\_[[OF2;PS<K\VOE?*>ZZTOWR@RSUX&
M5#%]59XC6/P;5%8Y/OUBU+_]>QFN+97M+R4/[47C\VI"]6PUO[]!7Z<=ZTOP
M_<:^[K%5HZ]E5P#/?6KI,,K^(Q*V\KH":-72?A%&>4$,(K=4:9D1U]]@$[_:
M5S=>[Y?QO;]RCMZG";DNBED\(FTKKU2XHNU75C_-L^ 63Y#AN9R@ZV_PB3OS
MYR_S:,\Y^/=VD_C$6#?@):H3"V@[5M%*]4*?>$D<HOP<<>/?X!.W_Y0>W.:G
MZJ>S]N;SB67J$PMH259T'GEAS"+7^%A._/LWV$3M:[51\^Y.RL.-\DZ,-5!>
MHCKQ^]W*:E6ML09U906'>(*$\&6&\'^#3YPYEZ5!\Z?_T-[;?#ZQ3'7B]SN9
M51I:9=WTB0U./$B7V']E?H"I!H_HSZX&7?%#9JI'H8<_W\0"^P4&1F=1BK[Z
M@=,Y"C(SEH!PX>LH<2DJ>_&:I7_VCIJWM95C<C.'0HMLP)<!U0RM;I:9<# '
M==GWU<^?/W6LC^'NVE)7T9KM94 54]?)TR8:S$%7IG=^7GGH&L[-^DJM(DWN
M94 U0\O#9<;GYZ"NKXW@]OSSMUKC?.7\Z#-25[E4I,>]#*ABZCIZVGCV''1U
M=-H(ND.G>E!>O1XDL])5N:"K%P%53%?5YX@"ST%='>/*KK;T3^QH?:FK4E#7
MBX!JAAR+Y81-YZ"K[\;?K=NV\_F+M7JM]6:EJVI!5R\"JAEZ7BPSV#@'=56^
M'!W]/*E<W5RL+W75BD+AU8[7918*ZSY&[&3P#H<M$[AY4;SL$F'U!#[XUK6,
MKMKL]VTXA);-HD4/7<>T<"U?_<8\IE[I@>6WK<V.^>5*]*47&S?]\[9@0>=M
MBL='+"B+]0S]B^ZG]^;/P\N5<_,L>W[SO(>62FPHEWX_#:JLU2M%4O5+4DP6
MV(M@KBRH1S()S_@47M_\W:OJZQII*9>*9EPO ZH9M/^EETH_DKQZC=O/_>ZE
M?5]?N5SDF<FK2+]Y&5#-X!)^HD+C1Q+9R<-M;_\?^^;GSZ+.^'?4W;T%E 75
M]_8*=?<%L8K<3+VE5QD_DDDTC9.R;AV=5L]7+GSTA$7&O\,>]G\_S5_;;:S^
M$)F"/3R!L^R)2HP?R21*[S_I]\</H=UZ 4QB>9I$N;0 5K&_7["*E\0J%M@!
M>+F:Q%%8=B_??ZE^_K1Z4VZ?K+SX=[C#W,,JJZ _U%:>*:P=#:XF5#/4*SQ1
M8?$C^<-[M^LT#NR2Y:]<W.VIRXI_ATO,/:NRHE66U,BHR%E8D"Z[_7H\4V$L
M^4#,\R: 'Y.R<(VUQ["\#4\$KOJ9L6!*\L(&9ROD1DJ6DZT043TG=L<<'ZS
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M]31@/;56JFS=O<:"WZOC0_62=4);)WY_M?U14P>,L*'ON7<6,A*Z^[9KV^X
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M;33\,0$;R5?\XN+XG.X.[+1M_/<9_$?>IQMZ*ES92Q:?\TB(.86JU>NHOF>
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MN;CT=,M/AH(P@\/!/);<_:,MDM"BJ"D0\T>C4931X&-%53J=08E 3&I/8-S
MWY2=0%44,N"DQFDNS+&P]C7QMKA\&9["?3"Y"RTN%4.1(?@#8):2^!$O?'58
M!W0R'GU"E52W;%>\N ?V@^B@P4Q:H^5BC2D-4$/TY8E#?DCG)[>UHUZ%I-D0
MO(GWN6VX=X7O.?]T<4W30GQ'#4NH=KP\V^?/1CV5*%!'>HS0JC!6WW9#ASI"
M%S'T%=T(V45L@EDTU=+'7R"#)+LBITA39EGQ'#))1>G^($KL&DBPE5'NDVL#
MC6#M#.9  H_!-LHR8]0M:DLVI.%T?AB;"-)>G& .C%D#T5KX(N:VM935D[8-
MT5H0*J+HE0,KP>%9?A<9;<)%P]\B_A*![;BFE;*XY,WUQ> ]Z;J(<I&%_TTY
M3-SJ)WV@;NEYGI6C^.RE7R73%H[EE^Q7E,P=HQ.-EE9$QM29&R44X \2\FPL
M(<KUQBTUT>:%KG. 7#BNX(CF]\D6]2FT5M)HC:T8'#C!"5M7,=\@D'T!<JU'
M6$J39XZ-CD2K :GE&UT7VT]A-@.R;5NH"_@5H1.E\X6VH QZ4<3%V;W(BP-H
M?X4N1SW5'_HX5Q'%/*6KIU/*N/#..#MJX1E@ SX;NQB8E)=)DER+.T,AH9$\
M]*V R5TE+W7B412L?X4VTDRT2\K1=^G:*>G.#G@Z8,\U ;2XD';4%9/0"#+<
M(<E,G@@KQ[,F-^!PU]^@S6RQ5-BT*XIOE).7L,:R6_Z-7A_J&1TN_>UD%[8Q
M41XW3D0N0?4*H_T3E1GZ)WJD]$3V%'P)*H@J6QE*(8=_G.F^J?\28'ZF-.N$
M'14'6= OFRJ#RLB:WU'/(Q!,E\F<>\QTQOUA>HIAQ5GK65W?D*_Q,H4Q)6;\
M<!6ABH!T9OT@T5<RN?%T'SH\ Q$JF'8,!7=<H8T@V469[$)5S\8.1,IQQ3"O
M[1F5KC#/ !X<=4'+6H%* A11D4#:749O,J[(QB4&F'?$HRE)4!W8=#ZGX+4'
MO-&.U>LQD_I?\4(43G6I6I2$4UO:2JE.:^) (J_59OJS5PW-%YT16"TR C$C
ML%ID!*Y]IZB%M9>8\V?X1:H_9I:JQEM0$+,GKUW,TJ63UA>=](?H][*X>A-*
M%T#4]D>4M,'BH<'B-!8U-@0-<C++P.90>/ \9C L^ C[P/(3SJF$^SA^?[H^
M+V;JZ\4,5XV%S^_H=91T>](E:RLY:RD)=>)-NJO48@:TSC2,=:&*ZV:-.26\
MRQYT6EGZH-/__9_]QNY^?+Y/.NR4E%D^$&VDKG?,\SSNSQ49(#EEYGIZP!*H
M/UBQRM?W1:,.H;DKZ'+E37 M\JBAT2RZOB5Z U.GV='(XS2:G&4+R:"DC'5+
MYWTJ8B*7S^K1'.^-EHVJ[%,[5=,[%0)#20/)/=C2SJ#T.,K5,G2?:2).(LK^
MN)&!81\*NI-K8*Q4.QI&AU<J 8BW_+__L[=?2^'?V-C9)V-2\PNH@B-M'$?*
MZ&@>:5H4],OH;BY5L$RO^QA/XZB/BZT&^A<RNJ"(L9=CDQB>L* /*4*5M'TP
MXIF6'I$M)*,:MF@<@^-IJ$'-Y!'CZXGLJV]5G;D\![MM&1-\CLC">%Z4S/6@
M1A^\6QE/,*!Q;TPU7=XP*9K<QL=#8'X;CE-*)&Y%0<<B,KT:$;BG:V)6!!/G
MZFR6D1:PB'9F<;T'[\J?V\%,R>Q@EM6V+#MF,=:Y;*YF9<JCFY4E<WQ&FC5-
M:U:6'>7Y_2YEZDB7,FY<Q2<SL3.9,JE.@6:=S-RI3)V[4]G8%)G\3F4R%S8K
M@_ 13<JH(UFB'9D2]2)+]+]*0Z6):I_Q7F2)AS!OKKS[UI^6T3;>KBS30R%6
MGIP;]YA>9I-7E,EZUW#)D_J:99-D;@LS-;N%68]Y'89)=(G>9)KRF.9DZH3F
M9%F7,KU9F9+UL]]K7J:.-2\['&M>ENAS-K%IF5\H-<^KU("*BPEVNH59U7RD
M=:'2/!\:W2#G4$93GM61E&<MFQFD@F>"DM&>#&PNC/7HHH4T&RWX2>I12J1'
M%>3YC'F.J0%AIW(DE!1AN-:A'# ^(L0*,G[F<I4ES V3'6"H&<5ALAE%5JOU
ML3EBZE//$5.NIY8;K_4<L=7'] 7SHYFFC24&C!6)V"N*@-?SCB";1LVK-H(L
M#9\<.:8L;.28!#'U'DV=/IA'B5G^'+-X)E]#,8MGI;C&I $]!8=<44R[7N+4
MGNKXU)[*TJ;V3,&PM;^H5<.X1:>OUXKT=4Q?KQ7IZQN7/?S4Z>O243YYDN'8
MB#*]A<W[,T:459YT1-EZ,;AUU=3DZ X%!WD4"MCS*F K.+]CHCI5S._8').M
MF-_QK,>?,[\C,;/C^D/SF@_=^'#^Z>@8OIPPPT-VQ$]W6V^J9\??U,-/S:O)
M'=:5D0[KB =/09N;@@B+MHGJA4V$-E&]L(F*(1]\R$>MF/FP?)C%ZM1Y%'V#
M8+F!N>9AE9?T\D:]JN"%S;&PQ:0Q(+'7KBE&?V JGP=6*E=5_;YM!<4M/Y7^
ML;1Q'YLCZ)\I2"F,,S;6DR7N@\3I[]&S0 3]X701HCPE07DR93%I)HX/[,T@
M6976A_]V.M1B$IM68>1S $!'S1%:+!A@$]_R-O"5[7*)NJJ+/^JI\2&7X@W\
MI5?XAKBYI1^V?HID+@H9^B--KK+'%VCXU=^AP]"A52E5ZM2*:J:9+#*IA5KP
M,L/6T3#6S3M1SYL.G'@CL:^,K8BNJ+*;O$+V_7AX-F&/QWEJU"L(^P/9<-0A
M*AOP(VYLZZ;)_7-7HK/T5HNZI3:QO@W@/#T]C8H-8QQ1QG"$.D0#FNITH.@:
M',&R1-PE<W?+<!4J!V.NPO6E^8UB7GW/ZF'(#IW-F!W!,ZQEV4 >Y\I#'HLJ
MQ!)9V*F:\KB>-IDB+QO-I3A5LD\WL 9J$!__'$LN>'J]<($A8O+" $1]RT&'
MF2TZ8L&:UW$#N$/A6Q,MX-1O3&DQVV)W,HLK?W/)5#E*09^8+L=/(\IWC[A$
M:IOH:5.HSY_H%$NL-Q_<#4"ZC:&>4]YO-8?K)U(K-=X+&*/F<:[D/+(?$(72
M"Z-,QS@-.R/VCH)@"J^GJEZ0GSB!P&KG97B"Q/;);L=ZT$1E$Z*TDK=TU*E\
MU@$M8X5/.VI3I%-J(T*:KTT2::1[4T:!/C\WD-8M(1#%H(.HL'^\)8E(K>)*
MT2B5CQ\094"(;7I4T#2),V"%FFV[ YD@G?Q.),J/L-K1U(R:AC.GTOEKBLA]
MPQ[MJ;B"Q$SITT^.8& 6K1"EWV)U3#*1+D_YR5;1%"R(DNHIWF>T;+ZJ$>?7
M16U!4TK>!K")C>%W.?HV)0WR^C[!&:BW#%$S6@]FE(^KR<3!:1HH((]X$LF?
MTQ7JY:F2#U76UB)C%<$UJCN5W6BGO 6'BS!1:@J8:E$[(&*LN>)7UK$H4B/)
MU$-R,^6[>I2]:L;9JW0J^-Z(<8URC%&N,*'-N&2K$W-/1])E,Y9)$N;62,*L
MDI\P^SJ9)?LHH*+,^1F2^)7Q)/Y$6^*QZ0^R6!HLWSO=LQB/N[;U:':@Q%L\
M^D&7$4NDL7YC2:[T]GE//3$5YX[:1&-X%7MM",GAB^:$O$$S-@B$E7F!K"^F
MYHGI&QCP3?T4%./M<;TZ6[9A4^3DLG_!5CO8<Q#1G[1/COI@<(>^11G.)E"/
M[?9)QZ8\7])[X !#T3<:C@1->BPAITWPUP-4Z(#$A7?44]'#T.;ETS'A9$ZC
MF*"QHZ$"YJFOZ)%= $O\4=XIE1(& C?1>QBM1F0FN>9*%=_&_?!Y3\DU@&\0
MLC CI&"^[&EEZD-?W8*G;=>AXEG0E*+(NW!8"% _"9/C2VJ:B7JA.\Q^31V[
MD1N&/J(/U>SB/,DA;^:5RS8X;\7LZ%'*Y84RO\<."A&[0AMI^O(R,:8/B' $
M5T;:+^#* /^K4M?V]ROPG_J$!E0Y*2.:6F_L:Z5R(ZNA/?^]$O>+B205$DK4
M+V]\^%E*Y^8S@?QD7X51W1I@JFNE2D4K5ZJC@"A9[?[F @3$ JCB03XD.^J!
MCL3BIJ;$*F.].V<ZUZB/-Q!S.Z7=9]:*9*@CFC0/%6RXHP'!D^.,NR_R5!AN
MH/C,YLPW::!H>6E#\>XXKP:>!&\-^<RZB)_Q+E\\G9#XMLZ; 0@'K^@L,\D3
M1$I+^:UZ+#JJPQ%F=G3<$9[A#:#>C6%#Z!?,M.GE$!O1MR-M>V=VDLF:-!7I
M\R)E+M7,GHA1%F!-B6=P=WJT5"8H.?,[,CUQ</2@"O+F9M)Q22.6HZ%-O'F.
MS=*\2!!-U$KE.H_&07/@#($F09$70_0-07TP<T"7X,BP!52F[&$AKU=H(V>N
MTO:X/83IFA.P*_*&":[L4R#.IQY&N4P4F_+X =-I@.!PQ)_3=?FJ2CQ>,]E)
M0788'X=OMG?SQ3?@CE8-V1:=9]8H\LPPSZQ1Y)FM?9G$<]?>2)Z)X0&>^A %
M"5+"V,+!CBR,U)4Q'KNC'NN1&C-!(. #W/FC]\AA@F2A=S+[#:<AR#4X,AVJ
MH@@A&<TU+3.U2FHL5Z8LHFBQ[J4;?V=L2D9@1>3EC]).J51.^&:V?,;F,"0N
M<<8&A3HLA_L#3>D:DLDE11W24]<A8<Z K\B&?!G75^2F/6_ 9L1],399GEH%
MBB&UD[RNL2O '_9:KBT)&+#@\-/E.5ZSH$+NC!=I)8I+R5[(5''> %%[J >3
MF%6D*J<32?@@^+2W.S7V((LC\5' @AWAE[/EA%QC0,NB%"KY"VVB1YJ<P>@;
MAS=WQ/!V# EW?$W)3OR(UH]=T)F^\1''=F']K=!&SAV%!ZM+%*VND0]/Z!!
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M!T<<^3P=C3._<H.GZOP.5E/"B&Y@Q"O^U52J*[!QA3:"QN$X'T?6\KCH/BP
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MH7>TXH WF(MR*Q7=C_/\DV54R:00+RLQ9+1#]]3N<SOJ"1\<@0WO4WB5JA'
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M7H7-Y,:'L/9 %0..V6(T=Q7U,NSWVH\  L29./E;/744U,UXWZJ9]A#-(=@
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MR-%CI/L%WL=GIQ@X;65!I_P6%AC@.XF%P(M;J;TH$_:"\XQP/.)0 .<. .M
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MK2\E*%JP/3@BB[LAI4 EGLZET!!1%Z0;<7$##I/=<QN3;S^Y08_UX2APCIG
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M&9#<\Q_L-Q37SUCDR[9W)O"?B>GG1.I7F)UZ^'YU4%[_)?L@CU_FQ4\?/+O
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M9Q&'[<A2]7WR>PXDU=+YM0M/E3#.M._@%5C%H4_UF*8!B!99$DD]2@D?V9N
M2F7&CNSO@(Z4]!M42(E,66PBLM+E%8%(\IQ0*&38R+*#A8=-)6=^ID1<KJV^
M<#"P%N6>K&03SZ<D$W6AEY1@(.E!>9;",KATAM@1 Z<GG:@HZ9-![A\T)_-'
MB9)6]K=?/H*.1'DE/]LT/'7S]:EMML29H+B.G016O-[,)E*6.FI[D>PQ074
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MD$?B-2#WIC,U20L3= L'B(4?S-5=$1*HIB-BGALA1SN#X)J_ ,&T5QG!Y$;
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M_"<G*EKD32J(%^*Y'\2A@9 9")F!D+UP)C00,L,U!D)67MXP$#(#(2MCP-Y
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M!]X?[#>+V;8;65BB$I0F446*T^4W(EHBW3VL+8)TYWP:A"+8<X9:2.35350
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M    " "T9:U:Z2B+][H)  "U"0  "@   &EM9S P,2YJ<&<!M0E*]O_8_^
M$$I&248  0$! '@ >   _]L 0P *!P<(!P8*" @("PH*"PX8$ X-#0X=%181
M&",?)20B'R(A)BLW+R8I-"DA(C!!,30Y.SX^/B4N1$E#/$@W/3X[_\  "P@
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M'$B 8"J!7/\ C/P;8^,=*^RW)\N9.89@.5/^%>*:A\&_%EI.R6]O%=QYX='
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M" *@_/L)]7\GM/]&_[7OG[I1_GG/OY.>?@!(L%$44-O04$@ J"0H:"0H3[V
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MMIN1DO&K@B[+<%0B85@72\@\,PMB+<W:=7BJ]C()-2)^<XH^I4]R2\Z5<V&
M7":?M/0=#84@XOT,O;G/E)F?5K6]_E!SPLN16F[_7TP;<*KIU!ULR7X7DIJ1
MU(I%L_J58=99539X9XL. ]".3FM!X%FGZ-I-\& 33?SO<?FXS$9]\*[.R.EG
M8Z#3 ZL6;8>!=7+.I4(-_-,[!BLZP1Q;)V)4H3G[:0C"VTU_EVPT-$7NW&Q@
M5J+EA-5X4\"'1SJFEG:VL(-D,Z$YX)1WA'+MJ_82[W!N>!_E]\AB.##C^:T+
M\8TZ<#>:Z^NN\,C'%V?WQTX#-97LS41\T!UJ.A_0$E)[G39!T4;!;PALO8A'
MJ=D>O0&D A6?--QBU[O[[ S--OU"<_S#-?][E[K72.F5/=AY06NZ@>>C\(TJ
M35Q2)'LYRH:!7P?::ZR-:2AVN\4:>-- 8RRS0/''JJ('&6[K]K*7D,5 9GF&
MY0([X5:]=G/^D&Z'CA2!BUC_,7AX3^"CV+O!Y #004,8\WP+D5WHR*K3>4G'
M:X]:X$\>#_67V[8Q&1S-A!.WK\.IN35"/D3W<(D=S6_7<,(K'4J5:7WD3*WG
M*$C()F"7#IMZA+,L,2Q,#(0?4^P.VP8F!\P(.[WPI.[:QL59&TUTR6'O"^D2
M359!J2Y,;D>P[F7W='X_E.)'IN4NE0&$"&7RTE!3)%[X#U?5[IK@$-G!_(&B
MXFTWXU*%ZI$,\9A/8C)V0E%Y7U[\L@RH'&F63LL,_2(QN]XLI3\^(3*<$UD=
M+=/;S!X/<ER4DL?/RM#>,I\7J5:;#!HUU?Q$2A4/X(Z^8P*Q!0J+1/+LT$O]
MZ@094/,G.IS=RS&?Y?EGF:NM]9?C).LXQJ-,CSB9D6Q%1-$JBF$50/&E<ASL
M Y__COYX+CSZ3$KO\ZV4>V-/YG:TQCDS-&V'Q+K4<JBA_Y7*S9:JH5'\U[WZ
M<[.>B)<UOR-@N!RVK<CO',/WU;M]S)Z+VQ$,O#K7E\))MN>$P>$?8HNM5%OG
M(9JR#WFBJHFINPX*-9]40E=J\@[3DQ^*PVAZNBJR6_I/Q?78IX^N.""N+7&X
MKKK0WO1;QF<':IP_XROS3); /O\ V6#S/* _UOCS[7$9WS?>CV&X_\5Y]<)/
M /(GP!+"P.L? :K?!H&AO'C'EMVB+5;CM$LQCLL)9+#8L0A^HS$UW4/[^5JA
M=A(?%?B;W(B3WWM<V;9GC5^<HZ%!NPL4%<Z1NS[>SR?I!9,_I+TI>[\-YYZI
M:<Z+$P,D=/Q,C@IKHO$:Y%B"=?N_\E.D:5T?Q1JFQ#+AS=X4CS8RBVVFX1WE
M:RPR-N5=:N6*WEI895&;79V]SQ1:O S&R-,R&L.<I![8R^I7H;+DI.\R^.Q8
M\,%+O%F@Y'T2,XFR6' **<CE:#$<UHMO,\B#;NI#_RO%UI1;'QS4F=(ZB-B%
M6LP2.X-\>LM))R7;5/;Z"2.)C6W%8U?DT='=M%3KZ%N[_ P^5_)$60Q%+>S<
M2,EE+H3(_?69#CE.EA&^2/3H.+/,.T6 @<=ZU3 >3='F0+4 I2+1YPZZKODZ
MI#B:O;F7J-XSU70QM\EQK>*;9\9F1_JRBC\ME$XZ;*K8$:I8 :IG[#T)HB W
M7_J1.-!WU3'.9NZ1J/US?=R*EXWCN<6)WD.I2 @F^V#\N>_68$$U<6Z\%8^U
MD:9(U+'4;K0(58K1R?FC*C_+3WW3!40::-=3GN.C'FO7084Y(7%N@$.+?>O5
MWLOQ]V<:O<N-/!09H+G8JN50^AZ:K:"AIE\OTR*6E]?Q7TU9A.^0 ;WF7(Z%
M!E2^*&7DPH&% 7]Z)2H<V3"23Y-M0C7+7\:0.4ZO\G9_[TUBM/Y@-CMI*BV9
M]@I#R$^^Z/OW/\.MX?#DNXJ 2>\A=]RAK>6MJ!V%=BZ'.%$3T1PFDD%6CX%:
M=3O%%O-)+_:WL[1-7:U2P?1C&')Q/MF?BUZNGAF!D[47QY-&EGVC3QNTHI:D
M1MF*JY7EN -<)>RS4FN^FB+2)3O?$0/WN'!_;IQVSY0Y<5[I&.2EKIR%4K$3
M[>@)?<S173'L#*UE#2>0#V7=>-RHC0N=)9??6Y&BNZ#O8Q[1H?@Y7"71HJIU
MH_G9GJ]EX^ Z6LWS8%^76PZGY1#7NWA77%=LBZFJQ5C1]?J"_F,?O=RU=.@9
M=,CZUT=/3<<7W*^^^=.,.7-RQ9!W.=H&TWTZ8>CC6-.*TL,<%Q^>;*P&8IG:
MP5*WU)G;E'MN;-]D![+L>%-=KT@^L)&$&G^</3^E)2647^KY,$NC8!YWV$?M
M\[4=,9&_5&27 #Z1$.ZC6L-;3[S&%+6(7=2:;+9@$UA.WK6$.%4NC,99L-(W
M),+M!RC-B\-X$/+RZ@H!BO%-H63;;3GASF]B;9.G0FH61#O8MG'8"()']S#4
MP&*OO":I,>E6%"=^[_'>^L?:HU5MATN$J?YBQ]5V>+2<=^3W#)J]KAB0#I$)
M3!WK'K"*62%;YXD[J:8"PAU@3?R5;+3\0\U%;+_2:-^$4Z:]:J)R8)[2WHY?
M-]53=06Q5U6LY:,H+ [M+=MU;*I/VNE37 L\Z^?8Y@SB'7G3,GQLS'Q&5VC6
MM].K,[?\-5-W6WV\R\A639(9_8RQZ_EN!K$=0AZJ!;G8DQ0;&'8G7;QQC]I)
M8/[(.'K=WK)WZ0@T;YS\M=:-'8,>H:=Q/*/0U6B59?N,UW^_F*@/=GZ/-YA#
M;.+,IZ),3?G"B5 USO$RANJ9RA!UW3W\G*[[I5F^/KX[3?QU[B1^<?>7UR_@
M2N$M>SRS]X6?#WE%WC5M+%USH^1WY'7!@GM3Q(<-DN,6\5ZXAT\] ;2 Y;%6
MT3P3LH98B>MK/2<!OR6*, </CCWY$$WP$3;_Z-.1T5O?0N& ^B2=U^4YRA#M
M]3SB VV!'84,^A](U0O*S1O!#=/U0I^6:Y6JKOFVN,29D:OIXC0CT225:K>5
M2*0[([GB![6*S%.:UW2YI0T!*\';BJ&I/;;5>*45JF-K[=OX.G'<9SY+(G6M
MH_9./KQ=[M3*E'Q0C8C!8^&6&E3FTUL7RG'U'?U0432VG<P8[H($9^&TJO0W
M>&)1W-URT &-2)']N6:M;B"YN%*ELJ;]>YZW332% 5-;E<SW_ .QSGOV8V,W
MJ".QOWNWVHK8MLLZ_ SCG@$<#:)HB"L;XK-<+T_!JX439'7M%D>(]U<Y/:U!
M.15=,,B@IV7X/1E^SD"9D<:98)+O%7C :72PRC;7VZIB1:.'W;\5Q?]L+RL2
M5C;O2;81]$,D(6:?RWF9()OTJYUAOV@V3=J\YNZTX ):_N4HM2@S=L6X99^*
MJ1P$\FB(<13F^1>12 V$V![2#&7G=-7PM>++=A\R95A+=;M9Y7I*9JMP6XM<
M)J95%'D$P;,[OPM0GKSXW$\QHF-@X9 L;.5VKY@C."CB(9N]S9TQ^#O+RJ#:
MMYHIA6)/#5ZJLF\TAA&<>J.\00\>OF$7'BEATU\XQR30&UCP_BBDHE5[R&'1
M*I4^*8&RP&A.P9T\^N96M;AP$<\;YPS<2U4H/-AT--;(?&9C4!!1'VSNEIF1
M]7Y[#BU,GC+C:_2L<KPI<5XW>V*:BV*)CCG4L(X<KY,Q4]I5KA=*ZO1H'&/=
M77_EL<N;(;O-2966;CKWTEWSU4CD.KG?3X8X.HU\$V\ 1-R%DH?2DW7]D=4_
MW'+SE9-2YW;B\NY/'#S\ -OC#>3UD)-S Z4FW+.M A2JXV"_#ZO4OX%LBOMX
M9SNF.9Y,$J6I- FWA90X[2O'F:"$?>O#M?@L9F,6Y$&0*Y2#91G(6NV5JI4T
M,T,,Z&>%VN+N18LH;141=M (GJ*J!!_2)L^;$(<+K8%=_V^AA/S7;G(.J35G
MQS)*"&3(BQM<E_#HE2^H(,-.^@ G_F[;R* _[Y\G]^<A6&N0</JL'G_9DR78
M\3[]R$H:NZ)R9<ET$&>G*??:L\!881P,#6$*><,A,9WC*^ >L(2Q\$ ?Z,:3
M9_<$N+(2@T? _7@UE(7)(?33UQ-"*RYT$]Y0<7?5QB> >AYX_%\,/@ %$OUQ
ME8RQ:.GPQ57%8Y)QE M=4DAB2PM9B21N1M$YR(KI^D6[@F^/E3U5RT;815H3
MQR2+@C@IG.ACT00,R6L&P/O0(P. RP)0 1'M\';4,/&_B/9C$7@@.#H#B2@\
M@,,S<J]N-2@H*,B.O01H$RUQ-+3$WP8EF+)<!@M1(%DNV *K^2;LIK'UW9"M
M<)ZN0[8[REMWA.OO45NTE1@E)D8B^^Z@UHJACL'6>ZDL+&@X5<-*G%'<OKJZ
MJ9N/^*V.@WH1>*F'][<01\=CU-1D!L\G$(]##VR'N28H)"J75"@*>&Q\/(40
M=VA\7$$7""9_"Z$FC&/D59N19YO*I[2 0O8A"+=/7&YD!85!9,4CYBL:Y'?J
M=C->&CKK:F-8[-2AQ+U+$#*U!-4AL5 +U10+U2D+A-,W@>#IKS6Y=O/YX0U+
M7L(+W@*T+)9D104P^JRK?=4$UPMXKFV$L:NW"VV9&Q1=B^2M5/3!ZY*ESB+?
M!P[8X0;SA;L5(LPV#R'^!5G:4MA=TG'00JC B=*I8@6"OX9'Z!_KNW+?G2Q-
MIA/BLIBIAG\_@D*UWLE"C?J6^]ZF^.\@W)20N8QYI@%!^8$/=#-"1C\5/UGA
MT,71!]F^%=+:5[U:\"-HO/ 7"@S^UEUD8W9!T5&QVA%\463TX'^(<")9<'"U
MJ\9@F4]TA[QLIU/IV"YI+/!VH=-F<=J'6KFC'E(LQ[U-F5J,B*RY-XK"@GS%
M3W&-ID$6_WV0< ZFBH.(C,JWN<?M)0T!3 H?YIQLE34HR$J=Y"'7<5 -RN/;
M?[IG,6B=UK[&1>5W7\G6D\Z5BSTF?"J8O.G@)2EV/#S-'A@1P#G].@/(DP<F
M!@XX[ DP'W)<V8?EES0<9"#UV?/\%;M@Z[D*K% VF20E%=<5'4>DVLH?M9_J
M/SH)O_":18"8Y2;A^;FMQ<>=N+CP")^L=,(AND35N.JEB:5F-X>.U9I*RR<
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M/H&0;/(7QX->C'_"Z? ZEM81WO(X#D/J_9'*D^)Q];-?\BNHPH#/2W!@$:[
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MM"QZX(5\X]_X?H0\0J@E( .0]@UXI]1AE7^16 GL<#//[_/ 5?GCLZ__ :5
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MDM;+)+ZG4ZHXEK1OK>]),]-[Z4=UJ*+QY]L/HF=I/C\6IV/7V9;'S(C; 2]
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M*_R>IZ"?$+F8 K.TFJT5Z40;BFD-L_V="N-75H8I<\Q5W+29ULQ.,7\MD<1
M8-;\EUJV-TP$P&B'8,6XYJN<F+Z!$=Z-I=0P#RV:.UTP1$/9IS0,S%< _\H2
M^]O?M?>+70JSFZQVXSM[3P=DHRR/6!4JKGVQ=:7K=FGEF?8:5C-7^= 5%W-%
M^A9''L>O:,66=5?A[Q$!:(J_IY%Y,O!LA^B,MO0?*[O8-PK.RNWN]$*W_#-
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ME]+MY8,USYR1V+](;1(#NPK6KQ;K711C]3BK=-WB6EYY7[\ZP)G&]R5\/=9
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M.#[AD%C#"HC+:&L#&?U;2>7)E<9?G,'JLV.4:[1Y2X^+=6#&\?/-U"2PS\9
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MQ)$796\<>KPJ[H$=N(69>IQ,9JO@5MOHN:.T3D^1B"V/M<!QPIQ?^DY9-6G
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M;)(UNXVT**<DF*R+'=X:R2(VZU)?-K,0!12 7T3H&.:$5%5Q0?WQ8_7AX_J
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MFL;-+[8]Y%J21CI\5NQ1O8 7!Q)NG6I6;'?)I+!S40TJ0/R>IAQ3H8"8\E9
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MQ]N@DME<XS:<5IGL88>;3.'/$=F;/OHYOC$VI')S@7&-\%>:G.D$)"NE;48
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MV5PJ,1)QLVD6Z-U/(B8HUP.:.;9.Y8,QCW3(Y!J#CO"1(@<J3W&"EGIC_L)
MP-!-,X0_!L?N>O:^,&19VKF44EYG$3N\^4'[0L>VHJ]S/D@*.)M+*(F.@1Z:
M,:BA*$F.+7\B6Y[8&R48QHZ"S61\D4:Q:R217$C+$7+M%ANUO[\UWM>8&T[#
MS<-=>_?45OSV^P"L<\MSWVTL)1<G=-?SWC?0@&#%&C<MHNJ:<P4HA >1KMTN
M&H]Y/OV/2/Q?\?-%:T989"J2V-<LX>#AN_^0?OQFY%N$$-DC%Y4GO3E3!2Y&
M-U-ZB8#7O)>'\@O @(J"F@HT:PSCZT061/K9C#N)K2P_P\)H8-YJBBD&?LQ"
M>="MHW7"5N3&A2Y9M#;"S68S1J\",:N"7.J'A^YT3\[#ZM;70*""I4F*UE<3
M0IXL_N5+QD6G<Z"@[3\;2,\&7VLPJ*&QJBHZ.;J2W#/^?%[>15X_GIHK#)WK
MTE+CR[EH]2059V->_$['N>5O3\T%ZB]Y!)I*$Y&1LM@W"?HXJ"L=T;JO/0SB
M I7=(KC<0:D6'6:IFJ'$)P9\C&]JVG8N6$-M9#]DN('BG.CDRZS9],M-@H,&
MJ^N63%8>00DW6;XGJN6$/&[-?P MGZG2*7TEV^WZ?2-@D?G&[H*K3MHZBV Y
M&,GCQ&,VT9RXS@6=-N*05PD80R:VAH_AF*HE91T[A!L'C ;84GL,H"</+0 ;
MM/JTI(SM\S4R)Z@HH8%P$8 ?;^7 )A-N6EE[%/F$3R7WGD-"G0B11&$QHM"F
MSJRD\ F<EN/SWVXY6V@SI7-?-9B266M:JNWU/!Y9CH-D;,*138(X(4G[))P1
MA" I[29OX'Z7@BW!F"U.1W-OAQ"_/.W<UWL<7TXRZSRUVU@/O/0\) >)81_^
M'+VP3^V(9R*G8<A4:B+D*@H]B)%5D96K55G((4\0O+_N<*^J;RA0V_9&#XMD
M%W+7G&C^#8$KRH$MK#]GA1Z'/P &H/?%/BB1_UH+W3RU0D!W2.$)+=U*\CJJ
M9:[Z3U[;;"W)S4+1\"YL]@GD# LAD/!O<D_3/EN-5X#6-ZV?W-AMMB89YZ!9
MCZ&&6#)%:1685Z'.D)]3=!28[3:.AC37)2EPS]?=ZB,A5\<%_1ET/"1=*J\Q
M)-4:.J#"=$$1UX%/-@"W8'!#($OBI 57# .3W2YS;UO(&V$VD"H6-ZA$_*R]
MHUB^I0%%,=.&D;\7Z2M/FB4%6)&[[E6>?3&S<IPAN)S6.T;\T47Q^E'MO7 T
M$A'-W8VZ3*?FJ.(S9-(T;R]1N>)G(K:FY*<%1<%)  4I4)(9?<?LYMAJ[X\Z
MXN7*J"98HZP'V[]W$>#179R_T])+>'O$U_LDX B0O0!A>!)[O]KDW35^*4%D
M1YWQ.<,3<FS##?(3*:P)SQ8 QS\6=NZSV,VR:UV5SP7B,?-SU_-CIL*6S++R
MC+ZSN%O-X[1+[W5._,YHC&5D<+2%Z8$)6LDG-TR#'?+6ETZ4SF$_W#VY1,62
MBO-X6EM*PZ58:T>=5@:&(B8N5'&A+D3I<H<@%XJ=FE7)H%;=ZH;$*9#EER:2
MW:$;%QT4\1L'#<FD/MLN0O/R)5_?4",-J*7V@QNSM/93MTSHG]*_SA#UG_2]
M$7UX)KEDYMB51_B>F-KFHYI7'R80L^%4:4[)') RS5 86K70?P9YJ%!24+Q&
M,Q"5A23\CXR N#Z_U*T=P;8.=S#,(WX/WU^>R/]44>X0+-CB!9]&10E$(=HB
M7\*6LIS6:!1_R%:8P]' T)#  Q6?6^5WU/!Y3J$*Y/U)+-R;6#%* L?KX&CX
M7S(LT\N>*<JEC:3'?=T:G$C_U#S9L@"CL,925?XS"VG]=0HNTXM7$3%C(T4G
M7'_)65-K,L2.H;6$YE:0/S:5T5FW:TSZINFS0AQ]S()I8\\I0=E8%DK[;Q[7
M6WTYXC$F$9T,S_@YO?'8U?L60H4X5_82]G6\/168%;P?/81(/2/9[C#$T"QI
MIR1/YT9Q.-P&<$"(<5<D?+V2XG&VAV/O-DM(;S#2OW]N+ZC FJEF%'G$M4KO
M7(NI.,H=%*B]CZ2-I6NSND#HS*U8R*IM:..A.<W-/8XAH>)&RJJU_SJ92FP%
M-Z*S>XI=LP?YW#84\3H[4=E&BS'<)%,KC<!N[XFM^&>>A]^7!]($\EG]X_[[
MU3X".''N-8F5D6B1%J]NKNFHR:FT/N E3DI@-$N[!0#Q)&',8XNKJL_JU7O;
M[_+&F6AP:;LQU/A"ZZU8-[3#;)C-;XSO"2 ^LQ14)>MXC=4ELP8N1Y<^<6+L
M>%O\MOB9MV>Z1VRR03WIWLG \YM65K>P,G30'9O*\]R=KMG L#B@RJ<G"RF]
M_-NS0PQ+4)Z:\Q:'5OK28H.,@2=L-Z5LA!Y! O(D$Z4L,U0(T8WMD9*72!<]
M@[60.8%-B\2GDS5^%1@-./!20#0+I*J^?&?6G7<NAYH'WV+ 2(;(V.X#< ,\
MYF?"ESN)P E,%Y#[ #Q;\UZC![)'O7!\#2HHWI9*("VSF]N5POLL<!J)H4=-
M=4F\X2,BH2!\>-*[E7I_S&E<NQXVY5.)'\*ZN:H+O2H(W/!=MN[(PE/HKZ?9
MZ&*8$15OK8!^8>FV#1\KNJPBH1#5@]6NM]R9:MU9K_3 HO_'W=<PV %C+O)Q
M5=JQ9( :\9S]G5&]5%)L%!6B+]0GP@\(PX@U)3E8]KH>A36&EH*+:]Z2, A=
MGO1O-<-R\$A0 H.XG'.V[B5E:08J-NI2E1H8GY#5*48<0.-U\=-?6_?W69L?
M!>)E8FS9_+;%B7BV/.FF-Y%@I)M./P#;<)H796/BT5L_@PZ)BZG0HAK7P!"9
M[@JHJHKLB67D52ZST15FZ/^83S=CKKXSBT-JQ-#6RH\#\NPN](BRI*$O"#H,
MCJS%(D+D@&C!T:OCR243A@>ANYH2-JOIK4F=KS*G'/7Q2*O@*FOJ[$O-AE1O
M0FX,$TK)>E%<[1]/W)L21JD_2$>*M?V@\/>ZK(V02_[IW?<JK)>B,/%BZ!ZK
M^7 Z*#D&<DE)EAM-L$?K"UL:/_X796\95%>W; V3X!#<'3;N@> 6-NZ^<7=W
MMR1(@(U[<'=W=]=LG(V[NTL2WN><Y[[OE>_6N??[TU6K:M7Z,>>8H[O7'-T-
MT]V0R(GX!@/K.(4(B*9YZ&BT07)E9-0XK?[&S8$8ERS9GF@.X+:_87*8$VV2
M[^FMR%V1OOI*XS9YX;X9@JS0-3@3XR8\4$]($-#C]!09:KXC%F8,]1W%M^%T
M+LG;-T"<E\>DK/A0$_2]HW'E(JK>NB/(%R-/8.[BEP!2]WN, ]7/4E9_N;!W
MB+<,.06?_@IVO@8_)RG/I/WEX7J!O\;ICR;_('S;HOQC@7-G^046N+5A-ON!
MC7J:P+,<LS23N\.4IH6T5"K'?MS+2].E.*Z6>JG!D<J1<;D,FCNWUW2-T>=*
M\G.C(>%=#*\31X:/Y,'3^_OJ'39_R+A=[\(BSVPC-!U1&ZDTG[N509SW=;0:
M*OC%2@>57/?HF8"ZR&$B)5#G O2*H!SY\4IV@GHY-BT8278#Z=V%1&E^$-FD
MP[)/N\I AG[XR?"D-X/9:@K?OHH9>G>WR<P;C'6B6?)'X\3@ZVXJ(\,0I3<8
M*TQ:TH =<PMN+[,XC3WLDK[<?:*KZH3328,^807&01]Q"V.D(5)31"*'?DPU
M!SP]5>C@Q[XOPG [L>02CN:E]=M:KN%Z+HD?.27+MQ^S(BG>8/:9J(-M!^DK
M],W]_EQO4ZTNJFK&ZZGT?5]%OX%*$O/-[*^RVJ)6$<MZK6BSJVBV81,NKO"A
M=)2KC50EH60W1-:7?VM>$?0A>P2BSN7A@4GJ5FT%@S/-;6'YCPO8A/CAC."/
M= 0,OZD:-&+^]L('8';MJJ6D$=&B8B:Y3)#V /FN4<2]8@?>*>L<J>TNN3\\
M>5!H ='V*"R%9Q5#-(\=2>_ED(82N9PG?3X09N'ECQQ,L(LU$)/Z:1@I)+.M
M(\[67-E8E!D:/2,5#L7L1DP]&ZE\)M(4AXOZ=-(YN9MJAW=#(3,1L.1YOFD!
MA74Q_/\-%-%_YYNEPRRDTGU/6/P<DHA4'<$DO>9.#SJN'E.+#^)E'C>I0J?9
MUKI"SCV=S6S4X=4H]N%ZV @]>1. \(49"\_IA=%DD2!>'D'B!5?]6VK?!%3F
MWF;GQ4&+IAANUOF0U>'@Q=!9NN\A.R$VUJ^:FG5[FGY=U"2,B3>32HVL037C
M!K8;6@D'WO+!'_L-)K\GZW-;58*\-' =D#2H!BV'QD!U!:I2H^:;=TK#=8P<
M#KE:/C75T1;\CS=KD!C?)B,V5"9.K#&4H-W2[/*@\%SB'[,:@E:7 :4@"8;[
M!_UQEYJ@1_3VP.Q^OBL:OFQ62^&('LKX,%(G%SB)^Z3Y#^*:&W;4DQ$'/+-"
ME3QLL +<1F1<?$6N\M94(YXEU.J)*A %EM";)K0<+VB"&>^\;>R[E).\J( U
MCV^&00Z97"%A)X*ZJZSCI,0V<([/3]$SW/RDRG]TCBRL*Z [*JD50'5OY;Z$
M'._=:<D>_FBO3T'V=,,=J(8OPR3U.?4U-JH@C7.+Z9"(%33*BW1T.SPU?1H[
MTQA>&A7!0IT/W8QCGS!\0[_:)]='EE<LB"7;0AU#0KK:4>QHT#GF*V;GTS0F
M6/0#B6,#.3@5@WR4C&W2?^R4O%8PS)[A!D:N'HDL^!<,@0/U6H7TH_&FLQEZ
M%S#3X#7;ZYYR(F'H@"066,(:4(*F0+1&(JK_#A'>2)_3)'X3Y?1"A. H)O,#
MHW[^E8;]/XAA:V+F14DG44F>JDK@2NG8RX)4,?5%HH?J[[!_Z:))^1212/ED
M#S/MJMBLC3)>_V@]H-5"4*L[D+/31./^C#ME*9&!_0GO'K;!X3$W2Q$<3\3;
M84OXPEXZDFRL-4>II3;Q337NQE^@(X5%J G*H]ZW03D ]72535-[S5G/#&CD
M66B2$"E4.48ZF/K* HX?W.9U]D!V]L=FA?)'20Q+D_%^>?WFL-S<'[./%2VE
MVTR_B3HT\^=Q">*JY!LAP-KX6JHEX<)1+9N,L,PJ]'/Z6N/W(8DE&LV\]OS5
MJ.SWS(].GJLG>*+2< -5>A?B/[9D&[-BAD;L\^N25Z4BW%>S58K&NMS3B_N0
MZ3OA%N8MI-94$$-UV1HT["PA7)%I 'RS+.&=&'^)/=+ME0ZM-5?^-9$#IYA,
MGZK.OQ+"B&2G=I)SC1"BPHI3@794GZH@B04/N!]ZOE]L8<M9AT)>#J"<C>J%
MW9\(2[UE4MM1%UG,6[N#*)2"8+S"[ZR(I%%D@55.EFD)OQ-K([%:+LDL<=S,
M]I3[H+R,6'3<^L@KJAH!!G"H,R:4RKATOY#Z&K25@FM!+99^%5&.:)-7+M=M
M3AZ^NM^P67Z_XNT+3P!/.EU#.AN"RWFZ:9Z)HUA)-(M)]GN8U0ID!>@#/]E%
M233#M:=:+&;E?EM.QVB]^X9H_F<?Y\[SRP/""KK_?X,*TA84:CGS>4MB>BS,
ML>)O]3024%Y5B3NZ(-SP*0%% )C"M=1VY;*]1 [,]OI+OF5=\AQB.K A(U0%
MU=]O6=07C]!5F&)=[>SD=R%U(6VPCA\,^-ZQ$4Y3@T+DQ4 FP5#1/9;;0W[S
ML\_MQ&6<F9POKZ%BH#*K81A:[_ \8D '#/X9+I-PFT &WLT%5_))+!YE5P>O
M%0S%X@F8U:]2SRY3\C# L#8*H_' , 2A-2/7Y@, =/^\2<<T^E=#2=!@@7 _
MK",KPUS7"69[$-<@DD"@8B@6SHXBH@"2U(0C-E;,243+FE&D^Y/G$Q?9MSH'
M/"Q9+X,%F:2(0-8Q/T^).VO!OYO&,RS]GEV0EP[N?&\Q#Q7PC4LN$=#P77@G
M'SB56N<%]>,B1CXNC7U_/I9*P-FZ[&ILQC[&;*PQO/]!GMWGU2TX^MI=&\>\
MAP3.HU'"WXRI,4NI](+)#VZ,K$#+%;E\4GA:PHW09S7*E-J[_3I)B2TBBO-;
MRAQAY[G-C:OFV7:0_7'[>S(#,MK<Y-.*B[H2X_;?H22/:F\P8Z\5?,G,":[H
M:O=)Z.F.7J;Z>2G>CX$RX+OIE%><ADH@+K9AN:V(OGI<[I)X[7?2;9%0L%O7
MKKQ:C[^)EH^?2@I[%6F&LB90''2,IR:AQ8N+"ILR=C7$DJ @X)T6_&-?=B=)
M@[5?P? 1END9GII]M$2U,,@JU6Q8@LZ?3]!XXZ+ 6J:XE-C:(5FC&$1'#G:S
MRVPP5?^XR#*B=LM\(?>[C5.L>,,40"^_5#T01P$KUXYDO!8:09!G&5)<8=I.
MM[KHL%9).U 5;Q(R:WS#R[%-\9NPLDU]-BOFSIK. %-&C0Q]SX1/TP'H0!BT
M#Y"7$Q+TX<)*<V<P-OAR?6H4./'E-]HK%]:[.51!&F\-&<<-VT'S^TE'DXY1
M<,B#REH=\J<]AR/2$).:(6CNRN<K'V>B6\E4GE>%I]36Z ;[(EA.6FI%@U7/
M6;@!4WV4[DMS8"41:/7!XX6+0O5:D32:= 89,\TZ'HV':PVG-E[%DSVVC@OK
M[N]>.(\'HEX[9VO04"-.=?=S:F1+3(/OL4E?M;<9,[2TJWU):NQCON'O,3]B
MX7(]6].<?S?DK=L1KT>(KW:-E,>OW;UN0WLUZ'_V\UG2LU6,_L:#RI*?A]DM
M6!JYGHZ<LIJDZ7WXM3S7BS%9VH 9S/$<7SJ NO>!W[ !N^U0P]-TT(D#DP"M
M!J<M*62-EY9&M'G#CUQ!NMO2H_9ZUHAK-8T]J,8N;B[Q)YE'8Q])S.J%=@VV
MUT$E/Z0,BSD I!';=L2,#5P\OTFI8BHUV7<N,T]EF-5JBA4,,5W6$51Z%W?-
M6-@,C<U*;X7+(P5M<Z'7GUR\!,/ZW_!$SURU2T>+:9?4/3NM97YW".2@YQ@S
M"1\F.+ *!?15X-?_N.5QJ%>AC^L*Z-A4!P9S N<][TFORS@&FAZ"!.YR;*AE
M[;[%H2N*J,,*;'  ?+]YKS$$?99(-8' ][L>=V]MF*\E?V .@JVF$L.=NL%U
MKXN(2W?>QGJ#.?'KV5F!?B$L34<6N<?^A-$<ET+C^S*<$S7HC;Y FCM\.8^R
MR"&CX"AY>^%+HQ2W'IYCRU5R<D0MAXA/6A(Y&)4P<HZT)W0W4D4*_J$D8//>
M(BS,CCJPK"OQM7/Y7+WT@7I<N!VC"&.K?YOB_0VOM&>\5D9]LDWS^T\<)#06
M5;.XOK>^^=3"'8^J^LZ\Y^J;[A#'_ZO@L8O]R3'7%6DBG83[HJ"3.:QAQSS.
M;>%F>\RV*-(XJ<KS3%,G+VL=_9/PR-8%3V.!9-V=D =BT.1E3#XZ^&//L^Y8
MR4([X\-N]77 9PHV6C3(!$>AK9RHB()K'M:<*LC'2!1^60 52$_*C'MU6+%P
M#+HY/UO=]B-9YCZ-=U6<:$D>/1,)0.8D^9&$]E,"0<JX^G36/,L4D.NS4AB6
MD)43\#Z+I2"61RD,)?>2[PV&DB3MO$&Q%VWH1WV1*NF@1OR6>EZC&HB\B48T
M"[[%LI_: A1![OO#G9_OS\<](>?6G9$H=?):JO$:(\; $;MDZJ7\)\\L4/R*
M:)9HL2EQVJW(C\OG>V_MHJSU%#Z5UN-+BA\MR)&,L94L<?1-":)9-*7[<I',
M9:UAUJ_HD6*4O0GNU<'D C2P'X?9&]];?34WBU1>AE_I9:'3IE"8-[YAF,]?
MJ?%!+C:H/#[3@A"X(Y?,-&^7-<?KV[34Z$79-R!P6W>K./<Y'YV:M9^;RX:7
M9BEI\-.YIMI]#:VW!@R_8V0CR9H,<;T/*'3+H#(>Y0=H ?=M&'50.=Y!21Y#
MMMS/3SRL&2=Q]K B6C*U<N0T0JG2.'\92UF2RRYJ+'*0,/](SJ 'CE0Y'*%0
MR$YUN%/8=BN'$TQ\07&_D-#7^L:WFU'>TK9[C45L@0:_<=Q(/J0!!6EM;P(3
M!?ZIYT!FAJ$.O_H^J@>X9PRGM"_MLBT&,\\TO[*;'G&M'NAT5^ON25,D[+6/
M/DTS9)8PV;&T^7V;3R[TLK.\"EH5F0RM3]\-V@O^+@5X.!!LJ[46DBRA)[M@
M6"/TWHL:!]$@/H$CGC0<C9^SD2JAR:&';,P-:@Q65?TX=%+2N[^D?C/HI?31
MW2[/FJS?^:&J[KJVVK2FF?16L*F^P7P<_S9HAIX.&2<8 1LD=,T@,PS*R$3T
MN)P>,2/.X_/G_@P3)Z$/T^']M9-?$2GJO0@;[@T&,$\3. W#??$W3VAV%0R5
MQIHEK]$AD41*?@_1-]Z5-%+Q=#M(U&<F7R@W,8NGY'4\34&_G:^^1N"N5!P;
M91F7\.I:^P9:GP,6G$',N3-=32<(9RQ;1HE&FG<TD>#]34A7R8@P*PW1^G\2
MJ1G\(!'902J9$89OP<*#7K\6TCJSV(U7M9:_<A*9?+*O\"RE&4:TF!VAP3U!
MP<H>HR^2!K(@T/4S?R,"/#$PO/"3H^Q>%\?0VT<_+<\:. 8%RG342*0Y-5C2
MKD25>5H+Z#]6A?:GR=MJU=E+*;08U#U,AG<?[1Q%K2H$%(W1+M[1C:X]$%4?
MG^$<0=W)*T8 _:X]1#4[0EPQ$D6.7:DDH0 :R3<8;EO0P- /1.SLBFX52;?E
M:EFU\Q/5<T7$M0JY\F5&NJ$66P\JSS<8'4$\=ZQ_Z#L^I&/3T&ZZ/Z4ZO,&D
M[D)<<YFO'-HONH0S:H8[?+6 4"R<F=S#?Q (',&_J GY]YJ,OY6"Q+]5F2S+
M8,,:O9*QNK/S5"WZ3T]IJ.R*<&J3"2Q6&X!YI3?LU$9:LIZ/1*0''[M_\%*Q
MO%@]7:(.9GD^#N[H[,X8<X!X>=.+Y69: 0\G660,(2'XX57*M20A\S;'W\DF
MQO0BX<KW]CY8)>@51NU8N9&;PHPF#CEVBG.KSE^9CI<Q,?N]A_\IO*37,1ZT
M,YX]1YT^%>3Z!ZC%6<;AJ)W+++"E\"4,Q@13>CP-+42,?5=P00-THDJ#'#[Z
MZGJU6Y.ACC+^*8"4@V=#46W!N<ME5=81]%G ";58<6UT-<HCM:WBE4>0#VQ+
M+C\6O<0[T.8]-Q#8@99H%3O1-F1/!PO=4,UI'LH CA$.,E0--NIC#)8_1O6Z
MA'@D2K['$I-$XQVY6+-,EEFQ%5"ND8>5-*$"C<FOU>3F)%.54,Z.>O?<G:]D
M/SO5IEM3-=?X\;1F.HJ.(;%$8F5:VH[+;!RNEC3F:D45=@<2Y;_!W*+).M;A
MS) A-@"7XXM,39GJK_@6?DB[YY@,6_*?"0EZ,NM;Q!749W]&Q;O.5\((_7V'
M%5;6=M,KD>'04?\0(;0:C4OU!L-!X&2#,WR;-/CEW3H>N.;.$^*@]208+'[P
MA1NM^=T.T@@>F6;(87/JP]!N+C^+49H)5@^0'V9'0K'EPIU"52%5G16[-"'1
MN#RW/+<#S+93=,I0T]?C&$3WMW:,7&AZM)*<["?U<D1GG]DLOCC6>LQ\2<$]
MAH;U*6,:VH<RQM9& R89PYAUA,Q]2DT$TJ\G8H0QK9FLV!8A[-;.^P7/E#1C
MO\[.6JM;]YG+YJN2"D]!+N^T:LP@XLI6_'IQW)Q<:<MKT*8$'U3"8#ID"Z&"
ME!:Z,6FFG50]< )A?[H+MM3,%YQ9E*"@4ML\=8Z&-$N,IOC=&JN*\,:^&WE/
M;M76N5]-?I@\M":NI%>,VIVE'YN-0? T?#<>Y^L7Q"CNUG>3D@6.Q;@OOQS;
M=_PRG2)6)ZK]V'=_#94<S_P:2,P,Q))+#)[@)@#2,C6NRF7DUWCF$U(=MIK
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M<[ ]K:G__D$F!#OI5_P3Y_!"*@FD-D#B,<P&LJ+FCH7-KUKN;JJ42UGE/NX
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M9Z.-/^5_@_'KHL(V;3P.MHU^*9>N/?I(+A2)R4^ S;F5S"3!#\)INTKO$K@
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MAOJR26BL! [Y^$JK[KU=3MYK7'.8CPGAW6BIQL>;$#3:\:V=:%%)R7+(<(M
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M='U0%*BEIF430_LU=@*Y=C1[L;.,9>&*&JQ;VHO::'.TK+_\L0Y+FA>WG#'
MEHO5#24^GQ]P%?=[5T@R2JE]Z2T^E$*FC)B.E-QK$5Q0/"38MVS?#RP8C\8W
MUO'V<N'457H,GFUX[;<IA>T\)WW?#3+.W-G@6U&P12A.!^R<2X<JA6P^2GAJ
M3Y!D@(E8J?."1$D1T=CLDSJ=F"%ZI:L=Z7"P@>$^0,F/Z'4HW34=JB ">?P#
M<^A.0LQ_<)T9:)7>^=J^4VE]TL:MMH<]$Q&Y)?<B,U 1?5W%S& 4:-!TN70\
MZ8FQJ(/5G#MEVA<O7'JY'7.R4'+>"9'5?6,>+C[M33$Q_6+6UEN%TT>!U.T
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M>9Y/L">TVIZORUGE%5$6@(.VF1@Y0AD?W!;BNT$9ROCU5U_1:EM!%]M[A/I
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M\'5+5UKU<+O*?;^=85(%JN7+>%>\=CQ9:^8'94_W*EMW'6>Y;-9TOQ8T(-/
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MSLG*:47_>XYW-*K";VYWX-*/J-,$!V0>@ED:H=7R JWZC_F$'F>4Z)$1+!/
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MM@Q1UZEZ9'A?J'1(#7'XFIO85;%8?J88;Q/ +I-4\$)BUH66Z+BR$ZV]E!3
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MVHJP7YPZ)'*I@P0TLR96?AXD40H_@^FXJZ/ F,A!O4@>YG-R<U="F5^(-O3
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MI1S/ZWZ_/[$8EV[-J)H_BID-#124?Y29IM0TYC+*<U>-?*BUZ-L]JI$FUX8
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M,\\ ?2X+*]:N4G9;???*@,,9(X$^\\P-DS(V 7$]4^(G/3<,H>-7(FN66U&
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M 4(C4B+V$_L2BL_4X/2VW\/*^FQ$[55^JM^81CH!#L84*:B3M^,^$L!L-7F
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M.[5J>5:CDF_37#[AFG[@%BN<O4+Q<;D]\ JUN/ 7;\2R6FA:V[<$Y52FS:=
M7 K$)L\(]:]#':8K)67B4,WF#=N6^IV=L^O/D+8=0=H5]JJ>V_/D5OC#!B7)
MS.01_AGE?C#R#[/OZZRJ) TKCALT)X+((T.QPH'AC44ED.U*+TQGNA:ICK('
MIPQ9,[>Y=86Y_6AS><H'TFF4?JL'J8[]/".PZ&EB?0MC0E3W?&<8IR\I)*%U
M20RG*_:B1@C@PSN*5:TT,YV=,=VN33<-PYE:E[\62^H8:$!)ZF,>W$)K<^YR
M2-B:78?= YMM9MQ\0.(S(78B.U LTM1^ZA&PO'!!02/0#E8@4E.A^LVI*O9
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M!G!J@<8G+'W^S$Z"-!-B. /Y1P(2&PSBW;"OWR)6J@?+IBR(FM'Z96"XHLH
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M&Z5/0H23^<^:-02&^_+M2;D>'R[+%E+7)WWVP1!WX^8R9=D)BWHHC<L_<IL
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MK4ZB&'H?T<Q.NE[X_@L@\N>+3S7S)PP;+M?;2Y5'P#56 0G^9LF5UMI2.##
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ME-"X3HSUF9>S6(<W?;6):S<)WDMED&Y>DIZNF<C<+9]\&U6']F_%.>6S1](
M%ZQ ?DXZ;> ?'KMF=#I5QU%/5Y>G!0953*@.CQZ29-Q4"SOKDT#E933M<UI6
M!>!3^_V%-@@A*S4+=_I4I;U%30:V&:&.CQF]1+W+%'8.*7';EUD+!#48PO8Q
M W4G!!K"K33#\&L*.+/;.,<>!#MH?$0[8_C*A;SB7@+Q+L.P;M5 +(A7Q-&5
M FZGQ'Q/=,5 H=%#\XS5"=BVD_7".&N)$:8GS6HP9$%GEQQN7(N/<36CY #[
M5+ORK$1S,E-!F.BX36"0-.!^U'N]:FV3&I9!C2%=?E7SA@'X#!7R&8VR(N$J
M5^VV*L_KT&C0C2\M;5$JA9G5&E%T55.SM0#)XU1/J&(J C' [,/VU%5:4K#C
M.;8Q[L!OE"[$U^AKB(',QBO* >L1W/=( $UM,QWHY4Y&8Z-Q\F%124NS5B;_
M[B:3M1MKO2%A&7)!:TM.BYUD3^#8KURC]-!\J^Y@M!NT\C8ZE=.QR=((G]WF
MW*V,(WEQ6(F^K2$5<?#S7T#]_T. ?QF[Y1**MA (=UT7E D +ZO&ZFE$.P-G
M49['8V;O/87+.&_31@__>!770HIC?0>3V;U9.\Y \8D7/SU9&]@,<FW>Z76<
M[/OQVXXU,;W%A[U?')$-+\MIU^AM'[+*(FITZ=W[\K"\GBH$.QJ5#<VX6YEY
M,#YYE;M=7#12!K_9XW<][A334NACJJ_&V[<F%SYOT]JR!Q;'N6LPFM"YF.X&
M0!*;I-9/4J8\EK)_>#/TB0EV=I,CH]4+5?DGT _(W+0UU=YI/Z<ZK1[ZDWCR
MUGCW=!\%-B/W#<)_+25/5NR1CKTL1=&F-1MP0^STP 5>?"&A:9FC_EN(34&4
MN\\6IO<@C;,D(P<^YELB/=+\5K#E(L-XP7Q"5E N;O]+800[H1MOTP$0K[A6
M8=UTYRGK<S/O JP[:P:K;FRR'MCRQZI"7:ZS?&C(X/MY3H*'A0*ZC76.A4VS
MG_UIY9[YRO7;G:[RIAQG/,TPIZF@9=:+%IK1-+I\8>CXLO"##%;V F]8F>\R
MR@<7].78,"0N/>\T+GRV$"BMT95&/4B): ;13+.[49A4$T^34*.,?VP&V\N7
M])FS^Q9L0>G:$"#R]V2=H.F.6+-)PZO51R]O#6\NJ-=%(]+PSH^>'$P\B>N[
MT2-!F6,K683ABFJ],%'#OWC?$>0S(O?5A[VG\BQ-N>_5[^T^Q:E%M.IMR3$H
MY9!/0B6_)-=B4I%0**/?]*MZP##5;[9736CA;4N!?%V,^>.0:<:%ANHK-PE4
M=R?X9!B.@A[+#@JU+4DM '6,![=)V$FDP<M+B\TPH94PGW";67]=(DE2Z[A3
M'S)YEU>F-M[<RP6U\0*^9DH0IA$!>Q +OV.H-VW_^0F@$0UD1+58>ZEVK$H[
M*]H$QM)L@E?*IYQK5R-?SCYU&K?^Z:$9YW?U.H2]'F<7:'<-YX@HZ!-S.K&+
M5(!NF;LQP Z=N/?;/;7N!7^?TJWQS<A .])694/&"R)[ .9+BM?S1Q75T-WV
M=WY&'B/)AU"@A="O<M,*X8DIY*W \Z[&QD<V)AZF3KP'KS+\=-@U"=*E,0,P
M6[9W;4@A]W[)O:)&ZXKZI[Z^://*B0I-<6.PWXY,5&\VMY7R6 .F&:!@MH:S
MCE81EP5Y\*L$>()JN/6Y!%I 6S8STC7RQE\2Q##MA_8L#,T,LH[QT#6950/D
MTH3SS*PY=#];'1WL;3*<]">'T'R)6S!$PV&:JVE#5G3%LR0:^@@HNFCC+X#<
M_5G(%9NEQ(2W@=C_OG2:>1@4V?Y\,*3E!U'1R&#"S11+T?I:]_3Z(GMO]1:@
M3^5W_.]4Q)VXM$T9D$P[&X\0@7<>Y9#"+C98Q<E,'?'_S/FKK&61)+N R$RY
MD.>F 8[%&3K3#,AXG-G\4Y^&*GY^ 3%Z>M0;LC4D4IL'<*0#Z8< U,K>_0RN
MY=05$L TY!'ZO^1*_3,I0MBPH*JL#"#@3<Z)U;3Q^X*G)B2=J>9FX)B6LL>[
MK8,+%VI2)B)[R-YO[__K],']*;@W'*!$Q2EX/O(N4H&H/=CD^:S00J>PQY[I
M8#UVZL5P>3>RQ;>@SR8@7NQI1K+HDEO.H(6V(C.5M=&+GZH);@P53\*L]]NW
M!3XF2%C!'J/WOXS7?(0ZBY;H1)57A :=D$'HR581P:MRU8:0B0W8S]U4FC+=
MOH<R&UE096CXN8ZNNB-U+,#DWVTWWF=@01'A(_!GL%:05*R-7&]!R;8O+M3D
M7OG]TLD"%1WR R*@F@[D]2B(-YCZ'O&3+@\8PZ7'')S\W#WBK6W4(5EBW48J
M1F3QB+BXG=A$ '[%F7!B2ZZ*5,'!)"E:.(>@@@F*[[@#3B3]W3^_75NX1;.W
M7,(Z(_+V1'AG-H'VAO??#Y4&[ \1)+L 4H4]=ZT?!"Y#O2ABEB/\;])?8C1\
ML: *WBRD?9:O,.CB B2:U[*8&(K$#R!"% XDXT,>^R^"8SV^"K$]K_<W<1UN
ML_"UK7S_-,VHXMG')$G_.:STO3T!FWAO.CI=5]5D%9X8@C[QUJ9A]7I/>4GZ
M-ERTWTC9=$[E:/50:)=6:,J:+8.$SG" +_;(^&Z#JY%/>56$<]=VM$GX>Y6U
MV0V\TTB]TN?*"4Q;29NDU&J9>)U*WN7=_YBX(D#*%IJ.YJ#@,<;!#_TQ8#LW
M97\,ZS!-RB1@0O('>#!,0>0^C+XBP(RRJ)CR?9P3Q%HG1.X-?2$&8DB3R@/0
MO53ZIBBA3?(7;U+)G& '.]M5L/IR[M<J_QPE%CY09,;I&:\_O<0"4>AG,[$D
M/8[X*%RIFIIG\P^PW0/635:E<ZDL[?&=S6:S"UX@L1F*FS+.<S&GZ\YV>EZ6
MHWDW;[X&8&%Q:EXP6?^<I60KQ9;5CH]&6YC_TP2,=#/546'9FT?J*?CV[6T)
M3@^)7U/'*B;6TB9=8X>! (GOBL)3DF7)7Q6-?"DL3&];H4_U9IM3F\]3]U^Z
MJ$#47X]L;?7$R5";9#OU?P@\N!=)-F3<?\>=#!I*)=?)'DJ<"TK-JBNMD;U;
M$R6&6%RWV$L8AK=_\JB9@YL=V!8O0-Z%VM >8<VG=_LY8"B+6@')6(+T[$.I
MV!+U]GT:AIPF:Z'.%"Y9 4"Q6Q+5DT&M>'QZTD1QUGQ\6DM/-+&X9 "0QBZD
M3R:#Q8F/5]*<G03/#Z>2B-C?T^@M)^[1B'[8$B]WOZ) .7:^%15R#ZA(3&O"
M-C\"X(^E^V84VH8_F?^*(+5L]"W[EHC%=KW"@YL$BYPG(XCWP;[+Y7CFU:I6
MR^3;+2=$4V>FTX-;NDYU"N+#[T>^X2)*_^RS KD+E_Y$@VWEV$YJKC\9E85X
M^&AYN3TD8-+SS6DCE_LDS$R51B$WQZXP0!#[Y^M9+;5)]2L5W/6''SA%@\8[
M$H+MK@&\2[FY"W;JK+]X[ 33!\\FO)7<?WO3&EJ9[[,390GBE=Q?CU!W)>(W
M!DZML5 1#"#6D[<&ZE.#CI%<'P,>X2X3:'^J7 ,C7WW&%OKVR1P>0,CRQH1T
M!W4VG<G).W.(J+C=X>;?A/J;TEYUPJ(G>;1\DW,_L#U/\$4>9HV00PN3QM4]
MTDO*S]/WE.X1?6JT[D\%D-IZ/!5:HLVIW_SB*?NIJWPICOWJ\:RVN$43M[&R
M1WN:"NK!T."J0 #MK_+E]3")37->B?F5'X;T\XR_(<&5F":>0[ $8>-3(9]'
M4NZJ@WS5B+D_%S$\V42V&HZ&R8T+%^(-55\3F9;3W-]&L]JNM'JDO+-.0YO*
MA2G_Q2N1M)=5+P$.Y*DC]C@JK(#X&QMY799N?)=IQHLL'ISOY/D$.W?NU7(:
MT6-,C(J@B\[DS"8*VYMBW[!+$%+X[LU^:#W!UD.@8&*=H@R9*U=#O\-:H1=P
ML-Q'H7Q4/.NH-;KNA@,?S;4E$&\]T)CV=1:GS@5^S.MN-<5:U<CIOA?,OSB=
M!&];'ZK22="BI'H-4**E>8^+>/=G>UCH475M&++U],78UHE^WXAN7+*5?: V
M(B:1")Q2V/,7KXEO7H8*=Y/K?D-%,O8J&; ?\&%7YH'D'QF2_YG$G&56?R)?
MGS_;0(3^OX=1&?^L>:OWNM7B7B#/:+RKO&KS3$NRR:CCLI!85M84&=O3[EFG
M>E/0@T_$<B:K7P"(AQ_-SL>:$OS=0T;63+^5>1)I5%A)+1^P&.]7!H15#*/F
M4:\&G63%RJBE,\58+NLH0L73B:S?IG(=9$G-:GV0N901:QE9CK>.2H!(BDLB
M]+[LU6&V4S,WKSQ>[_O@S-K5AR3E<Q>B8*9A>;8RE8$+4:#C!6_XXZ5$]<//
M(,&:<Z$H]$(R!+GM^&,$$',[T BPI@F6A9XGN-EA9](:#95MN(Q]<V;@Y.B[
M9ZQF8AH.> QBZ$E4DX%^L@L^>YQP2QFO5*?&8W')'79(3K)OT*A"(T3]C<M8
M\IE,^A=\64[>5>XJH)>&Y1<3KV&ALHKT6#J?,G%#AR3C9)<S4 5AL/?][DN)
MJ1%*HAT*B;81SX;UD<O.\#;QDJG$J.3DE4*0(F@C@V#ZN1$SA"":2A42\IJ!
MK]3WSG3:%(.IMW7*^44$>L3/3F*13-#1Y>OT*->DZ.=KSY?FF+JQ.35=,I.D
M#AQQ>G>ZM2_M+454Y7?7(>73IS.(XS2I\-JJH<*I\\%[UP]I\><F50A7>?XO
M$4>]=[.F%"FC4T>00[2-W7BT'H3/69GT ,:.KU-ZV6(H?-:,"RV/%PF_)[A.
M=88D:6BH)(DU[5[NE#95G0%R9OW6!@#E23*_*JSJ0-4F=JV]])0Y>L>XMS"-
M\DE,H>&)/90PP$ZOCMY*/7)LEM@RYY1VEU[4:]3!K6437FS6/Q;2O23]4W)L
M))O#B7*1QF:._^CY5NJX+"-RD-=1!E'WV+:DT2LA]]7LHN^;E8UF(F&[L^I8
MMU0/XQ<F+_H#V:YX,RO4W+MXU FK:TW7\]E5UC)]PDY8:H^RQ30*B<=*;,S:
MG^^G"8?G/VW9K*D,L38NQC3HELQENF*-B@V,KI6>!S/82^HZ' W/- ?8B0A,
MPZ+EE!M?#,'I"K1%%R&;(N=>(%Y@^69= 47RRU0.'D'B1=0_"\>L#BMO93VF
M8P+QX<G4'VA>YNMO2(XKM[?4U(P$ZZ$U)-<ZWN>%$IB6$KG(G.%^SY%W&)]1
MQ"OA&J/34WLEB4&(_7V,=#9E-8 TAQ<8X9H!C3OCD8*-]GDGUW&7=%ML"1@0
M5/S%\Y>_-_:]LE;?@5HJVYI[6-6HFS'SOL'+)DEC]@F,"^[\$],_>31&L=BC
MI4?7C!%_NFD2(X T*4]];XXLS@@F7?D?@&\\;NT1E+3$.D9&UX)U1NM4]CN9
M.!M*L2G*PE)K7?V'A(6D ) V!QX ,??I_';LB7U@X(^E&SCE058 ,9LF$0?(
M7\.FE6)3[$[EBLUG,'UPQ$),K?5^.GZP$V+N*/TD+.@X #_OHKH-F7"H7YG:
MTDQ/KAA(9!DK;IH^M3:Q74N: A-6MW05!+YLY!/-PS<-FOPP(_7*_>3 SZ/R
M\?=LC'%K 51J'6/\CM61O\G=\XF/7MY?O,<9BS_6'PJ!>)U-1>C07B^O&]K%
MX<+RM'WESP+"SN8J5KPF3,R32+_"VQUF^MH>Z624GB$O%2\J(;3$G<QX)XV+
M7JP2K/HH(U33>)<;5#BW)]1=U+;IF&(VO2*7&^Q&KIK84MU@Q%C[(>(CHK$P
MZ*2RM)W#;+D)"_6X.2P$SWYHA29;*$T\7_5=R+= $3ZLD=AVREC6'GT3O95!
M4"CF)+E]65-P#BE5ZIX3A?J#&G A9*-MC7A?A/I1LP)#(,(<$G)N.Y2 5@?1
M\HN%Q:#FCP)TPKN>1V/U.@WPG_"$9W)KD&T+IQ6;OAXSS6;5H+Q&$OH&N11:
M@ S5"923*F.(7_CLC:VNDR67CJKLD)&=EJHC"DC.$@W K0H8_ILK8 $(^X?8
MF(PB3)DQCR&M-L$W$@0N6)0%JDJ/+"DIP8"-'])?."&N2MG,K5X;$>;R(I'!
M3EF&^'3H_^#MAL1VZ*39>Y*$=Q8\^1:K.VNXD,-$(J *JRF*X0U29?1B!ZU]
M144PY^SX QK@PU<#:<GO022D1^UDO/@VNBGV@YJ8X#\>:^6W *=D<6@8 &&N
MZBFVI,:0!E\.$L&4SF>1@O4X[SS'_44TN)3UDF/D*J\UR5H^:V%1(]+96B 0
MQCMO 8D2)1J9?6E&+U$6\93A7BWC'_^8\CK0;J%%VHO>*G 9"?Q[A$7-Q>UE
M"VGP\=OKGJ.8S]3(;1>I!I<>''ZEZ'4%RJ]+"D-5;5U1RW,,G*/485PYL!H'
M@U-=C][0T-45;:OZJK8KZ4(_\Z9-T+[&I<'!H,#D+:#R$7WK.\$R^\SS_)'N
M%5OO,YN]D0,Q;$@Y[^G:+,[]+UXHB);U^&>KQY0=[+5^FL\"] 2B8?9R&'49
M)-Q1M[7C5+C]U,?<'8=R'IY82<LH$&&O"NG/"4<V=M!15+U+MXD5LW6PK&%W
M$DE3=^?):R#/>($3N9])U*ME3Y@YK&LHP<O+1=UB4Q$P AB@,?;>.9D^E/RU
MP,%,9IZ1F&6G9A23H;,MP^NGT-^5JO>IUW^J[B]>\3SD)4>)/8]BGR$BO:F$
M3$,G ?_Z"8@@SJF,D_[WNRW,4%E/\6?$W=.[R1VE'0FZK.2@K0L_:,+TJS,A
M'^CT(ACZ+BK]8?[]79S_XG_U9G7RZG)#!P8=D]R4H7G^>^8J#_TQBGS?<#[N
M?EOFFL?3%;3"[O#;)B(=[8]!5++P; 'WO7&P/4IK*; WB%O>*"^GAUMKB]^?
MO?Z>ZGSQ=>NNYL('>>>:TK8D:R_:S:COJ,4]D1PK:<[,DAZZM.:M\2Y37X@"
M23' ,@U<MZ59)CT+MI[SV.>9.#XX0JL*L6V/J)..N,,/+TJ9',U^,B"L+-VE
M6V,5SE?Q\4M4-Q?WHWKW QZE"<T<F3%:?Q$N_'@)G-G +)0>H7I-DDVV!9,;
MBC334_/4%(@93O@/!K_9;FL(>T!88?0+O+F#DGST49XS P<40&F#;R6]8R-.
M+-O0_O3'!=4<,E3:'010X[XBUO"M(D-^$Q2R!N)*)?+=%;V]Q?40"%'=03W
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M]D-O6FK$$_V1FU.>F>N[7A&,Z;[C@SAAHSWNBZ$0H=UE"U3CI173*YG=*?>
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M/ZM2\Y\-%@!QHV'*=\%%%LMO2X],RQEQO4?T?HN'FKCI$7&5B=)\,-83EE#
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M,[<R$G*2.6TW)(?1)6D&\<57!&:6IJ=(\@EKRV!* J%6I7.YJGY,D^59J8A
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M_3\PKBJ+!0/A;_HDFC6DP><I"AV=*^K]VO=<!@#\;EE!W4[=3AQ/P'.=<OB
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MWOOG_KCG[)EDS5KOO#.[/OO9PQIA30.BUJ>M3@-L;&Q .'P K!G@@$6XGS<
MV-H"Z@  \,)KX@ '?,4&'_\1UCA@#K"SL?T[_TLXN#C^"3<G)P<7#S</S[\?
M+Y\ 'R\O/R\/#[\0/[^ ("P\?,(B0H+"_Z[_/>3?]G^[X%.0EX=7\+\MK,^
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MER),-&9>YZ]!O3HKZ-HJK]0?>>HGS\R>K$P7+9LP0P2<1Z<TH!B*,U3L7&N
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MQLR!LN[R*7_AY8ED#>'U!-NO+;S E^,+'#WFWJ272#EH$+NOGS3='7"LU?U
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M$H.U?@3=RK?YH^*E32-^4[(+>BG>5O4M#$\]B1R]8,NLAJTLQ_-$25>.5K"
MI N.QI2*FPL$R:&Z=/O0:]E.HGU?^Y1O'?GZI67?&JJ*D#:)[,?*,1 TNT^5
ME@(+IHB^E=5-WGFSOD>^5R-4'$IC/TJ^-_&(0<4V#O]U9,C)TAXY@3@87FX/
M, Q]0L+U< KAP>>K!BL\E5L.Q2)K6Y0(9U^<,O,<Z+[&L$3E3_BO9H'[,!D$
ME ]&$>I%[]7T=G$SGUXE,S'G^WW"&5\&+C4<'G7FWGM=UJ=35I9_D&T+R=C;
M!W<%-C!N5KK-7A3['<?), ]Y#AJV.-0_F1,1_5.@JI$E.HF4<&I1%^WRD_ V
M.A*GEW9@790;W8D:6=PRH<&M^"?=S!<GB)5;Z+A"LVMP>V%YWQSCQW\HPJ?X
M\HYGRI[K5?,YDN:ZZGC=IL9'YS\5S<[Z:6NK!2M7?VDK/JVF\K#82BW'/A(.
MTDC/%@1^^ ?UM%=5L\@X2-M4:%B_2^S5Y*1JH4^$<OVL16X7PC?5+*9A_S$S
M-=_O\-#W$B\'AZ"[!QX#!%$^]%6)!;RH"<^<O;2?0?7$1+AWL\!K[&#5,T^%
MDNY4SO['URZ?F>5D :(FCG-#K3I7[)4=3O=URN^Y$]*R7^$$SS/);7@D(W?#
M,Z>H$0M(H+T.9 $.DQDLX$L(=34ERB("G@G%_LK5OSCF=D.NI+L@[((DOW?^
M:>WE&$#6PP[@* (@/&FZ'YXLAI-Q-WM&[5O1 HR(-Q/^[H=!E$J#TU_#H(@"
MZ5V]O\U<V2F::R?@U[MN9LSLO=].<M78@9M(G,K<8^@'0EK6D/DD2C36-7IB
MZE;2K6@00R&56 ,0DC3=@*A*)-"%8#7MF@Z%H\]5Y0];#=?Y,2[,_+$.R%RU
M_51DY>%+(U_$&4A @X+''#L-' ?\B($_7+J4)9IGS\QGI#;>%#9G-^)4/"')
MA'L/V1$W?9\D"#NQ L\Y0YW*D+*5;MU%%B(3&9>\V#^MI&C,!>4I\U5,"31)
M[3/H/6')O\CX!8WCJ/YPY(WH"C?D$GY6YLV0$*#IX!>:?]'EF@#?*Y+S>O7;
M#I8'C'CR[ ^S\PJV<,9$:]&UX+?]P4F82D8=&-!#I"#X:M$I15L%[/ D@AE?
M7'UAC]US]7@KVJ=0[D)6X<!5M2>Q38=@9*C'D4--D3BRJ[Z6H2U-[PHFWE1Q
MP9![U9;Z*O,[!<+*6GP;K QSM7O=QB&:_,;E^@VWKJBX-U&HH0VTM +WWYZN
M(4E&#4]1QGKD+4["(CH VTZB!OQ>MJ#[VOJ%O 3]6YKDJ!/DD[N4*L+8CIB2
MI]9/E\::')ZC:RQ #@!]6B81@R;79@44-&QJ&@;K;!UFC]G8V#@5^:W\RHY5
M#GS^LW TF<U,.8<+.XP=ACF'/3T+5.)AR-N\]3-5OA< :6%[(:V^FXT.?09S
MKUYB0S;D0C>.>J5J6!D^SM.Q/\@5<P']$D^UQ(&&TC/V#/$5%YS,HK0HPP[\
M]&X/36@SI\W_F;CPSX'E3HQ6<L"K,$\E('3'>BGI&VEZ8154Z^GH 0_^OF<J
M!MI,KR9I;4X@6K9W$PD5:1DW*.U';CO(!#0Y/PF3O/QAWH?=?-$,T66VB'XC
MAUCR+/-'4_WJ7\QUR;N4IP1 AW'-Z#N2NO7?CZ*J#7>7G?<6!Z=7;1*.LX!D
M9YB@[&<!>E,6,([7G&4!<YM,)1SY,.G:0Y(/"E1F 2WH>Y!)OV:(5I/X7<2>
M/X;N;FV-U5,[N>@K1B<=SK2X=HGMR_-RC3WQ5&3V[29A"@,:(B%^%%U^%&K;
MM6S.RBQ"-V?Q,4Y2HR=&XB[3O!-\ S;I1J_NQM^?[!0[E:.K=,HSKT4T.T]3
M0#V"P-C3 0EN@1G4X?9=?#(+\&;:V-.(L;>>5"I15ZIP"IF$%QRY\V_7JEN"
M93J^+O6]%Y3,2RV47Y?N0%!M5S-0PB;.S*2*<-VER%=FHCC_D<[!Z:A.(_>F
M#39Z!(RTDG -QI,\D:/^, %(@H08[* E[=?B-FG<<&O,MC+WE=_/T.2YQ-"J
MW.6SHQY7COQ\+9#D<09=O"$"&NO.$-/TQQ60UG#21C,.P;EB/:-U<VD9H^7]
M_F/AB+JEG':.\\3#!'XVY?L X0$+\.H!#=*VJIAER.6B'C*$H%+2CJDR71QI
M"G!F>>BT'XM0>3AC=UM"C6CBN()CB U 0A6@)PR0+<-O&7=G;6VQ!Z/<$C5/
ME+N.\NHMLST4FO(@>G1T_R7Y!C=6AKX]47B&9\Z'H2! 2W+XP*QHE*1V0*)X
M$89&%14=?U/?S;-94='7Q:9V>),W?CB8;W^BRI.V]S7$=>LU+:PK1RJC@R=L
M>&=X8Q%N$,HX<E.3)FQ7)MAC W928W];89+E#+(5L\I![.9<C6WDY"&%F6*-
MN 27Y-:WZ2K[W?72N2_(.*, $QA".?O!4>IX1VF+W' LMJWR;:Q2 +/JFEJW
ME<QD[H._O'!:]A*7..@H&!]T2=>1(X1F[-$&"L0>_ARWY*1=AQ8/KUSINCRX
MHOV53T7 W^!WXOE]7DX>*=?EV:?KK1C_,&(<1S;7)$V73!&'DZ/N/G6Q]YR.
M5NT7$0*M*;ZGD,(% 8TO]B""N_.M?HTR3$,GAS9XEN#4YGZ-[2?59=9YALPF
M1QVCUI!KWMW-\&8!YXE#MTP:8\X:U%=79>_>K[82?U*JV>CS@EF-FA[$C4DT
M(VKQ*;7XN&(Q%A"?-?,I_;[YBQM%Q)3:$8P^EQ1MI_I+0N\SW8B';B\X$%<
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M,C R-#$R,S$N>'-D4$L! A0#%     @ M&6M6DF@<)=* P  "!4  !4
M         ( !>@,  &-L<F\M,C R-#$R,S%?9&5F+GAM;%!+ 0(4 Q0    (
M +1EK5JVWF.B.!(  $[F   5              "  ?<&  !C;')O+3(P,C0Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    " "T9:U:#8W#<2P-   !I@  %0
M        @ %B&0  8VQR;RTR,#(T,3(S,5]P<F4N>&UL4$L! A0#%     @
MM&6M6NCL;'*P$P$ JKT+ !(              ( !P28  &<P.#0X,#5?9&5F
M,31A+FAT;5!+ 0(4 Q0    ( +1EK5KI*(OWN@D  +4)   *
M  "  :$Z 0!I;6<P,#$N:G!G4$L! A0#%     @ M&6M6BT!+Y9V"P$ 2R8!
M  H              ( !@T0! &EM9S P,BYJ<&=02P$"% ,4    " "T9:U:
M:+^(Y'7\  "T%0$ "@              @ $A4 ( :6UG,# S+FIP9U!+ 0(4
M Q0    ( +1EK5K-[7+#'R(  $@C   *              "  ;Y, P!I;6<P
M,#0N:G!G4$L! A0#%     @ M&6M6M6:W1[5!0  > 8   H
M ( !!6\# &EM9S P-2YJ<&=02P$"% ,4    " "T9:U:-3&A'FX&   9!P
M"@              @ $"=0, :6UG,# V+FIP9U!+ 0(4 Q0    ( +1EK5HQ
M1@I:\04  )4&   *              "  9A[ P!I;6<P,#<N:G!G4$L%!@
0   ,  P T (  +&! P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>g084805_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clro-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-05-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <context id="From2022-05-252022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
        </entity>
        <period>
            <startDate>2022-05-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000840715</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000004">0000840715</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011">CLEARONE INC</dei:EntityRegistrantName>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="xdx2ixbrl0028"
      unitRef="USD">-8983000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="xdx2ixbrl0034"
      unitRef="USD">-560000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="xdx2ixbrl0040"
      unitRef="USD">-20556000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="xdx2ixbrl0046"
      unitRef="USD">-7694000</us-gaap:NetIncomeLoss>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      id="xdx2ixbrl0078"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      id="xdx2ixbrl0079"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      id="xdx2ixbrl0087"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      id="xdx2ixbrl0088"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      id="xdx2ixbrl0089"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      id="xdx2ixbrl0090"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0097"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0098"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0099"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0101"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0102"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0103"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      id="xdx2ixbrl0104"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      id="xdx2ixbrl0106"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      id="xdx2ixbrl0107"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0113"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0117"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      id="xdx2ixbrl0120"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0123"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0125"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0126"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      id="xdx2ixbrl0128"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000013">&lt;p id="xdx_841_eecd--AwardTmgMnpiDiscTextBlock_zHfIXq293Jp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Equity
Grant Practices&lt;/i&gt;. The Compensation Committee recognizes the importance of equity ownership in the alignment of shareholder
and management interests. The exercise price of each stock option awarded to our executive officers under our incentive compensation
programs is equal to the closing price of our common stock on the date of grant, which is the date when the Compensation Committee
acts to approve equity awards for senior executives. Performance-based equity awards are also granted to our named executive officers
at this time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Compensation Committee establishes the criteria, and directs the implementation, of all compensation program elements for the
executive officers. The Compensation Committee considers the Chief Executive Officer&#x2019;s appraisal of other executive officers&#x2019;
general performance and looks especially to performance against predetermined goals before making its recommendation to the Board
of Directors. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_909_eecd--AwardTmgMethodTextBlock_c20240101__20241231_zJtJubIV0rEh" title="Award Timing Method"&gt;The Chief Executive Officer recommends for the Compensation Committee&#x2019;s approval the stock option &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--AwardTmgPredtrmndFlag_dbT_c20240101__20241231_zFbkr6XPFoPa" title="Award Timing Predetermined"&gt;grants&lt;/span&gt; and
compensation related to achievement of non-quantitative goals under non-equity-based incentive plans for other executive officers&lt;/span&gt;.
The Compensation Committee did not employ any compensation consultants during the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;

</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000015">The Chief Executive Officer recommends for the Compensation Committee&#x2019;s approval the stock option &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--AwardTmgPredtrmndFlag_dbT_c20240101__20241231_zFbkr6XPFoPa" title="Award Timing Predetermined"&gt;grants&lt;/span&gt; and
compensation related to achievement of non-quantitative goals under non-equity-based incentive plans for other executive officers</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="From2024-01-01to2024-12-31" id="Fact000017">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2024-01-01to2024-12-31" id="Fact000019">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000021">&lt;p id="xdx_80D_eecd--PvpTableTextBlock_dU_zCdGZOumUPA8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PAY
VERSUS PERFORMANCE&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_988_eecd--Additional402vDisclosureTextBlock_c20240101__20241231_z5vbjxqxEUcg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to Section 953(a) of the Dodd-Frank Act and Item 402(v) of SEC Regulation S-K, we are providing the following information about
the relationship between executive &#x201c;compensation actually paid&#x201d; (or &#x201c;CAP&#x201d;), as defined by SEC rules, to
the Company&#x2019;s principal executive officer (&#x201c;PEO&#x201d;) and non-PEO named executive officer (the &#x201c;Non-PEO NEOs&#x201d;)
and certain aspects of the financial performance of the Company. The Compensation Committee does not utilize CAP as the basis
for making compensation decisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth certain information regarding &lt;b&gt;pay &lt;span style="color: #252525"&gt;versus performance&lt;/span&gt;&lt;/b&gt; as
of December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_zKvkjphnUBCe" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
    &lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary
    &lt;/b&gt;&lt;br/&gt;
    &lt;b&gt;Compensation &lt;/b&gt;&lt;br/&gt;
    &lt;b&gt;Table Total &lt;/b&gt;&lt;br/&gt;
    &lt;b&gt;for PEO ($) &lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
    &lt;/b&gt;&lt;br/&gt;
    &lt;b&gt;Actually Paid &lt;/b&gt;&lt;br/&gt;
    &lt;b&gt;to PEO ($) &lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary
    Compensation &lt;br/&gt;
Table Total &lt;br/&gt;
for Non-PEO NEO &lt;br/&gt;
($) &lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
    &lt;br/&gt;
Actually Paid &lt;br/&gt;
to Non-PEO &lt;br/&gt;
NEO ($) &lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ClearOne&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shareholder&lt;/b&gt;&lt;br/&gt;
        &lt;b&gt;Return ($) &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net
&lt;/b&gt;&lt;/span&gt;&lt;br/&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income (Loss) &lt;/b&gt;&lt;/span&gt;&lt;br/&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($000) &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEpKDIp_zKZkMbQt60Vf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,053
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_fKDEpKDMp_zrAJkg0U8RCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;301,654
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEpKDIp_zaUFirdKEGL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;313,016
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDEpKDMp_zRToSV5od2zd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;346,567
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--TotalShareholderRtnAmt_c20240101__20241231_fKDEpKDQp_zC0vievn2Urc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;96
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLoss_dxL_c20240101__20241231_fKDEpKDUp_zk0Umzwpha67" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right" title="::XDX::-8983000"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0028"&gt;(8,983&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEpKDIp_z7dZGVZfxyX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,047
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDEpKDMp_zefMaHFoZlWj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,476
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEpKDIp_zS0qesyw9Wh6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;364,940
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDEpKDMp_zH6KK4rf15p3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;324,129
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--TotalShareholderRtnAmt_c20230101__20231231_fKDEpKDQp_zCdLGP4yhkok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;90
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--NetIncomeLoss_dxL_c20230101__20231231_fKDEpKDUp_ztJ0gyOHgeQ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="::XDX::-560000"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0034"&gt;(560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEpKDIp_z5chmf2WeW47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;557,277
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDEpKDMp_zk9KQNqddKW5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;532,457
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEpKDIp_zGUJQibgNuSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;230,000
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDEpKDMp_zoJpt6h6OjSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222,409
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--TotalShareholderRtnAmt_c20220101__20221231_fKDEpKDQp_zRpuB6tx2Kg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--NetIncomeLoss_dxL_c20220101__20221231_fKDEpKDUp_zYtnSTDvfPCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="::XDX::-20556000"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0040"&gt;20,556&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEpKDIp_zJrYtK1zF6ge" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;418,750
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_fKDEpKDMp_zOnO9sOKd7ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;378,848
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEpKDIp_zdGI7hg4Rjsk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;251,625
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_fKDEpKDMp_zfELDaCihS59" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;227,684
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--TotalShareholderRtnAmt_c20210101__20211231_fKDEpKDQp_zBIxb2JNU3Rb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLoss_dxL_c20210101__20211231_fKDEpKDUp_zGTbYnMA4MBe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="::XDX::-7694000"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0046"&gt;(7,694&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; width: 0.3in; visibility: hidden"&gt;&lt;span id="xdx_F06_zz3oS2A8Jhpg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;(1)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"&gt;&lt;span id="xdx_F1B_zejlcHmtQpPg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;Zeynep
    Hakimoglu served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. Derek L. Graham
    served as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO
    NEO for 2021, 2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting
    April 17, 2024. &#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"&gt;&lt;span id="xdx_F07_zaAaXyETk6Bc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;(2)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"&gt;&lt;span id="xdx_F15_zNjgxfPMlYag" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#x201c;SCT&#x201d;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"&gt;&lt;span id="xdx_F04_zoHHm6RBVyW6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;(3)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"&gt;&lt;span id="xdx_F11_zfUjOVmZwz4h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"&gt;&lt;span id="xdx_F06_zEsHeG9JWfxa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;(4)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"&gt;&lt;span id="xdx_F11_zu3zMLy0CcNi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;Total
    Shareholder Return (&#x201c;TSR&#x201d;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden"&gt;&lt;span id="xdx_F0D_zN7vWGotiKVf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;(5)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; visibility: hidden"&gt;&lt;span id="xdx_F1E_zYSQZBxFL9D4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_846_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIHNkDeAmKH6" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"&gt;(1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90B_eecd--PeoName_c20210101__20211231_zc8nXPLn9QD1"&gt;&lt;span id="xdx_90B_eecd--PeoName_c20220101__20220524_zW16YPtlQJk8"&gt;Zeynep Hakimoglu&lt;/span&gt;&lt;/span&gt; served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. &lt;span id="xdx_900_eecd--PeoName_c20240101__20241231_zDhwQLISGaU5"&gt;&lt;span id="xdx_90D_eecd--PeoName_c20230101__20231231_ztC3eFAM8tTh"&gt;&lt;span id="xdx_90E_eecd--PeoName_c20220525__20221231_zX92O3nknRK6"&gt;Derek L. Graham&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; served
as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO NEO for 2021,
2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting April 17, 2024.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_856_z3BMs82CEOYd" style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#x201c;SCT&#x201d;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;















































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Shareholder Return (&#x201c;TSR&#x201d;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</ecd:PvpTableTextBlock>
    <ecd:Additional402vDisclosureTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000022">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to Section 953(a) of the Dodd-Frank Act and Item 402(v) of SEC Regulation S-K, we are providing the following information about
the relationship between executive &#x201c;compensation actually paid&#x201d; (or &#x201c;CAP&#x201d;), as defined by SEC rules, to
the Company&#x2019;s principal executive officer (&#x201c;PEO&#x201d;) and non-PEO named executive officer (the &#x201c;Non-PEO NEOs&#x201d;)
and certain aspects of the financial performance of the Company. The Compensation Committee does not utilize CAP as the basis
for making compensation decisions.&lt;/span&gt;</ecd:Additional402vDisclosureTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000023"
      unitRef="USD">283053</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000024"
      unitRef="USD">301654</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000025"
      unitRef="USD">313016</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000026"
      unitRef="USD">346567</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000027"
      unitRef="USD">96</ecd:TotalShareholderRtnAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">366047</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000030"
      unitRef="USD">366476</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">364940</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000032"
      unitRef="USD">324129</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000033"
      unitRef="USD">90</ecd:TotalShareholderRtnAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000035"
      unitRef="USD">557277</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000036"
      unitRef="USD">532457</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000037"
      unitRef="USD">230000</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000038"
      unitRef="USD">222409</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000039"
      unitRef="USD">67</ecd:TotalShareholderRtnAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000041"
      unitRef="USD">418750</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000042"
      unitRef="USD">378848</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000043"
      unitRef="USD">251625</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">227684</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000045"
      unitRef="USD">57</ecd:TotalShareholderRtnAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000053">&lt;p id="xdx_846_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIHNkDeAmKH6" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"&gt;(1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_90B_eecd--PeoName_c20210101__20211231_zc8nXPLn9QD1"&gt;&lt;span id="xdx_90B_eecd--PeoName_c20220101__20220524_zW16YPtlQJk8"&gt;Zeynep Hakimoglu&lt;/span&gt;&lt;/span&gt; served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. &lt;span id="xdx_900_eecd--PeoName_c20240101__20241231_zDhwQLISGaU5"&gt;&lt;span id="xdx_90D_eecd--PeoName_c20230101__20231231_ztC3eFAM8tTh"&gt;&lt;span id="xdx_90E_eecd--PeoName_c20220525__20221231_zX92O3nknRK6"&gt;Derek L. Graham&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; served
as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO NEO for 2021,
2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting April 17, 2024.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2021-01-012021-12-31" id="Fact000054">Zeynep Hakimoglu</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-05-24" id="Fact000055">Zeynep Hakimoglu</ecd:PeoName>
    <ecd:PeoName contextRef="From2024-01-01to2024-12-31" id="Fact000056">Derek L. Graham</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-01-012023-12-31" id="Fact000057">Derek L. Graham</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-05-252022-12-31" id="Fact000058">Derek L. Graham</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000062">&lt;p id="xdx_840_eecd--AdjToPeoCompFnTextBlock_dU_zktbON4pGhN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zw5UFPqMe3Dg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_303_zjvMQTE3PX8c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Summary Compensation Table
    Total&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEp_ztIEVFc6FXAg" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEp_zFPmHf2vIwqj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;313,016&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zs2jyxiUvAid" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEp_znd71MrwH95c" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;364,940&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zCqWFJsTt7R9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;557,277&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEp_zkQD2Vnx0Co9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;230,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zVTwDOePmla1" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;418,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEp_zhYv502HjhBj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;251,625&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(-) Grant Date Fair Value of Option Awards Granted
    in Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_znKNoIZXEsub" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(24,336&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zVc01fFMYQPc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(40,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zq34aOVQdG94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,900&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zGd3guyWU8Gl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zIANvmwVty55" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0077"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zAIi2qc9MMa1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0078"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_ztwx085tLj71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0079"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zvvIvGUGwn7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0080"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Fair Value at Fiscal Year End of Outstanding
    and Unvested Option Awards Granted in Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zZxr8Fsx34qd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znqZFeJo54Ih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHmKunO23AH5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,637&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znuQY7veDSDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,697&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zy7s2t0gBNna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0085"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zBKbaang0jij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0086"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zqrafkcuAcH3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0087"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zIDYUORb0Pjg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0088"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Change in Fair Value of Outstanding and
    Unvested Option Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zwoVAV218org" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0089"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z2EIQc5WZRug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0090"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zIgiQtYUlTme" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,309&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zqfSUrmqcYpj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12,926&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zvdjqdD8nBZk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(22,059&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zkX0zoAL3LNf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z4V364rvF1ye" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(43,666&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zNnR0wAjszf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Fair Value at Vesting of Option Awards Granted
    in Fiscal Year that Vested During Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_znrA0X8DAk48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0097"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zlx3MMLgiKu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0098"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zdrOO2zhcnU8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0099"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zV6tkOMW46Of" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0100"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zDI6thyn3B15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0101"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zgcSl3baLeD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0102"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zYcJbkfnMQih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0103"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_z2QDDjF2SUPh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0104"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Change in Fair Value as of Vesting Date
    of Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zysPhLGdjCRf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zrcLuTUJm3a8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0106"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zm6kMphRlx5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0107"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zFzkm9XlUjjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,588&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zAcF1aiDI3O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,761&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_z0GLaxEzulb5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,991&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zDu1oRGQ3MLc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,764&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zGohn6Bl0isf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,259&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(-) Fair Value as of Prior Fiscal Year End of
    Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zotxkpBz5QL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0113"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zleyzy3NohWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0114"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zj6ZlravDgui" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0115"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zLfrp7KWOThk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0116"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zeUVwtb205Rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0117"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ztozsQZraVr1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0118"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zJOtatw5hSt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0119"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ziwbjX4D5jX5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0120"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Value of Dividends or other Earnings Paid
    on Stock or Option Awards Not Otherwise Reflected in Fair Value or Total Compensation for the Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zJi6E5UgPrMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0121"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMNENFfHkyia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0122"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zOT8D8xZCAG" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0123"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zc00AY3wS4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0124"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zwY27UfvKNL6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0125"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zbL6TbuFEaa4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zvLNBkFrSD77" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0127"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zP7UBF0gL6X3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0128"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zhs5glIOxzo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;301,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_ztgmL40trfU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;346,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zBOPWg0YxqNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,476&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zVKATGF2znuh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;324,129&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_zgGURNbWeN4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;532,457&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zA1NR0PhJkL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222,409&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_z4I0ZThw5uDi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;378,848&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_zZRQn6mBJ7b3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;227,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F0F_zO3McgkuRBwj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zk49F7torW5c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A0_zHdolzGOK756" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000064">&lt;p id="xdx_895_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zw5UFPqMe3Dg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_303_zjvMQTE3PX8c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO
    &lt;br/&gt;
NEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Summary Compensation Table
    Total&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEp_ztIEVFc6FXAg" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDEp_zFPmHf2vIwqj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;313,016&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zs2jyxiUvAid" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDEp_znd71MrwH95c" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;364,940&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zCqWFJsTt7R9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;557,277&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDEp_zkQD2Vnx0Co9" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;230,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--PeoTotalCompAmt_c20210101__20211231_fKDEp_zVTwDOePmla1" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;418,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20210101__20211231_fKDEp_zhYv502HjhBj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;251,625&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(-) Grant Date Fair Value of Option Awards Granted
    in Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_znKNoIZXEsub" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(24,336&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zVc01fFMYQPc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(40,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zq34aOVQdG94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,900&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zGd3guyWU8Gl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zIANvmwVty55" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0077"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zAIi2qc9MMa1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0078"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_ztwx085tLj71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0079"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zvvIvGUGwn7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0080"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Fair Value at Fiscal Year End of Outstanding
    and Unvested Option Awards Granted in Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zZxr8Fsx34qd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znqZFeJo54Ih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHmKunO23AH5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,637&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_znuQY7veDSDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,697&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zy7s2t0gBNna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0085"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zBKbaang0jij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0086"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zqrafkcuAcH3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0087"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zIDYUORb0Pjg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0088"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Change in Fair Value of Outstanding and
    Unvested Option Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zwoVAV218org" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0089"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z2EIQc5WZRug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0090"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zIgiQtYUlTme" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,309&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zqfSUrmqcYpj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12,926&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zvdjqdD8nBZk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(22,059&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zkX0zoAL3LNf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_z4V364rvF1ye" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(43,666&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zNnR0wAjszf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Fair Value at Vesting of Option Awards Granted
    in Fiscal Year that Vested During Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_znrA0X8DAk48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0097"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zlx3MMLgiKu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0098"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zdrOO2zhcnU8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0099"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zV6tkOMW46Of" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0100"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zDI6thyn3B15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0101"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zgcSl3baLeD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0102"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zYcJbkfnMQih" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0103"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_z2QDDjF2SUPh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0104"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Change in Fair Value as of Vesting Date
    of Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zysPhLGdjCRf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zrcLuTUJm3a8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0106"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zm6kMphRlx5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0107"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zFzkm9XlUjjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,588&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zAcF1aiDI3O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,761&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_z0GLaxEzulb5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,991&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zDu1oRGQ3MLc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,764&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zGohn6Bl0isf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,259&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(-) Fair Value as of Prior Fiscal Year End of
    Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zotxkpBz5QL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0113"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zleyzy3NohWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0114"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zj6ZlravDgui" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0115"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zLfrp7KWOThk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0116"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zeUVwtb205Rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0117"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ztozsQZraVr1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0118"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zJOtatw5hSt2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0119"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ziwbjX4D5jX5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0120"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(+) Value of Dividends or other Earnings Paid
    on Stock or Option Awards Not Otherwise Reflected in Fair Value or Total Compensation for the Fiscal Year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zJi6E5UgPrMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0121"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMNENFfHkyia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0122"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zOT8D8xZCAG" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0123"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zc00AY3wS4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0124"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zwY27UfvKNL6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0125"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zbL6TbuFEaa4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zvLNBkFrSD77" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0127"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20210101__20211231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zP7UBF0gL6X3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0128"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zhs5glIOxzo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;301,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_ztgmL40trfU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;346,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zBOPWg0YxqNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,476&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zVKATGF2znuh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;324,129&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_zgGURNbWeN4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;532,457&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zA1NR0PhJkL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222,409&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20210101__20211231_z4I0ZThw5uDi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;378,848&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20210101__20211231_zZRQn6mBJ7b3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;227,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F0F_zO3McgkuRBwj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zk49F7torW5c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">283053</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">313016</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">366047</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">364940</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">557277</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000070"
      unitRef="USD">230000</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">418750</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000072"
      unitRef="USD">251625</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">-24336</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">-40560</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000075"
      unitRef="USD">-21900</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000076"
      unitRef="USD">-14600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000081"
      unitRef="USD">44466</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000082"
      unitRef="USD">74111</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000083"
      unitRef="USD">26637</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000084"
      unitRef="USD">-8697</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000091"
      unitRef="USD">-4309</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">-12926</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">-22059</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">-4600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">-43666</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">-26200</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000105"
      unitRef="USD">-1529</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">-4588</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">-2761</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">-2991</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">3764</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-01-012021-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">2259</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000129"
      unitRef="USD">301654</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000130"
      unitRef="USD">346567</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000131"
      unitRef="USD">366476</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000132"
      unitRef="USD">324129</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">532457</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">222409</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000135"
      unitRef="USD">378848</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000136"
      unitRef="USD">227684</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000139">&lt;p id="xdx_84C_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKG2IF5OZYmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Relationship
Between CAP and Total Shareholder Return (&#x201c;TSR&#x201d;)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
graph below reflects the relationship between the PEO and Non-PEO NEO CAP and our TSR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;img alt="" src="img002.jpg"/&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000141">&lt;p id="xdx_84E_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zDtRPUQV0v12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Relationship
Between CAP and Net Income (Loss)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
graph below reflects the relationship between the PEO and Non-PEO NEO CAP and Net Income (Loss) &lt;b&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/b&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;img alt="" src="img003.jpg"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
the amount of net income (loss) reported in the Company&#x2019;s audited financial statements for the applicable year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000047" xlink:label="Footnote000047" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Zeynep
    Hakimoglu served as PEO in and in 2022 till May 24, 2022, when her employment with ClearOne was terminated. Derek L. Graham
    served as PEO for the remaining part of 2022 and continued in the role for 2023 and 2024. Narsi Narayanan was our only Non-PEO
    NEO for 2021, 2022, 2023, and 2024 until his resignation effective March 1, 2024. Simon Brewer served as the Non-PEO NEO starting
    April 17, 2024. &#160;</link:footnote>
        <link:footnote id="Footnote000048" xlink:label="Footnote000048" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
    reported in these columns represent (i) the total compensation reported in the Summary Compensation Table (&#x201c;SCT&#x201d;)
    for the applicable years in the case of our PEOs, Zeynep Hakimoglu and Derek Graham, and (ii) total compensation reported
    in the SCT for the applicable years for Narsi Narayana and Simon Brewer, our only Non-PEO NEOs for the applicable years. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnote id="Footnote000049" xlink:label="Footnote000049" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
    reported in these columns represent compensation actually paid; adjustments were made to the amounts reported in the SCT for
    the applicable year. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnote id="Footnote000050" xlink:label="Footnote000050" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Total
    Shareholder Return (&#x201c;TSR&#x201d;) is cumulative for the measurement periods beginning on December 31, 2020 and ending
    on December 31 of each of 2024, 2023, 2022 and 2021, respectively, calculated in accordance with Item 201(e) of Regulation
    S-K. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000050"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0028"
          xlink:label="xdx2ixbrl0028"
          xlink:type="locator"/>
        <link:footnote id="Footnote000051" xlink:label="Footnote000051" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    dollar amounts reported represent the amount of net income (loss) attributable to common stockholders reflected in our
    audited Consolidated Financial Statements included in our 2024, 2023, 2022 and 2021 Annual Reports on Form 10-K, respectively. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0028"
          xlink:to="Footnote000051"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0028"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000050"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0034"
          xlink:label="xdx2ixbrl0034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0034"
          xlink:to="Footnote000051"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0034"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000036"
          xlink:label="Fact000036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000038"
          xlink:label="Fact000038"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000038"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000038"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000039"
          xlink:label="Fact000039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000039"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000039"
          xlink:to="Footnote000050"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0040"
          xlink:label="xdx2ixbrl0040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0040"
          xlink:to="Footnote000051"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0040"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000042"
          xlink:label="Fact000042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000042"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000042"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000043"
          xlink:label="Fact000043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000044"
          xlink:label="Fact000044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000044"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000044"
          xlink:to="Footnote000049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000045"
          xlink:label="Fact000045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000050"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0046"
          xlink:label="xdx2ixbrl0046"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0046"
          xlink:to="Footnote000051"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0046"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000065"
          xlink:label="Fact000065"
          xlink:type="locator"/>
        <link:footnote id="Footnote000137" xlink:label="Footnote000137" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Unvested
equity values are computed in accordance with the methodology used for financial reporting purposes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000066"
          xlink:label="Fact000066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000066"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000067"
          xlink:label="Fact000067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000067"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000068"
          xlink:label="Fact000068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000068"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000069"
          xlink:label="Fact000069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000070"
          xlink:label="Fact000070"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000070"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000071"
          xlink:label="Fact000071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000072"
          xlink:label="Fact000072"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000072"
          xlink:to="Footnote000137"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
